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1ABSTRACT
The literature on epilepsy is vast. The first review 
in this thesis presented a short introduction to the 
nature of the disease and its relationship to cognitive
functioning. The pharmacological treatment of epilepsy by 
three major anticonvulsant drugs (carbamazepine, sodium 
valproate and phenytoin) and the possibility of effects 
of this treatment on cognitive functioning is presented 
in the second review. This review identified certain 
areas of cognitive functioning, for example memory, that 
warrant further investigation. A third review discussed 
those relevant areas of cognitive functioning, including 
both theory and suitable methodologies for investigating 
working memory (Baddeley and Hitch 1974) and attentional 
resources (Normon and Bobrow 1975). The three review 
chapters provided theoretical and practical frameworks to 
carry out investigations of the effects of anticonvulsant 
medication on cognitive functioning.
Four experimental studies are presented. The design 
of the first study was a between-groups comparison, in 
which four groups of subjects with epilepsy (three on 
monotherapy and a polytherapy group) and a control group 
were compared on a battery of memory tests. The only 
significant group difference was the impaired performance 
of the polytherapy group compared to the control group.
The second study was a between-groups comparison of 
the performance of four groups with epilepsy (three on 
monotherapy and one untreated group)) and one control
2group, on c new battery of tests measuring working' memory 
and attentiond resources. The sodium valproate group was 
significantly impaired on two of the working memory tasks 
compared to the control group. No other group differences 
were found and increasing task complexity did not 
significantly affect the drug groups compared to the 
control group.
Of interest in both study one and two was the 
consistent pattern of results across the test batteries, 
which did not produce significant differences between the 
groups. Both studies revealed large variance in the 
clinical subject groups, such that a number of the 
subjects with epilepsy, particularly on sodium valproate 
and pheny^^ were performing very poorly compared to 
control group performance. No obvious reasons were 
identified for the poor performance.
Study three investigated the effects on cognitive 
functioning of a new anticonvulsant drug (Lamotrogine). 
The clinical subject group was very impaired compared to 
c control group), and a small amount of further impairment 
was present after the subjects began taking Lamntrogine.
The fourth study piloted tests designed to measure 
aspects of perceptual and motor functioning. The only 
significant result obtained was that the polytherapy 
group performed significantly worse compared to the 
control and the monotherapy groups on simple reaction
time tasks.
The focus of the discussion chapter was a summary of
the important aspects of the studies in the thesis with
3comparisons made to other studies in the published
literature.
CHAPTER ONE
INTRODUCTION
1.1 Aims of thesis
The primary aim of the thesis was to investigate the 
possibility of effects on cognition of anticonvulsant drugs 
(ACDs) as taken by individuals suffering from epilepsy (the 
clinical population under investigation). The drugs 
investigated included carbamazepine (CBZ), sodium valproate 
(VPA), phenytoin (DPH) and Lamotrogine. The subjects in the 
studies were individuals diagnosed with epilepsy and 
control subjects i.e. individuals not suffering from 
epilepsy. A second aim was to compare the performance of 
subjects with epilepsy to control subjects.
A further aim of the thesis was to develop a suitable 
battery of tests to measure cognitive functioning, based on 
robust theories of cognition.
1.2 Aim of chapter
This chapter will endeavour to describe the format of
the thesis in order that the reader can follow the lay-out
and knows where different types of relevant information can
be found. The chapter will not include literature revi^w^^,
but instead will describe the functions and content of e.ach,
of the chapters contained in the thesis.
51.3 Contents of thesi s
1.31 Chapter two : Epilepsy, the disorder and its
effects on cognitive functioning
Chapter two is one of three literature review
chapters. Relevant information concerning the clinical 
manifestations of epilepsy and the classification of 
seizures is described in this chapter. The relationship 
between epilepsy and cognitive functioning is explored. 
Also included, is a summary of factors, relating to 
epilepsy, that may effect cognitive functioning.
1.32 Chapter three : Anticonvulsant Drugs (ACDs) :
actions, side-effects and cognitive functioning.
The main treatment of epilepsy, i.e. pharmacological 
treatment by the three main-line anticonvulsant drugs is 
described in this second review chapter. The literature 
exploring the possible effects of anticonvulsant 
medications on cognitive functioning is presented. From 
this literature, variables are identified that need to be 
monitored in this area of experimental work.
The literature in this chapter is divided into two 
parts. Firstly, the literature published before 1987 is 
described as this literature is used to inform both the
hypotheses and methodology of the experimental work 
described in the body of the thesis. Literature published 
after the completion of the experimental work is then
6presented, as this is used in the interpretation of results 
and discussion of findings.
1.3 3 Chapter foha t S tikly On e t dyvost 1:5^01-1 ti
cognitive functioning of subjects with enilensv on
anhiconvulsant meaicchtoi
This chapter is one of two chapters presenting a study 
carried out at the Dundee Royal Infirmary. This study was 
designed on the basis of the information presented in 
chapters two and three, taking into account the practical 
constraints, for example, the limited number of subjects
available.
The study was a between-groups design, comparing the 
four clinical groups on different anticonvulsant medication 
(CBZ, VPA, DPH or pnlytherapy) and one control group, on a 
battery of tests measuring, for the most part, memory
function.
The study is presented in the thesis in two separate 
chapters. The introduction, the subjects included in the 
study and the methods employed, including the rationale for 
the test battery, are presented in this chapter.
1.3 3 : Chapter f3 v o : S-biedy One ; Resuvt s
The results from the analysis of the data from study 
one are presented in this chapter. The results include 
descriptive clinical data about subjects as well as the
quantitative analysis of the performance data from the
7battery of tests. The results are summarised at the end of 
the chapter, but discussion is left to chapter eleven.
(Note, the summaries of the tests are described on 
Card One to remind the reader of the test battery when
reading this chapter.)
1.35 Chapter six : Cognitive functioning ; theorv and
application
The theories of cognition and the experimental 
paradigms, that provide a useful framework for the design 
of tests for investigating the relationship between 
anticonvulsant drugs (ACDs) and cognitive functioning, are 
described in this third review chapter.
The concepts of memory and attention and the merits of 
the working memory model (Baddeley and Hitch, 1974) are 
discussed. The model is proposed as a suitable model for 
investigating the relationship between ACDs and cognitive 
functioning. The use of dual-tasks is also suggested, as 
these tasks allow the investigation of the effects of 
changes in task complexity on performance.
1.36 ; Chapter seven ; Studv Two ; Measuring cognitive
functioning using a new battery of tests
A study carried out at the Glasgow Western Infirmary 
is described in this chapter. The the study was designed 
using the information presented in chapters two and three,
and using the theoretical ideas presented in chapter six,
8The study was primarily a between-groups design, in 
which four clinical subject groups (all clinical subjects 
had a diagnosis of epilepsy and were taking either CBZ, 
VPA, DPH or no ACD medication) and one control group 
completed a newly devised test battery. The repeated 
testing of some subjects allowed for two small within-group 
sets of comparisons of firstly, subjects, for whom 
medication had been changed and secondly, subjects who had 
recently suffered a seizure. The performance of subjects 
across test sessions was analysed to identify any practice 
effects on repeated testing.
The introduction, details of subject selection, 
rationale behind the test battery and the methods employed 
in administering the study are described in this chapter.
1.37 ; Chapter eight p srudy hwo : Resv1Ts
The results of the analysis of the data from study two 
are described in this chapter. The qualitative data 
pertaining to clinical characteristics are presented, as 
well as the quantitative analysis. The main findings of the 
study are summarised at the end of the chapter, but no in 
depth discussion is included (see chapter eleven).
(Note, the summaries of the tests are described on 
Card Two to remind the reader of the test battery when 
reading this chapter).
91.38 : Chapter nine: A new drug.; Lamotrogine
A study is presented comparing the performance of 
subjects suffering from epilepsy, before and after they 
commence on Lamotrogine, a new anticonvulsant drug. The 
study is a within-subject design with Lamotrogine being 
taken as an adjunct ACD. The complete study from 
introduction through to the summary of the main findings is 
described in the chapter, with further discussion in 
chapter eleven.
1.39 ; Chapter ten : Further investigations using
response time tasks
This study developed from the information contained in 
chapter three and the findings in study one, i.e as few 
differences were found between the subjects with epilepsy 
and control groups on the memory tasks, it may be possible 
that perceptual and motor aspects of tasks are sensitive to 
ACD medication. A between-groups design is used. Clinical 
and control subjects completed a battery of perceptual and 
motor tasks. The methodology and data analysis are 
described in this chapter.
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1.39a : Chapter eleven : Discussion and Conclusions
The main findings of the four studies are presented in 
this chapter. Various aspects of the studies are discussed 
in greater detail. These aspects include those relating to 
the design of the studies, the role of clinical factors,
the test batteries and analysis of the data.
11
CHAPTER TWO
EPILEPSY, THE DISORDER AND ITS EFFECTS ON COGNITIVE
FUNCTIONING.
2.1 Characteristics and classification
of epileptic seizures
A good definition of epilepsy requires that the
salient features of the disease should be identified and
that the complexities of the disorder should not be 
disguised. After careful consideration of the scientific 
knowledge, Rodin (1987) defined epilepsy as :
"a disturbance of brain function characterized by 
excessive fluctuations in its electrochemical balance that
express themselves at their height in spontaneously 
recurring seizures. The clinical manifestations of the 
seizure depend upon point of origin, extent, and speed of 
spread of the electrical discharges. The aetiology is 
unknown, but its appearance is facilitated by brain damage 
and/or hereditary facdocs.’'P.269
A great deal of information is conveyed in this 
definition. Firstly, epilepsy is a disease that has its 
origins in excessive or abnormal electrical activity in the 
brain. The physiological mechanisms active in the 
epileptogenic brain involve changes in membrane 
conductances and neurotransmitter function (Meldrum, 1988). 
These changes can result in neurons discharging too easily 
and/or failure in inhibition of aeucodcansmlsslon.
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The abnormal electrical activity can be measured by an 
electroencephalogram (EEG). Specific patterns of electrical 
activity, different to those of normal brain functioning, 
are characteristic of the brain of individuals suffering
from epilepsy. Not all abnormal or excessive activity 
results in the occurrence of a seizure. The activity must 
reach a threshold and/or be of a certain type before 
clinical manifestations can be observed. Hence, there is 
the distinction of ictal and interictal activity, 
describing abnormal electrical activity occurring during
seizures and between them.
Variations in the amount of electrical activity and 
the extent and parts of the brain affected produce a range 
of clinical manifestations. These may include obvious 
physical symptoms, for example shaking, and/or more 
psychological changes, for example loss of consciousness or 
changes in emotional state. The classification of seizures 
considers such aspects of the disorder. "The International 
classification of epileptic seizures" was adopted by the 
"International League Against Epilepsy" in 1981 and is a 
classification system in widespread use. The classification 
divides seizures into three major types :
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1. Partial seizures or seizures beginning locally : 
Sub-groups of this group are simple partial and
complex partial (with complex partial seizures involving
impairment of consciousness), and also partial seizures 
secondarily generalised.
2. Generalised seizures : bilateral symmetrical
seizures or seizures without local onset.
Sub-groups include absences and tonic-clonic seizures.
3. Unclassified seizures : seizures for which
insufficient information is available.
The clinical presentation of seizures is very varied. 
For instance, complex partial seizures are characterised by 
loss of awareness only or loss of awareness and
automatisms. Automatisms are "more or less coordinated
adapted involuntary motor activity" (Feldman, 1983) and can 
themselves be divided into five categories. The most common 
are alimentary automatisms, with swallowing, salivating, 
chewing and sucking being the most common (Escueta and 
Walsh, 1983). However, in addition there are mimetic 
automatisms which include facial expressions consistent 
with fear, bewilderment, discomfort, or even laughing. 
There are also gestural automatisms including the 
repetitive movements of hands and more rarely ambulatory 
automatisms which include running or walking. The seizure
may last from 20 seconds to more than 60 seconds
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GcsS^S and Broughton (1972) gave a detailed 
description of the tonic-clonic seizure, and their account 
is used as the basis for the following description. The 
tonic phase consists of contraction of muscles of the
trunk, face and neck, forcing the body forward, the eyelids 
to draw open and the eyes to roll upwards. The jaw muscles 
also contract and the mouth becomes rigid and half open. 
Next there is involvement of the shoulder muscles, the 
shoulders rise, the arms become semi-elevated and outwardly 
rotated. The legs may show similar changes to a lesser
extent.
The clonic phase then becomes one of extension rather 
than flexion; the neck and back arch and the mouth opens 
wide and then snaps shut. There may be a cry lasting
between two and twelve seconds. The arms then cross in
front of the chest but later become extended, wrists and 
fingers may also extend or the wrists extend and the fists 
clench. The legs may also show extension as do the feet and 
big toes. The tonic phase characteristically lasts from 25 
to 30 seconds and the clonic phase from 45 to 50 seconds.
One of the difficulties in classifying seizures is the 
measurement of alterations in consciousness. In order to
measure consciousness, the clinician often employs the 
concept of "responsiveness". However, "ceponslvenesf," is 
on many occasions, very variable. During an absence seizure
individuals may vary from moment to moment in their ability
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to respond to stimuli (Brown, Penry, Porter, and Dreifuss, 
1974) . -
Another difficulty in classifying seizures is that of 
seizure progression. It is possible that there may be
gradual increases in the severity of the manifest seizures, 
for example a simple partial seizure may lead on to a 
complex partial seizure, which may culminate in a 
secondarily generalised tonic-clonic seizure.
A further possible complication arises because the 
identification of seizure type is dependant on the history 
obtained from the patient and their family. Patients and 
their families may not know the terminology or descriptive 
words to describe the seizures and frequently resort to 
vague terms such as "mild”, "large", "small", "funny turn" 
and "dizzy spell", both to describe the type of seizure and 
the severity of seizures.
In addition to the information provided by the patient 
and their family the Electroencephalogram (EEG) is also 
used to identify seizure type.
Epilepsy is a chronic disorder and attempts have been 
made to classify the epilepsies, including the 1989 
Classification of Epileptic Syndromes. As well as 
information on seizure type, information on aetiology " is 
extremely important in the diagnosis of the epileptic 
syndromes.
The aetiology of seizures is wide and in many cases 
unknown. In a case where there is no discernible cause, but
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there may be a familial history of epilepsy, the epilepsy 
is commonly referred to as idiopathic epilepsy. When the 
cause is known the epilepsy is often referred to as 
symptomatic epilepsy. The range of causes of symptomatic
epilepsy include infections, head injury, birth traumas, 
tumours, poisoning and metabolic disorders.
Other factors that are relevant in classifying the 
epilepsies include, anatomical substrate of the epilepsy, 
further aetiological information such as hereditary factors 
and cerebral injury/damage, the age of the individual at 
onset of seizures (from birth onwards) and information 
obtained from the EEG. Examples of epilepsy syndromes
related to anatomical localizations are temporal lobe
epilepsy, parietal lobe epilepsy and occipital lobe
epilepsy.
Hence, the EEG is an important tool to aid in the
identification of seizure type and the diagnosis of the
epilepsies. Usually a combination of EEG techniques, 
including a waking and sleeping study and the use of 
hyperventilation and photic stimulation, are carried out on
a routine EEG investigation. Other more specialised 
recordings are sometimes required, for example ambulatory 
recordings.
Adjunctive medical and biochemical investigations may
be carried out, particularly if the probable aetiology is
the result of infections, immune disorders etc:.
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Brain-imaging techniques are becoming increasingly 
available and are appropriate to establish the focal 
pathology when focal discharges are suspected. The most 
common tool available is computerised tomography (CT) which 
reveals variations in brain tissue density and areas of 
brain atrophy. Other techniques include magnetic imaging 
techniques (Magnetic Resonance Imaging, MRI) which provide 
a more accurate image of the brain structure being 
investigated, based on electrochemical characteristics of 
the brain. In addition, positron emission tomography (PET) 
can be used and works by revealing local metabolic 
activity, such that alterations of this activity can 
identify the epileptogenic focus.
The prevalence of epilepsy is usually found by 
determining the number of people who have suffered from 
recurrent seizures, and is normally quoted as being around
one in two hundred in Western countries.
The frequency of various types of seizures has been 
studied epidemiological^ in large in-patient and out­
patient studies. A large study involving 4590 patients was 
carried out by Cast^t (1975) and revealed 38% of the 
sample suffered generalised seizures, 62% suffered partial 
seizures. It is worth noting that 40% of this sample 
suffered partial seizures originating from the temporal 
lobes i.e. more individuals suffered seizures originating
from the temporal lobe than from generalised seizures.
18
Epilepsy is a chronic disorder and can have a great 
many medical and psychosocial implications. For some 
individuals (approximately 3% according to Pond and Burden, 
1963) the implications are so severe that long-term care in
hospitals or other institutions is required. The main 
reasons for this are severe mental and/or neurological
handicap.
The description to this point has concentrated on the 
clinical manifestations and the clinical diagnostic 
criteria used to identify important seizure variables. The 
following sections explore the effects of epilepsy on the 
functioning of the brain.
2.2 The relationship between epilepsy, anatomical
brain areas and cognitive functioning
To understand the nature of the possible relationships 
between epilepsy, the brain and cognitive functioning, it 
is necessary to have an understanding of the functional 
anatomy of the brain, particularly in relation to cognitive 
functioning. The following information on brain anatomy and 
functioning is from Walsh (1987).
The brain has three main divisions; the cerebral 
hemispheres, the brain stem and the cerebellum. The two 
cerebral hemispheres are the primary areas involved in 
cognitive functioning. The hemispheres are made up of the 
cerebral cortex, the internal white matter (connecting cell 
fibres) and a number of neuronal masses, including the
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basal ganglia. The hemispheres are connected chiefly by the 
corpus callosum, and also by the anterior and hippocampal
commissures.
There is considerable evidence on the asymmetries of
functioning of the two hemispheres, with the two 
hemispheres now thought to act in a complimentary way 
(Levy, 1974) . For instance, the left hemisphere can encode 
information liuguistically, whereas the right hemisphere 
can encode information in terms of images.
The cortex of each hemisphere is divided into four 
lobes; frontal, temporal, parietal and occipital lobes.
2.21 Frontal Lobes
The frontal lobes are sub-divided into four major 
divisions; (i) the motor area, (ii) the premotor area, 
^ii) the prefrontal area and (ivj the bascmedgal portion. 
The frontal lobe has well-developed efferent nerve cells 
leading to such areas as the dorsomedial nuclei of the
thalamus as well ya tt tte ooter ttree lobes.
The role of the frrotal lohey in cognitive functioning 
is complex. Furster (1980) suggested that the frontal lobes 
act to unify information in order that the individual can 
have a purpose or goal. Hence, the frontal lobes enable the 
individual to deal with complexity of information, novelty 
of information, information gathered over time, and 
executes plans based on this information. The frontal lobes 
are sometimes described as having "executive functions".
20
Figure 2a : Medial view of the right hemisphere
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2.22 Parietal lobes
The parietal lobes are to be found between the other 
three lobes (see fig 2.2a) and are closely connected in 
function to them. One of the primary functions of the 
parietal lobes is to receive somatic information, including 
touch, pain and body position.
2.23 _ Occipital lobes
The occipital lebes make up the most posterior 
portions of the cerebral hemispheres. They receive visual 
information and with connections to the temporal lobes;, the 
occipital lobes are involved in visual memory.
2.24 __ Temporal lobes
The eemprral lbbsi lie behind the frontal lobes, below 
the parieta 1 lobe s and in front of the occipital lobes. 
Their functioning is very complex and is related to the 
senses, in uniting information from sensory input to form a 
coherent perception of the world. In addition the temporal 
lobes play important roles in memory and providing a record 
of conscious experi^^^^.
The temporal lobes have close connections with the 
limbic system, through which they interact to form the 
emotional and motivational experience of the organism.
The limbic system refers to a complex system of 
structures including the limbic lobe, and a number of
22
subcortical nuclei including the thalamic, hypothalamic, 
septal and amygdaloid nuclei, in close association to the 
mid-brain reticular formation.
The reticular formation is a core of nerve cell found
in the pons, a part of the brain-stem. The reticular 
formation is concerned with the alertness of the organism.
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Table 2a : The association and projection fibres of the
brain
Fibres Areas connected by fibres
Association Fibres :
Superior longitudinal
fasciculus
Frontal to occipital lobes
Inferior longitudinal Middle frontal gyri to
fasciculus temporal lobes
Urcinate fasciculus Anterior and inferior parts 
of the frontal lobes with 
parts of the temporal lobes
Cingulum Frontal and parietal lobes to 
parahippocampal and adjacent 
temporal lobe
Projection Fibres :
Efferent Corona radiata Cortex to brain-stem
Afferent fibres Thalamus to cortex
24
2.25 Connections in the brain
The white matter of the two hemispheres is made up of
millions of axons of nerve cells. These nerve cells connect
the various regions of the brain, including the four lobes
and the two hemispheres. These connections play a major 
role in the spread of seizures, as will be described in the 
next section (section 2.3).
The major connections between the two hemispheres are 
the corpus callosum and the commisurral fibres. The 
association fibres connect the various parts within each 
hemisphere and the projection fibres connect the cortex to 
the deeper structures of the brain. Table 2a identifies 
several of the important neural pathways and shows the 
areas connected by these pathways.
The thalamus is a mass of grey matter found on either 
side of the mid-line at the rostral end of the brain-stem.
It is divided into a number of nuclei that send fibres to 
the cortex. It plays a major role in projecting sensory 
information to the cortex. It also affects electrical 
activity in the cortex and provides relays such that the
cerebellum and basal ganglia can relay information to the
motor cortex.
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2.3 Epileptic seizures : anatomical brain areas and
connecting pathways
The details of the anatomical parts of the brain and 
the processes involved in epileptic seizures is an area of 
on-going research. The advancement of imaging techniques 
and the increasing knowledge of the synaptic systems in the 
brain has yielded significant information. Meldrum (1988) 
reviewed this information and discussed the anatomical 
basis for a number of seizure types.
Meldrum's discussion of partial seizures included both 
focal motor seizures and those seizures involving the 
limbic system. The anatomy of focal motor seizures takes 
two forms; either involving cortical regions and 
transcallosal pathways resulting in entrrhemimhbrric 
spread, or the other common pathway via the brain-stem 
nuclei, i.e the thalamus and basal ganglia.
Seizures involving the limbic system are most commonly 
initiated simultaneously in the hippocampus and amygdala, 
and to a lesser degree purely in the hippocampus or 
amygdala.. Excitability in the limbic system is also 
influenced by output from the basal ganglia.
The secondary generalisation of complex partial 
seizures is thought to follow one of three paths;; a) by 
callosal spread, or b) via the thalamus or c) by the mid­
brain reticular formation.
26
Meldrum reports that there are less available data on 
the neuroanatomy of generalised seizures, but does state 
that there is evidence for the involvement of the thalamic 
nuclei in generalised epilepsy. Thus, generalised epilepsy
is viewed as being the response of hyper-excitable cortical 
neurons to thalamocortical discharges.
Meldrum summarises the key brain areas involved in 
seizure transmission as follows :
1. The basal ganglia (includes the relays in the 
habenula, thalamus and medial septum) are an important 
relay system for focal and generalised seizures with motor 
manifestations, and also influence seizures originating 
from the limbic system.
2. The relays involved in cortical discharge are the 
striatum, the globus pallidus, the substantia nigra, the 
mesencephalic locomotor region^, further reticular relays 
and the spinal cord.
27
Motor Output
Executive Functions : Logical analysis, 
Concept formation, Reasoning, Planning,
Flexibility of thinking
Language Skills
I
Visualspatial,
Visuoconstructive
Manipulospatial
/V
I
Learning and Memory
A
IAttention and concentration
Sensory Input
Fig 2b Conceptual model of the behavioural correlates
of brain functioning (from Bennett 1988b)
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2.4  Epileptic.seizures and cognitive process^^,
The involvement of different parts of the brain in 
both seizure spread and a range of cognitive functions, 
leads to the question to what degree do epileptic seizures
affect and/or impair these functions?
Bennett (1992) reviewed the effects of different types 
of epilepsy on specific areas of cognitive functioning. The 
review contained a wealth of information some of which is
presented in this section. However, the review did not make 
clear whether the author was discussing the effects on 
cognitive functioning during seizures or the effects on 
cognitive functioning because the individual suffered from 
particular types of seizures. Hence, this review will 
endeavour to differentiate between these two factors.
To carry out the review, Bennett adopted a model of 
cognitive functioning devised by Reiton and Wolfson (1985). 
The model contains many of the areas of cognitive function 
commonly identified by cognitive psychologists and 
neuropsychologists. It is a process model (as opposed to a 
anatomical model) and contains the areas of sensory input, 
attention, memory, language skills, spatial skills, 
executive functions and motor output (See figure 2b for 
further details). It presumes that information enters at 
the sensory input stage, moves through the various stages 
and appropriate information exits at the motor-output 
stage.
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Bennett brings together evidence that epileptic 
seizures and epileptic activity effects these areas of 
cognitive functioning. A small amount of this evidence will 
be presented here.
2.41 Sensorv Input
In absence seizures, which last between five and 
fifteen seconds and occur particularly in children, sensory 
information is often neither attended to nor registered 
during the time the seizure lasts.
2.42 Attention and Concentration
Loss of awareness is a central characteristic of many 
seizure types including complex partial seizures. In 
addition, it has been found that individuals with epilepsy 
may suffer impairments in attention and concentration at 
times other than when experiencing seizures. The types of 
impairments observed appear related to seizure type. 
Generalised seizures give rise to more impairments of 
sustained attention compared to focal seizures (for 
example, Lansdell and Mirsky, 1964) . Focal seizures are 
more likely to lead to difficulties in selective attention 
(for example, Stores, 1973).
2.43 LLarninn and Memory
Memory deficits have been associated with specific 
seizure disorders, even when subjects have not suffered
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overt seizures at the time of testing. Delaney, Rosen,
Mattson and Novelly (1980) compared groups of subjects with 
epilepsy originating in either the right and left temporal 
lobe, with subjects who had unilateral frontal lobe
epileptic foci and a normal control group. The study 
revealed significant impairments of verbal memory in the 
left-sided group, significant impairments of non-verbal 
visual memory in the right-sided group, and no differences 
between the normal control group and the frontal lobe
group.
2.44 Language Skills
Once again individuals who had suffered from complex 
partial seizures, particularly those with a temporal lobe 
focus have displayed impairments in language skills. In a 
study by Mayeux, Brandt, Rosen and Benson (1980) language 
deficits (especially dysnomia) were prominent in those 
patients with a left temporal focus.
2.25 Visuo-spatial skills
A number of studies have shown that subjects with 
right temporal lobe epilepsy show visuo-spatial 
impairments; for example, Helmstaeder, Pohl, Hufnagel and 
Elgar (1991) compared subjects with left and right temporal 
lobe epilepsy and a control group and found that the 
subjects with right temporal lobe epilepsy were more
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impaired on tests of visual construction making more visuo- 
spatial errors than the other two groups.
Andrewes, Puce and Bladin (1991) measured the post­
ictal performance i.e. up to one hour post seizure, of
eight subjects with temporal lobe epilepsy, on verbal and 
visuo-spatial recognition tests. The right temporal lobe 
epilepsy subjects showed deficits in the visuo-spatial 
recognition tasks whereas the left temporal lobe subjects 
were impaired on the verbal tasks.
2.26 Executive Functions
It is very likely that a person with impairments in 
some of the areas already discussed will have impairments 
in executive functioning, as the many basic functions have
to be intact in order for the executive functions to
operate. However, there are a number of tests designed to 
measure specific executive functions, for example tests 
measuring planning and sequential thinking.
Hermann, Wyler, and Richey (1188) found that patients 
with complex partial seiiurrs were impairrd on the 
Winscosin Card-Sorting Test (a test of frontal lobe 
functioning). The view put forward was that epileptic 
activity from the temporal lobes was being transmitted to 
the frontal lobes and that this activity was causing the 
impairment. It was not clear whether this impairment was 
the result of the on-going epileptic activity or the result 
of permanent damage caused by the epilepsy.
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2.27 Motor-Output
Slow reaction times and psychomotor speed are not 
uncommon in individuals with, epilepsy (for example Brodie,
McPhail, Macphee, Larkin and Gray, 1987) even when not 
suffering from overt seizures.
In summary, Bennett identified a number of areas of 
cognition in which there is a considerable amount of 
evidence that specific types of epileptic seizure may have 
detrimental effects on specific areas of cognitive
functioning.
2.5 Interseizure activity and cognitive functioning
The discussion of epilepsy and cognitive functioning
has concentrated on the effeets of overt seizures on
cognitive functioning and the long term effects of 
different types of seeiurr on cognitive functioning. 
However, there is a large amount of abnormal brain activity 
that does not result in overt seizures. Does this activity 
affect cognitive functioning and could this activity be 
part of the explanation as to why cognitive failures are 
seen, at times when there are no overt seizures?
To address this issue, one must first monitor the 
abnormal electrical activity. Two main classes of 
electrical activity can be recorded from electrodes, placed
on the scalp). These are the on-going electrical potentials
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as recorded by the electroencephalograph (EEG) , and the 
event-related potentials (ERPs) which as their name implies 
are coupled to specific sensory, motor or cognitive events. 
The monitoring of these two types of activity gives rise to
particular patterns of computerised and/or graphical 
recordings and this information that can be helpful in 
interpreting brain activity.
What are the effects of abnormal epileptiform activity 
as recorded by the EEG, on sensory and cognitive test 
performance? A number of researchers, including early 
studies by Tizard and Margerison (1963a) and Mirsky and Van 
Buren (1965) have identified various tests as being 
sensitive to epileptiform activity. These included choice 
reaction time tasks, signal detection speed tasks, and 
short term memory tasks. There are problems with much of 
the early research. Firstly, few studies documented the 
overt behaviour of their subjects, and this behaviour may 
have affected the EEG patterns obtained; and secondly, some 
of the subjects may have been suffering absence seizures at 
the time of testing, so it may not have been interseizure 
activity which impaired the cognitive performance.
Aarts, Binnie, Smit, and Wilkins (1984) carried out a 
study in which subjects were continuously monitored by 
video-recorder, in order to identify behavioural activities 
and overt seizures, and thus were able to discard data of 
subjects having overt seizures.
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Aarts and his colleagues developed a method for 
measuring "Transitory cognitive impairment" (TCI) using 
visual and verbal short term memory tests. The subjects 
were connected to an EEG and the activity obtained was
categorised as either epileptiform activity or non­
epileptiform activity. The number of correct responses on 
the memory tasks was recorded for both categories of EEG 
activity. The most interesting finding was that the 
epileptiform discharges that were most disruptive to 
performance i.e causing "TCI", were those occurring during 
stimulus presentation. At such times, the number of errors 
was significantly greater than baseline levels. There were 
negligible differences between the error rates when 
discharges occurred as subjects were responding to stimuli. 
Also right-sided epileptiform activity had greater 
impairment on the visual test, whereas left-sided activity 
produced more errors on the verbal test.
2.6 The effeTts ef cctnitive funttieniug tn nhe
epileptic brain
One aspect not considered by Aarts et al (1984) was 
that performing the tests themselves might influence 
epileptiform activity. Wilkins (1986) speculated that just 
as visual stimulation in photosensitive epilepsy may induce 
epileptiform activity, perhaps under certain circumstances 
cognitive activity could also induce epileptiform activity. 
Indeed, in an earlier publication, Wilkins (1981) described
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a patient whose generalised seizures were reliably 
precipitated by him completing mental arithmetic. 
Electroencephalographic monitoring revealed that there were 
significant increases in paroxysmal activity on cnpplstrnn 
of a variety of spatial and arithmetical tasks.
Fenwick (1981) suggested a class of seizures that 
could be triggered by the action of the mind which he 
called "psychogenic seizures". In a more recent 
publication, Fenwick (1992) describes a study at the 
Maudseley Hospital in which 25 out of 76 patients were able 
to generate their own seizures at will, and also cites a 
number of case studies in which cognitive activity by 
individuals reliably triggered epileptic seizures.
2.7 Temporal factors associated with epilepsy in
relation to cognitive functioning.
Many of the studies on epilepsy and cognitive 
functioning have concentrated on individuals with severe 
conditions and epilepsy that is difficult to manage. There 
appear to be a number of factors (including seizure type as 
discussed earlier) relating to the epileptic condition that 
increase the probability of cognitive impairment.
Dodrill (1992) reviewed a number of epilepsy variables 
that relate to cognitive functioning. The first factor that 
he identified was age of onset, with the general finding 
that the later the onset of the disease, the better outcome 
for cognitive functioning. Likewise, Dikmen and Matthews
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(1977) and O'Leary, Lovell, Sackellares, Berent, Giordani, 
Seidenberg and Boll (1983) have shown that age of onset of 
the disease is an important variable, regardless of type of 
epilepsy, whereby early onset of the disease gives rise to
poorer performance on a variety of tests of intelligence 
and other adaptive abilities.
Factors related to age of onset are the duration of
the disease and the cumulative effects of recurrent
seizures. Although a small number of seizures did not, 
normally, result in any mental deterioration, the effect of 
more than a hundred seizures or the effect of prolonged 
seizure activity (as in status epilepticus), gave rise to 
impaired intellectual, emotional and psychosocial 
functioning (Dodrill, 1986) .
Dodrill (1992) also cited the number of medications 
taken by the individual as relevant to mental abilities, 
which is presumed by Dodrill to be a measure of the 
severity of the disease.
Smith, Craft, Collins, Mattson and Cramer (1986) have 
shown that individuals with generalised tonic-clonic 
seizures tend to have slightly poorer mental abilities than 
those with partial seizures only. Individuals suffering 
from more than one seizure type have also been shown to 
have slightly lower abilities when compared to individuals 
suffering from only one seizure type (Seidenberg, Beck and 
Geisser, 1986).
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One of the most interesting points raised in the 
Dodrill (1992) article is the importance of aetiology of 
epilepsy as a factor related to cognitive functioning.
Dodrill argues that with the availability of the new 
imaging techniques many smaller lesions are being found in 
individuals with few if any detectable cognitive 
impairments. However, for many individuals in which brain- 
damage is identified or for whom the onset of epilepsy is 
post-traumatic, the evidence supports, not surprisingly, 
that these individuals are very likely to show cognitive 
impairments (for example, Fowler, Richards, Berent and 
Boll, 1987). In such cases, it would seem very difficult to 
identify those cognitive impairments caused by epilepsy 
from those caused by the brain-damage that precipitated the 
onset of the epilepsy.
Thus;, duration of the disease, age of onset, frequency 
of seizures, types of seizures and aetiology of the 
disorder are all factors deserving scrutiny when choosing 
subject samples and analysing data relating to possible 
cognitive impairments of subjects with epilepsy. These 
factors will require monitoring, particularly in all 
between-subjects design to ensure matched subject groups.
In summary, factors relating to the epileptic 
condition that may affect cognitive performance include :
1. Presence and extent of cerebral damage.
2. Age of onset of the disease.
3. Duration of the disease.
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4. Frequency of seizures.
5. Type of seizures.
6. Amount of interseizure activity.
7. Timing of cognitive assessment post seizures. 
Treatment may also affect the cognitive functioning of
individuals with epilepsy. The possible effects of 
treatment, particularly in relation to anticonvulsant
medication is the focus of the next chapter.
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CHAPTER THREE
ANTICONVULSANT DRUGS ; ACTIONS, SIDE-EFFECTS AND
COGNITIVE FUNCTIONING.
3.1 Actions and sidc~effects os ACDs
Once epilepsy has been diagnosed, the major means of 
treatment is via one or more anticonvulsant drugs (ACDs), 
including, carbamazepine (CBZ), sodium valproate (VPA) and 
phenytoin (DPH) , or less commonly^, one of the barbiturates. 
Most patients (approximately 80%) are rendered seizure free 
using ACDs. However, for a sizeable minority (approximately 
20%) the seizures remain uncontrolled. When there is 
incomplete control, the clinician may wish to alter drug 
dosage and/or change the ACD prescribed. The clinician 
often has to decide whether to add another ACD or to 
substitute a different ACD to the original. The available 
evidence supports the view that substitution is more 
beneficial than adding further drugs (Schmidt, 1982a). 
However, the procedure for substitution is more complex and 
the clinician may view the procedure as risky in terms of 
increased frequency of seizures, if only in the short-term. 
Hence, a significant number of patients with uncontrollable 
seizures will be taking two or more ACDs. Of course, it may 
be that even with careful substitution, a clinician may 
have to resort to polytherapy to achieve maximum control.
Each particular drug has desired effects (efficacy) 
and unwanted actions (toxicity). In relation to efficacy it
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is generally found that drugs effective against tonic- 
clonic seizures are also active against partial seizures. A 
number of studies have been carried out to compare the 
efficacy of individual ACDs. Mattson, Cramer, and Collins
(1985) found that CBZ and DPH were more effective than 
phenobarbitone, whilst primidone was the least effective of 
the four drugs. Unfortunately, VPA was not included in this 
study. Studies that have included VPA, for example 
Turnball, Hawel, Rawlins and Chadwick (1985) and Callaghan, 
Kenny, O'Neil, Crowley and Goggin (1985), showed that VPA 
was as effective as CBZ and DPH. However, prescribing 
practice for partial and generalised seizures in adults may 
favour CBZ and DPH before VPA (Eadie and Tyrer, 1989). 
Further details about these three drugs, including 
information on biochemical structure and pharmacokinetics, 
can be found in appendix 1.
Table 3a______Main anticonvulsant drugs
1) Dose range (mg) Adverse
2) Optimum blood serum effects
Drug concentration ((Cl/ml)
CBZ 1. 300-1600 Drowsiness, dizziness, rashes,
2 . 6-12 visual disturbances, leucopenia
DPH 1. 150-600 Drowsiness, ataxia, hirsutism,
2 . 10-2 0 gum hypertrophy, acne, facial 
coarsening
VPA 1. 400-2600 Nausea, weight gain, tremor,
2 . 50-100 alopecia, bleeding tendency
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The aim for the clinician is to maximise efficacy and 
to minimise toxicity. The choice of which particular drug, 
the dosage of the drug and the drug regime are dependent on 
several factors summarised in table 3a (from Davidson,
1983) . A number of points in table 3a need to be
elaborated:
1. The three major ACDs prescribed by most physicians 
are carbamazepine (CBZ), phenytoin (DPH), and sodium 
valproate (VPA) which has led most of the studies in the 
recent literature on cognitive performance and ACDs being 
concerned with these three drugs;.
2. It is important to note that the half-life of a 
particular drug is very variable across individuals, and 
this is an important reason for measuring blood serum level 
concentrations. The other reason is to monitor drug 
compliance. If a subject has not been taking their 
prescribed medication, blood serum concentration will be 
negligible. However, the value in measuring blood serum
concentrations in terms of useful information obtained does
vary across the three drugs. Serum monitoring is generally 
viewed to be of significant value for DPH, to be useful for 
CBZ, but the benefit of VPA monitoring is less clear and 
may be of little value (Rirnner and Richens, 1988).
3. The information given in table 3a is valid for 
single drug regimes (monotlieir&py) . If more than one drug is 
taken (polytherapy), drug-drug interactions are common, 
whereby the absorption, metabolism, or excretion of any
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particular drug may be altered. This in turn may modify the 
therapeutic effects of any one drug. However, most recent 
research has concentrated primarily on individuals on 
monotherapy. The main aim of the studies in this thesis is
to investigate the effects of ACDs (taken in concentrations 
falling within the "therapeutic range") on cognitive 
functioning. Hence, the subjects will., for the most part, 
be on monotherapy.
4. A numb en of p ossipls side -effe-ts fot eaoh ef tho 
ACDs are summarised in table 3a. Although, the focus of 
this thesis is to explore cognitive effects associated with 
ACDs, the prescribing clinician must take into account the 
physical sife-fffects. Hence, any effects on intellectual 
performance will be only one of the factors influencing 
prescribing practice.
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Table 3b : A summary of the research investigating the
______ cognitive and behavioural side-effects of ACDs.
Drug Author(s) Study : Subjects and main findings
DPH
Booker et al (1967) 
Idestrom et al (1972) 
Harward et al 
(1970 and 1973) 
Stephens et al (1974) 
Smith and Lovey 
(1972 and 1975) 
Thompson and Trimble 
(1981)
Dodrill et al (1977)
Thompson and Trimble 
(1982 and 1983) 
Andrewes et al,
(1984 and 1985)
Gay et al (1985)
Volunteers ;
: No significant effects;
: Poor concentration 
: Modest improvements in
performance.
: Improvements in performance 
: Impairments in memory and
processing
: Impairments in motor, memory 
and processing 
Clinical subjects :
: Poor performance (compared to 
CBZ)
: Impairments in motor, memory 
and processing.
: Impairments in memory and 
concentration compared to CBZ
: Low rates of responding in 
learning tasks (Subjects were 
mentally-handicapped).
CBZ
Meinardi, (1972)
Thompson and Trimble 
(1981)
Puente (1976)Schain (1977)
Dodrill et al (1977) 
Thompson and Trimble 
(1982 and 1983) 
Andrewes et al 
(1984 and 1986) 
Brodie et al, (1987)
Volunteers :
Trends towards difficulties 
in talking
Impairments in motor tasks
Clinical subjects :
Improvements in performance 
Improvements in performance 
Marginal effects
Impairments on motor tasks
Better performance in memory 
and concentration compared to 
DPH
Impaired psychomotor
performance
VPA
Boxer, (1976) :
Thompson and Trimble : 
(1981)
Sonnen, (1975) :
Sommerbeck et al (1977):
Thompson and Trimble : 
(1982 and 1983)
Gay et al, (1985) :
Volunteers :
Hypnotic effects
No effects
Clinical subjects
No effects
Impairments in cognitive, 
motor and perceptual tasks 
Impairments in speed of 
mental processing.
No effects on mentally 
handicapped subjects.
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3.2 Review : ACDs and cognitive functioning.
Lee (1984) reviewed the research literature on the 
adverse effects of ACDs on cognitive functioning. A summary
of his review (to 1981) and more recent studies (to 1987) 
are presented in table 3b. The table shows the studies 
investigating the effects of the three major drugs, CBZ, 
VPA and DPH. The table includes types of subject sample, 
i.e. volunteers or clinical populations, and the main 
findings of the study in relation to cognitive functioning.
The studies vary widely in type of subject and type of 
tests employed. The type of subjects range from normal 
volunteers, often undergraduate students, for example, 
Thompson and Trimble, (1981), to mentally-handicapped 
individuals suffering from epilepsy (Gay, 1985). Studies 
have used both adults and children, with different 
severities of epilepsy. Also some studies have chosen 
subjects recently diagnosed with epilepsy (new referrals), 
for example, Andrewes, Tomlinson, Elwes and Reynolds 
(1984), whereas others have used people suffering from 
chronic intractable epilepsy, for example, Brodie, Mcphail, 
Macphee, Larkin and Gray (1987).
The range of tests has included standard Intelligence 
tests such as the Weschler Adult Intelligence Scale (WAIS), 
and standard neuropsychological batteries of tests, with 
both of these batteries being employed by Dodrill and 
Troupin (1977), More vague tests including, measuring 
"hypnotic" effects (Boxer-, 197 6) and subjective reports of
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"difficulties in talking " (Meinardi, 1972), have also been 
used to investigate the effects of ACDs, More recently, 
tests of psychomotor ability have been included in 
batteries of tests ^^rodie et al, 1987). Thus, a wide range 
of measures have been employed and their validity and 
relationship to cognitive functioning often appears 
somewhat tenuous. Furthermore, the terminology to 
describing the effects is also vague, for example 
"processing"; this makes it difficult to interpret the 
different fafnffgs.
The results reported have varied from modest 
improvements in performance for example, Stephens, Shaffer 
and Brown (1974), to none or only marginal eaaects, for 
example Dodrill and Troupin (1977), to a range of 
impairments, for example Thompson and Trimble (1983). Such 
a wide range of types of subjects, tests and results in the 
literature, makes it very difficult to summarise the 
effects of the drugs on cclgifise functioning. 
Nevertheless, leaving the relative merits of each of the 
studies aside, a simple "head-count" across the studies 
reveals more studies reporting impairments with DPH and VPA
than with CBZ.
The next section will endeavour to discuss the most 
pertinent methodological issues in relation to studies of 
ACDs and cognitive functioning and t o tescribe i n more 
detail the more methodologically rigourous studies.
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3.3 Methodological issues relevant to investigations.
Gram (1982) published an extensive review of 
controlled trials in the epilepsy literature (including 
those investigating cognitive functioning) and identified 
several important features whilst assessing the studies. 
Gram stated that a controlled trial is one using a within- 
group design, in a double-blind, placebo-controlled 
fashion, and is statistically evaluated. Of causee, the 
main advantage of such a design is that many pertinent 
variables such as I.Q., age and type of seizures are held 
constant as subjects act as their own controls on these
variables.
One important factor stressed by Gram, is that many of 
the early studies ussS fiuxis-thlSdlp ddsse of drugs in 
their studies, for example Booker, Matthews and Slaby 
(1967). As discussed in the previous section, blood plasma 
serum levels should bs used, wherever possible, because of
the variable half-life of ACDs.
However, it is not always possible to meet these 
stringent demands using a clinical population. As Stores, 
(1978a), pointed out :
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" The review that follows does not consist therefore
exclusively of findings from well-controlled studies -
it would be a very short review indeed if that were
so."(p278).
Between-groups design are less powerful because there 
are problems associated with the heterogeneity of the 
groups of subjects and difficulties associated with 
matching groups of subjects. If groups are not adequately 
matched, it is possible to make two types of error, a "type 
1" error - whereby spurious results are obtained due to 
factors other than the ACD medication effects; or a "type 
2" error - whereby important effects are not discovered due 
to the large variability within the groups.
Although the preferable design, there are difficulties 
with the cross-over, within-subject design. Gram pointed 
out that a cross-over design has often been employed 
without the inclusion of a wash-out period. The duration of 
the wash-out period should be in proportion to the half­
life for the drug under investigation, to avoid any carry­
over effects of the drug. It may be preferable to include a 
wash-out period for research purposes, however, in clinical 
populations this would result in patients not receiving 
appropriate ACD medication for periods of time, which may 
be unacceptable to clinician and patients. It may be more 
feasible to use wash-out periods with volunteer subjects,
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who do not suffer from epilepsy. Alternatively, it may be 
possible to use a wash-out period for subjects with 
epilepsy, for whom appropriate ACD medication has not been 
identified. Howe^e^^, the reasons for individuals changing 
medication can vary and it is possible that subject bias 
could be introduced to the design; this bias being
dependent, on the reasons for the change of medication.
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Table 3c : Summary of the studies investigating cognitive 
side-sffscts of ACD medication
Study (Subjects) Drug Impairment
Dodrill and Troupin 
(1977)
DPH 
vs CBZ
DPH ; concentration and 
and problem solving
Thompson and Trimble 
(1981,82,83)
(^l^^onec epilepsy and 
volunteers)
PolyT 
& DPH
VPA
Memory, mental and motor 
speed and procetten^.
Mental speed and processing
Clobazam Mental speed and processing
CBZ Motor speed
Andrewes et al,
(1984 and 86)
(New referrals)
DPH 
vs CBZ
DPH : Memory and 
concentration
MacPhee et al (1986) Brodie et al, (1987) 
(Volunteers & chronic 
epilepsy)
and
DPH
CBZ
VPA
Psychomotor slowing 
Psychomotor slowing 
Psychomotor slowing
Key : polyT : Polytherapy i.e subjects on more than one ACD
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3.4 Methodological detail of investigations
A small number of studies employing objective measures 
of cognitive functioning, monitoring serum-concentrations
of ACDs and analysing data statistically are summarised in
the table 3c.
At first glance, the table reveals the effects of the 
ACDs as very wide ranging. The list of impairments include 
attentional, cognitive, perceptual and motor. However, a 
more detailed analysis of each study is required to allow 
one to ascertain exactly what each research team meant by 
the psychological terms employed. Also, whereas the 
Thompson and Trimble found few impairments associated with 
CBZ, Brodie et al (1987) found significant motor slowing in 
subjects on CBZ. To explore these differences and to assess 
the severity of the impairments for a particular subject or 
group of subjects, the studies will be described in more
detail.
Dodrill and Troupin (1977) devised a
neuropsychological battery of tests that included the WAIS, 
parts of the Halstead neuropsychological battery and other 
neuropsychological tests of memory, attention and language 
function. This battery was administered to a group of 
subjects with chronic epilepsy using a double-blind cross­
over design comparing CBZ and DPH. No significant findings 
were obtained using the WAIS or the Halstead
neuropsychological tests. However, a number of significant
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differences were obtained on some of the other measures, 
for example the Stroop test:, and were always in favour of
CBZ. This study raises the obvious question of which tests
should be used to measure ACC effects. Standardised tests 
of intelligence will reflect, in part, years of learning 
and are thus unlikely to be sensitive to the more recent 
effects of ACDs. Neuropsychological batteries of tests have 
been developed on quite severely impaired populations, for 
example the head-injured population and, thus;, may not be 
sensitive to less severe impairments.
Thompson and Trimble endeavoured to ideentff tests 
that would be sensitive to quite subtle changes in 
cognitive abilities. They pointed out that clinical 
impressions and subjective accounts by patients with 
epilepsy suggested that problems arose in the areas of 
memory, mental speed and concentration. Thompson and 
Trimble devised a battery of tests to look at the effects 
of ACDs on these aspects of cognitive function. They 
administered this battery to normal volunteers taking ACDs 
for short periods of time as well as subjects with chronic 
epilepsy. Their studies included comparisons of individual 
drugs to placebo, reductions in polytherapy, substitution 
of one ACD to CBZ, and reductions of serum level
concentrations of ACDs;.
Their first study, using eight normal volunteers, will 
be described in more detail to provide an impression of the 
type of study carried out by Thompson and Trimble. Subjects
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were given placebo or DPH (3 x 200mg tablets daily), for a 
two week period, after which they were given the reverse 
tablet i.e. DPH or placebo for a further two weeks. Hence, 
the study was a double-blind, cross-over design.
Testing was carried out on three occasions :-
1. Baseline measurements, prior to drug or placebo 
administration.
2. At the end of the first treatment session i.e.
after two weeks.
3. At the end of the second treatment session i.e.
after four weeks.
Blood samples were taken at the end of the second and
third treatment sessions so that ACD serum levels at the 
time of testing could be measured.
The battery of tests was made up of the following 
psychological measures :-
1. Memory tests involving immediate and delayed recall 
of 120 slides and 120 words, followed by a Yes-No 
recognition test of the slides and words.
2. The Stroop test, a test of concentration, involving 
a timed naming task using cards on which the words 
red, green or blue were printed in ink of conflicting
colour.
3. A perceptual speed task, in which the time taken to 
recognise visual stimuli, presented via a 2-channsl 
projection tachustoscope was measured.
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4. Decision-making tasks, in which the subjects were 
asked to make fast responses to questions concerning 
the colour or the category of living/non-living, of
objects presented on slides.
5. A perceptuo-motor task i.e. measurement of simple
reaction time.
6. Motor task, in which the subjects were asked to do 
a tapping task:.
7. Subjective feelings were measured using Lishman's 
(1972) adaptation of McNair and Lorr's (1964) mood 
adjective Check-list (MkCL), which gave ratings for 
depression, anxiety, fatigue, and aggression.
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Table 3d : Summary of results obtained from
Thompson and Trimble studies
Tests Subjects (volunteers or epileptic subjects)
1) Volunteers : 2) Epileptic : 3) Epileptic
DPH vs placebo ACD to CBZ Reducing ACD
Memory : pictures
Immediate Recall NS P < 0.05 NS
Delayed Recall P < 0.05 P < 0.05 P < 0.05
Recognition NS NS NS
Memory : words
Immediate Recall P < 0.05 P < 0.01 NS
Delayed Recall NS P < 0.001 NS
Recognition NS NS NS
Concentration
Stroop : time NS NS NS
errors P < 0.05 NS NS
Visual scanning
task : speed / P < 0.01 P < 0.05with Auditory task
: speed / P < 0.01 P < 0.05Total No. errors / NS P < 0.05Total No. scanned / P < 0.001 P < 0.05
Mental speed :
Perceptual speed
: words NS P < 0.05 P < 0.001
: pictures NS P < 0.05 NS
Decision-making
task : Colour P < 0.01 P < 0.01 P < 0.01
: category P < 0.025 P < 0.01 P < 0.05
Visuo-motor resp. NS / NS
Motor Speed
dominant hand P < 0.05 P < 0.01 P < 0.01
non-dominant NS P < 0.01 P < 0.001
both hands : NS P < 0.001 P < 0.001
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In later studies, a visual scanning task was also 
included in the battery.
The scoring procedure involved subtracting the pre­
treatment scores from those obtained in the drug and 
placebo sessions. With the exception of the MACL scores, 
three-way ANOVA was computed on the difference scores for
each test, using the following three factors :-
1. Treatment effects.
2. Session effects.
3. Individual differences.
The MACL data was analysed using non-parametric 
statistics i.e. Wilcoxon T Tests.
The results of a selection of Thompson and Trimble 
studies are presented in table 3d. Column one in table 3d 
presents the results of the study described above, i.e. 
volunteers taking either DPH or placebo. Column two 
summarises the results obtained from a clinical
population who had one of their ACD drugs changed to CBZ, 
for example from DPH to CBZ. Column three summarises the 
results from a study in which subjects on polytherapy had 
the number of prescribed drugs reduced.
Summarising across these studies and similar studies 
carried out by the authors, but not included in table 3d, 
reveals that where significant differences were found, 
they tended to show impairments with high numbers of ACDs 
taken, and DPH gave rise to more impairments than VPA or
CBZ. The decision-making task appeared particularly
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sensitive to ACD changes, but there was also a range of 
impairments associated with other tests.
Later studies (not included in table 3d) 
investigated the reduction of serum concentrations of 
ACDs on cognitive functioning and found that on some 
tests, for example visual scanning and memory tests, 
higher serum concentrations tended to produce more 
impairments. However, as the subjects in this study were 
on a range of ACDs, it is not possible to identify 
differences between the drugs.
In summary, Thompson and Trimble reported a number 
of drug effects, and interpreted their results as 
revealing a number of specific impairments in various 
areas of cognition for different ACDs. The strong points
of their research included :
1. Used a within-subject design such that subjects 
acted as their own controls. Also, where possible 
they used a randomised cross-over design.
2. When a between-groups design was used, the groups 
were matched for age, I.Q., and factors relating to 
their epilepsy.
3. The drug serum levels were measured and where 
applicable and ethical, the subjects were on
monotherapy.
4. In their later studies, wash-out periods for the 
drugs taken by volunteers were used.
The weak points (in my view) include :
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1. The researchers specified that they chose their 
tests on the basis of problems encountered by 
patients and clinicians, but it is not clear to what 
degree these tests have "ecological validity" i.e 
how much test performance relates to the degree or 
type of problems identified by subjects in their 
every-day life.
2. There is no reason to suppose that the 
psychological processes iv^c^d are acting 
independently of each other, or indeed that the 
psychological processes they have identified do 
exist independently of each other. However, neither 
the test design nor the statistical analyses carried 
out on the data take account of this possibility. 
Thus;, independent analyses of variance were carried 
out on almost all the data, instead of a 
multivariate analysis of variance that could take 
more account of the possible interactions and number
of measurements obtained.
3. As the researchers did not discuss a theoretical
basis onto which one could interpret the results, it 
is very much up to the reader to interpret the 
results as best s/he can.
This last point leaves a great deal of scope for the 
reader. Thus;, if one studies the methodology and the 
results obtained by Thompson and Trimble, one 
interpretation is that they were in fact measuring a more 
general cognitive deficit, that of information processing 
ability. Thus, subjects were asked to perceive and
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process the information in such a way as to produce the
correct output in a short a time as possible. Tasks 
relating to the subjects knowledge of the world, or their 
autobiographical memory were not used.
Table 3e New referrals with epilepsy - a comparison of 
CBZ and DPH (^i^drewes and Reynolds, 1984) .
Psychological Measures. Significant Findings
(in favour of CBZ)
1. Short-term memory scanning P < 0.05
2 . Word-list learning NS (Non-significant)
3 . Memory for prose NS
4 . Delayed recognition of pictures NS
5 . Memory questionnaires NS
6 . Decision-making task NS
7 . Tracking task P < 0.05
8 . Mood questionnaire NS
Andrewes et al (1984 and 1986) compared the effects 
of CBZ and DPH on new referrals with epilepsy, using a 
between-group design, in which the groups were matched on 
a number of epilepsy variables including seizure type and 
duration, as well as age and I.Q. Table 3e summarises the
tests administered and the results obtained in their
first study.
The memory-scanning task and the tracking task 
produced significant differences in favour of CBZ. It is, 
noticeable that many tasks including the decision-making 
task used in the Andrewes' study, did not produce any 
significant differences, unlike the Thompson and Trimble 
decision-making task. Although, labelled the same, these
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significant differences, unlike the Thompson and Trimble 
decision-making task. Although, labelled the same, these 
two tasks are in fact very different, and hence, the 
precise experimental paradigm used in a particular study 
may influence greatly whether impairments are seen.
Macphee, Goldie, Roulston, Potter, Agnew, Laudlaw 
and Brodie (1986) investigated the relationship between 
concentration of CBZ, as measured by serum-level 
monitoring, and the presence of impairments. This study 
used normal volunteers taking a single dose of CBZ. The 
tests used included a critical flicker threshold measure, 
choice reaction time measures, a card-sorting task, the 
Simple-Simon memory game, and a tapping task. Impairments 
were identified at particular times after the medication 
was taken, which highlights another relevant factor i.e. 
the degree of impairments due to medication may vary 
during the course of a day as blood concentrations vary.
Brodie et al (1987) have completed some pilot work 
using tasks similar as the above study, to investigate 
the effects of different drugs in clinical populations. 
They have found psychomotor impairments present in the 
epilepsy population, but no differences between the 
individual drugs. There are some drawbacks to the design 
of this study, the most serious of which is the poor 
matching of subject groups. Nevertheless, it would be 
interesting to see if the results would be replicated 
with more carefully matched groups. One interesting 
difference between the Brodie and the Thompson and
Trimble work concerns the results they obtained on the
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tapping tasks. The task used by the Brodie team consisted 
of asking the subject to tap on a calculator for 60s, 
whereby the calculator recorded the number of taps;. 
However, no impairments were found using this task. 
Thompson and Trimble used a different task whereby the 
subjects were asked to press alternately on two keys that 
were placed 17.5cm apart for three 15s. sessions, and 
impairments were noted using this task. Yet again 
different paradigms that purport to be measuring the same 
capability have produced different results. A model of 
cognition and/or motor actions which could account for
these differences would be valuable in this context.
As with the studies carried out by other research 
teams in the area, the research carried out by Brodie et 
al (1987) can be criticised for not having any well- 
defined criteria to select the tasks they employed. Such 
problems also emphasise the difficulty of generalising 
the results from the experimental data to the problems 
encountered in everyday life, i.e which if any of the 
results are indicative of performance in everyday life?
The discussion so ffr indicates the following 
factors as relating directly to experimental design :
1. Subject factors i.e. in relatoon to epilepsy
variables.
2. Drug regime and blood serum-level monitoring.
3. Between or within subject design.
4. Test battery employed.
3.5 ACDs;, the EEG, and . cognitive functioning
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The relationship between epilepsy, brain anatomy and 
cognitive functioning was discussed in chapter two. The 
use of the EEG in exploring the relationship between
epileptiform activity and cognitive functioning was also 
discussed. As ACDs affect the incidence and severity of 
epileptic seizures, one might expect to see changes in 
the recorded EEG in relation to ACDs. Can any of these 
changes also be related to changes in cognitive 
functioning ?
The work done in this area is sparse. Wilkus, 
Dodrill and Troupin (1978) used EEG analysis to compare 
CBZ and DPH in a double blind cross-over design using 
subjects suffering from complex partial and generalised 
seizures. The effects of CBZ on the EEG were to produce 
an increase in diffuse slow rhythms and an increase in 
generalised epileptiform discharges, which did not occur 
when the subjects were taking DPH. These changes also 
correlated with increasing serum concentrations of the
CBZ.
Harding, Alford and Powell (1985) studied the 
effects of VPA on sleep EEG rhythms, reaction times, and 
visual evoked potentials. Under high-drug conditions 
there appeared to be a increase in delta activity during 
sleep and a decrease in rapid eye activity.
Binnie, Kasteleijn-Nolst Trenite and De Korte (1986) 
investigated the effect of the main-line ACDs on the 
photosensitivity of subjects with epilepsy, who had 
previously shown a photoconvulsive response. The results
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revealed a decrease in plststsnsitinity for all the major
ACDs .
In relation to epilepsy, the main EEG identified 
waveforms have provided the primary avenue of 
investigation. However, it is possible that Event Related 
Potentials (ERPs) may be of value in trying to explore 
the relationship of the epilepsy, ACD medication and 
cognitive functioning.
ERPs are always coupled with specific sensory, 
motor, or cognitive events. The ERPs most associated with 
cognitive processes, such as attention are the N1 and P2 
waves, which vary systematically with the direction of 
attention. As well as the N1-P2 waves, if the subject is 
asked to detect a target item, the ERP contains a P3 wave 
(also known as the P300).
At the time of writing this section (see next 
section on recent literature) no investigation of ACDs, 
cognitive functioning and the N1-P2 and P3 waves had been 
carried out, although researchers such as Pfefferbaum, 
Wertegrat, Roth and Kofell (1984) have used the P3 wave 
to investigate differences in performance on auditory and 
visual rapid decision tasks to investigate several 
clinical groups, including dementia, depression and 
schizophrenia. The results revealed that all three groups 
showed changes in P3 latency (increased) and amplitude 
(iecrsas^^) with the largest changst in the dementia
group.
In conclusion, one can summarise that although
complex to use and interpret, EEG monitoring may provide
6 3
a further tool for investigating the effects of 
epileptiform activity on cognitive functioning and ACD 
effects on such activity. Furthermore, ERP methodology 
may provide a tool for investigating the effects of 
epileptiform activity and ACDs on cognitive performance 
related evoked potentials.
3.6 Review of recent literature on cognitive
functioning and ACDs.
The hypotheses and design of the experimental work 
presented in this thesis are based on the information 
presented in this review thus far, as well as that 
presented in chapter two. However, a more recent body of 
literature is now available and this literature informed
the interpretation and discussion of the results of the 
experimental work described in the thesis;.
Thompson (1991) wrote a review article on the memory 
functioning of patients with epilepsy. This article 
provided an over-view of the possible factors that may 
produce memory impairments in patients with epilepsy. The 
factors identified are those which were described in
chapter two), ffr example type oo eelieesy and 
interseizure activity. Thompson also reviewed the effect 
of treatment i.i. AACS oo memory functioning. She 
described different sets of studies, differing primarily 
on the subject sample chosen. In relation to studies 
carried out on normal volunteers (many of which were 
carried out by herself), she acknowledged several points
that may have hah o bearing on the selts Os obfaeded.
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Firstly, the doses of ACD, particularly of CBZ (600 mg), 
given to the volunteer subjects could be viewed as lower 
than the doses prescribed to patients with epilepsy. 
Secondly, the experiments were investigating the 
immediate effects of the drugs and not the long-term 
effects of the medication as taken by patients with 
epilepsy. Thirdly, the influence of ACDs on healthy 
brains may be different to the effects of the drugs on a 
seizure-prone brain.
Thompson also reviewed those ACD studies which 
included patients with a long term history of epilepsy 
and found that it is those subjects on polytherapy and 
with high levels of medication that produce the more 
dramatic effects on cognitive functioning. Those studies 
involving subjects with newly diagnosed epilepsy appeared 
not to produce such dramatic effects. Thompson 
interpreted this finding as being due to any negative 
effects of ACDs on cognitive functioning being off-set by 
improved seizure control. However, it could also be 
hypothesized that newly diagnosed subjects with epilepsy 
are more likely to be prescribed low doses of medication, 
as in the Andrewes et al (1984) study, rather than the 
very high levels of medication found in some polytherapy 
subjects, and at these low doses ACD medication do not 
produce impairments in cognitive functioning.
Thompson also discussed the nature of memory, 
pointing out the term memory is used in a wide variety of 
contexts and the meaning may differ in the different
circumstances. It is interesting to note that the way
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forward for Thompson is to unnsstugats the effects of 
epilepsy on memory by using tools that endeavour to 
measure everyday memory losses. These tools include 
observational and questionnaire methods.
Smith (1991) also reviewed the literature on the 
cognitive effects of ACDS. One of the interesting points 
raised in this review was the need to be cautious in 
interpreting results. To illustrate this point, Smith 
cited the re-analysis by Dodrill (1991) of his 1975 study 
comparing CBZ and DPH which showed that if reaction times 
were partially out of the test scores obtained in the 
study, the impairments of higher cognitive functioning 
attributed to DPH disappeared. Regardless of these types 
of possible errors in interpretation of data. Smith still 
endorsed the main finding of most recent studies that CBZ 
tended to show fewer impairments than DPH. Smith also 
reported that there had been fewer studies carried out on 
subjects on VPA. Those that had been carried out tended 
to find few effects of VPA on cognitive functioning, 
although this may be less so with higher levels of blood 
serum concentrations.
Studies in which there are few significant findings 
may not always be reported in the published literature. 
However, Meador, Loring, Huh, Gallager and King (1993.) 
described a study in which fifteen subjects with epilepsy 
participated in a study comparing the effects on 
cognitive functioning of the three ACDs, CBZ, DPH and 
phenobarbitone. The study was a within-subjects design, 
with each subject taking each of the drugs for a three
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month period. The study is interesting for two specific 
points. Firstly, a large battery of tests was 
administered, including measures of memory, motor and 
reaction time tasks, and on only one measure was there a 
difference between the three drug conditions. The 
performance of subjects when on phenobarbitone was 
significantly impaired compared to the other two drug 
conditions on a digit symbol task. The CBZ and the DPH 
conditions were not significantly different on any of the 
measures. Secondly, this study did measure the P300 
response as discussed in the previous section. There was 
no significant difference in either the latency or 
amplitude of the P300 between the three drug conditions.
Dodrill and Troupin (1991) investigated a hypothesis 
suggested by Meador et al (1991) that differences in the 
performances between DPH and CBZ in the Dodrill and 
Troupin (1977) study may in part be due to the much 
higher serum levels of DPH compared to CBZ. They re­
analysed their data having removed those subjects with 
very high levels of DPH. The results of this re-analysis 
showed no difference between the two drug groups, except 
for one motor task, which continued to show a lower 
performance for the DPH group.
Dodrill and Troupin go on to speculate as to the 
reasons for the differences in findings in studies 
particularly with regard to DPH. Firstly, most subjects 
undergo changes in their medication for clinical reasons, 
and thus represent a sub-set of that whole drug group,
i.e. those subjects doing badly on their medication. This
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sub-set of subjects may introduce biases into the data, 
not accounted for in the original exclusion criteria for 
studies. Also, many studies report very few significant 
findings compared to the number of analyses carried out 
(see chapter two in this thesis for examples) . With so 
few significant findings one needs to be cautious about 
interpreting results.
This more recent body of literature is less 
conclusive that there are significant differences between 
the three main ACDs, and in particular throws doubt on 
the view that DPH compares unfavourably to the other two 
drugs in relation to effects on cognitive functioning.
68
CHAPTER FOUR
STUDY ONE: INVESTIGATION OF THE COGNITIVE PERFORMANCE
OF SUBJECTS WITH EPILEPSY ON.ANTICONVULSANT , MEDICATION
(DUNDEE STUDY)
4.1 Introduction
This first study was carried out at the Dundee Royal 
Infirmary, with suitable subjects being identified by 
consultant neurologists, Dr.D.Davidson and Dr.R.Roberts.
The aim of the study was to assess the sensitivity of 
particular tests on the cognitive performance of subjects 
suffering from epilepsy, with special regard to the 
possible effects of their medication. The tests were chosen 
on the basis of the literature discussed in chapter three.
The test batteries of researchers, including Thompson 
and Trimble (1981, '82 and '83) and Andrewes et al (1984 
and '86) were described in detail in chapter three. These 
batteries differ, but one common area of testing was that 
of memory. Thompson and Trimble originally chose memory 
tests because patients suffering from epilepsy described 
having memory difficulties. However, giving subjects 
laboratory based memory tasks does not provide data that 
are easy to relate back to an individual's everyday IUCs. 
Two tests, the RivsrmeaS Behavioural Memory test (Wilson, 
Cockburn and Baddeley, 1985) and part of the Sunderland and 
Harris memory questionnaire (Sunderland, Harris and 
Baddeley, 1983) have been developed with the aim of linking
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tests and everyday difficulties. They are included in the 
test battery for this study. These tests purport to have a 
greater "ecological validity", thus allowing easier 
identification of individuals every-day memory problems.
Hence, if they were to be shown.to be of use in this area, 
they are tests that could be used as clinical as well as
research tools. ,
Also included in both the Thompson and Trimble work 
and the Andrewes et al work were tasks that had large 
visuo-spatial and/or motor components. These tasks included 
the category-decision and visual-scanning tasks in the 
Thompson and Trimble battery and the tracking task in the 
Andrewes et al battery. Hence, the battery of tests for 
this study included tests that have a large visuo-spatial 
component, one of which is an adaptation of Thompson's and 
Trimble's category-decision task.
The
therefore
study
tests
employed a between-groups
intellectual
design,
ability
and
wereof general
included to see if there were comparable levels of
intellectual functioning across the groups.
The battery of tests was administered to four groups
of clinical subjects on either carbamazepine (CBZ), 
phenytoin (DPH), sodium valproate (VPA) or polytherapy 
(POLYT) and also to a control (CTL) group. As the design of 
the study was a between-groups comparison, the groups were 
matched for age, sex and various aspects of their epilepsy.
7 0
In all, f eiey--ttref ssb jeets with lepsy and ten CTL 
subjects completed the test battery.
4.11 Hypotheses.
The hypotheses for the tudy. ereo asedO no the 
literature available before 1987, as presented in chapters 
two and three. The hypotheses were as follows :
1. There would be significant impairments of 
performance of the subjects with epilepsy, compared to 
the CTL subjects across the test batery. . A large 
number of studies investigating the effects of 
epilepsy on cognitive functioning identify a number of 
factors that would make impairments more probable. 
These factors are described in chapter two in sections 
2.5 (interseizure activity) and 2.7 (temporal 
factors). These factors, plus the possibility of 
impairments due to ACD medication, support this 
hypothesis.
2. Within the group of subjects with epilepsy, the 
subjects on polytherasy would show greater impairments 
compared to subjects on monotherapy. This hypothesis 
is supported by the work of Thompson and Trimble 
(1982) that showed that subjects on larger numbers of 
ACDs were more impaired on cognitive tests than when 
those subjects were on lower numbers of ACDs. Further 
studies by Gillham, Williams, Weidman, Butler, Larkin 
and Brodie (1987) also support the view that subject
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groups on polytherapy will show more cognitive
impairments.
3. Within the group of subjects on monotherapy, those 
subjects on DPH would show greater degrees of impaired 
performance than subjects on VPA or CBZ. This 
hypothesis is supported by the work of Thompson and 
Trimble in a range of studies which indicated that the 
number of impairments associated with CBZ and VPA were 
fewer than DPH. Other studies including Andrewes et al 
(1984 and 1986) also supported the view that DPH 
showed more impairments compared to CBZ.
4.2 Subjects
4.21 CriteCii eri idsrtiSsitu sub/etUs .
To be included in the study the subjects had to meet
the following criteria :
i) The age of the subject was between 15 and 55
years.
ii) The subject was free of any gross brain 
pathology, or history of neurosurgery.
iii) Anticonvulsant blood serum concentrations of 
those subjects on ACD medication, fell within the 
optimum therapeutic range as described by Davidson
(1983) :
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Anticonvulsant : Optimum, blood serum level
in umol/1, and per/ml fin brackets)
a. CBZ 20 - 50 (6 - 12 )
b. DPH 40 - 80 (10 - 20 )
c. VPA • 350 - 7 00 ( 50 - 100 )
d. PB J 80 - 180 (15 - 40 )
(Phenobarbitone)
iv) The subject was not suffering from any diagnosed 
psychiatric disturbance, for example depression.
v) The subject was not taking medication other than
anticonvulsants.
Similarly, the CTL subjects were between 15 and 55 
years old, not on any medication, and not suffering from 
any psychiatric illness. Most of the CTL subjects were 
relatives or friends of the clinical subjects who had 
participated in the study.
Verbal consent for participation in the study was
obtained through the responsible consultant and written 
consent was subsequently obtained from all subjects.
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4.22 Classifying of epilepsy variables
The clinical subject groups were monitored with 
regards to the following epilepsy variables :
a. Type of seizure.
The type of seizure was identified by the Consultant 
neurologists. Following the International classification of 
seizures (1981), as discussed in chapter two, and taking 
faOf account the views of the Consultant neurologists, 
three types of seizure were identified :
i. Generalised tonic-clfnft seizures.
ii. Complex partial sffzurf^.
fii. Complex partial -> secondarily generalised.
Hence, subjects with other types of seizure were not 
included in the study.
b. Aetiology of the epilepsy.
Indications of the aetiology of the seizures were 
noted, particularly if the seizures were of temporal lobe 
origin, or had a focus in one of the hemispheres.
c. Age of subject at the onset of the disease (years).
d. Duration of the disease (years).
e. Frequency of the seizures fas measured bv the
subject).
Frequency of complex partial and tonic-clonic seizures
were assigned to one of the following categories :-
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i. Several, i.e. greater than three, in the previous 
week (frequency 1).
ii. Several, i.e. greater than three, in the previous 
month (frequency 2).
iii. Several, i.e. greater than three, in the previous 
six months (frequency 3).
iv. Infrequently, i.e less than three, in the 
previous six months (frequency 4).
v. None recently, i.e. none in the previous six 
months (frequency 5).
Subjects who had had a recent seizure, i.e within the 
three days prior to testing were also identified.
4.23 Subjects Identified
63 subjects participated in the study, of whom 53 had 
a diagnosis of epilepsy and ten were CTL subjects. Of the 
53 subjects with epilepsy, 14 were on CBZ monotherapy, 13 
were on VPA monotherapy, 13 on DPH monotherapy and 13 on 
polytherapy. Table 4a shows the mean age and numbers of 
male and female subjects in each group. There were slightly 
more women in the study (N=3 5) compared to men (N=28) but 
this difference was spread across the drug and CTL groups. 
The mean age of all the subject groups was between 30 and 
40 years with similar standard deviations, supporting the 
view that the subject groups were well-matched for age.
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Subj ect 
Group
Table 4a Details of subject croups
M/F)No. in group Age
Mean
(yrs) 
(S.D.)
Sex (
CTL 10 35.8 (12.3) 5M, 5F
CBZ 14 39.1 (12.9) 5M, 9F
VPA 13 31.6 (13.7) 7M, 6F
DPH 13 37.4 (11.0) 7M, 6F
POLYT 13 31.5 (12.9) 4M, 9F
4.3 Rationale of the tasks used in the
test battery
This section describes the background and reasons for 
the inclusion of each test in the test battery. The 
procedure for administering the tests is described in 
section 4.5. .
4.31 Wechsler Adult Intelligence Scale-Revised
(WAIS-R). Wechsler (1981).
Sub-components of the WAIS-R can be administered to 
measure a subject's intellectual ability, although care 
must be taken in choosing appropriate sub-components. Some 
parts of the WAIS-R have been shown to be relatively 
impervious to general cerebral impairment (Babcock, 193 0) 
and are thus seen as providing an appropriate tool to 
measure premorbid intellectual levels, in the face of 
possible cerebral damage. Sub-components of the WAIS-R that
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"hold-up" in such situations are Vocabulary, Information, 
Picture Completion, and Object Assembly.
To obtain a measure of both verbal and performance 
abilities, the Vocabulary and the Picture Completion tests 
were selected and administered to all subjects.
4.32 Catebory-Decfsion Task:.
In the battery of tests employed by Thompson and 
Trimble (1981, 1982 and 1983), the category-decision task
was particularly sensitive to effects of ACDs. The task is 
a time-based measure requiring the subject to respond as 
quickly as possible to questions concerning the colour or 
category of an object presented visually on a computer
screen.
For this present study a sen-ane-paser version of the 
category-decision task was devised, as no computer was 
available. The same categories of colour and 
animate/inanimate objects were used as in the Thompson and 
Trimble task, and the times to complete all the trials in a 
particular condition were recorded.
4.33 Perceptual Maze Task (Elithorn, Jones. Kerr
and Lee, 1964).
This task was one of several tasks included to measure 
spatial and perceptual skills. This particular task is 
thought to assess perceptual and intellectual skills and 
involves a considerable amount of visual scanning to
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complete the test. The test has been employed to diagnose 
cerebral damage, especially in the right hemisphere 
(Sweetland and Keyser, 1983).
4.34 Benton revised visual retention test (Benton,
Glithorn, Fogel., and Kerr. 1963).
This test also measures visuo-spatial abilities. The 
task is used to screen for memory impairments as well as 
being a tool for identifying particular visuo-spatial 
errors, when subjects repeatedly make specific types of 
errors. It has been used widely in experimental research 
(Sweetland and Keyser, 1983).
There are four parallel forms, so allowing re-testing. 
Form "D" was employed in this study.
4.35 Rev-Osterrieth Complex Figure Test,
fBennet-Levy. 1984)
This test is the third measure of visuo-spatial 
abilities and the scores obtained provide two types of
measure :
a) A copy score :- This score reflects the accuracy of 
the original copy of the Rey-Osterreith figure and is 
viewed as a measure of the visuo-constructive ability.
b) Recall scores : - These scores measure the amount 
and the quality of the original information retained for 
either short-term or long-term periods.
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Hence, poor performance on this test could be for one 
of two reasons, either poor encoding of information, or 
poor retrieval of information.
4.36 Sunderland and Harris Questionnaire (Sunderland,
Harris and Baddelev, 1983)
Sunderland et al (1983) were concerned that laboratory 
tests may say little about how memory operates in everyday 
life. To address this issue, Sunderland et al (1983) 
developed questionnaires and check-lists that were both 
cheap and simple to use, and could be completed both by the 
subject and a relative of the subject. Sunderland et al 
(1983) used the questionnaires to compare normal controls 
and subjects with closed-head injuries. The responses to 
the questionnaire by the controls and the subjects with 
head injuries were then compared to the standard laboratory 
test performances of the same subjects.
In this present study, the 15 most frequently cited 
items of reported memory loss, of both the controls and 
subjects with head injuries were compiled into a shorter 
questionnaire which was completed by all the subjects and 
33 relatives in this study.
4.37 The Rivermead Behavioural Memory Test (RBMT)
(Wilson, Cockburn and Baddelev, 1985).
The RBMT was developed in part from the Sunderland et 
al (198 3) questionnaire. The RMBT is a short battery of
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memory tests, and was included in this study for two
reasons :
a) As the battery is easy to use and has four 
equivalent versions of the tests, it might provide a useful
screening tool, possibly at an out-patients' clinic:.
b) The test endeavours to have high ecological 
validity, but to also maintain the benefits of objectivity 
and rigour. Evidence supporting this claim is provided by 
work carried out at the Rivermead Rehabilitation Centre, 
where the performances on the RBMT and other standard 
memory tests are compared to the number of observed memory 
lapses of subjects with head-injuries, attending the 
centre. The highest correlation between observed memory 
lapses and test performance was with the RMBT, with a
correlation of 0.75.
The following quotation of Wilson et al (1985) 
provides a flavour of the purpose of the test :
"The RMBT was developed to detect the impairment of
everyday functioning,.........The test attempts to bridge
the gap between laboratory based measures of memory, and 
assessments obtained by observation and questionnaires."P5
4.4 Protocol for Study One : Order of
presentation of tests
The tests described in the rationale section were
administered to all subjects and were completed in the 
following order:
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1. WAIS-R Vocabulary and Picture Completion test:.
2. Category-Decision task:.
3. Perceptual Maze task:.
4. Revised Benton Visual Retention Test:.
5. Tasks 1 to 4 of the Rivermead Behavioural Memory
Test (RBMT) .
6. Rey-Osterrieth Figure : copy and immediate recall.
7. Tasks 5 to 12 of the RBMT.
8. Rey-Osterrieth Figure : delayed recall.
9. Memory Questionnaire.
The time of testing was varied and subjects
assigned to one of the following categories :
i. 9am until 12pm.
ii . 12pm until 3pm.
iii . 3pm until 6pm.
Whenever possible, after the testing session, a blood 
sample was taken from the subject so that a blood serum
analysis could be carried out to provide accurate measures
of circulating anticonvulsant levels at the time of
testing.
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4.5 Procedure : Administration of tests in battery
4.51 Sub-components of Wechsler Adult , Intelligence
Scale-Revised, (Wechsler 1982). (WAIS-R).
The procedure followed was that described in the WAIS- 
R Handbook (1982).
a. Vocabulary test.
The vocabulary list consisted of 35 words of 
increasing difficulty. The subject was asked the meaning of 
each of the words in turn and his/her response was recorded 
verbatim by the experimenter. If the subject had five 
consecutive failures, the test was discontinued.
When it was not clear whether the subject knew the 
meaning of a word the experimenter asked for further 
elaboration.
Each item on the list was scored as a ”2' ’ for a 
correct answer, a ”1" for a partially correct answer, or a 
i0«» for an inCorrect answer. Hence, the maximum score was
70. The raw score wa s the n converted to an age—•scaled
score, with a maximum score of 2 0, a mean of 10 and a
standard deviation of three points for the oorrnal adult
population.
(For further details of the test : see WAIS-R manual
(1982), P70-71.)
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b. Picture Completion test.
The materials for this test consisted of twenty 
pictures presented individually on cards. All the pictures
were incomplete in some observable way. The subject was 
asked to specify what was missing from each picture. Each 
card was shown for a maximum of twenty seconds, and the 
pictures were of increasing difficulty.
After five consecutive failures the test was
discontinued. Hence, the maximum score was 2 0 and the 
scores were converted to age-scaled scores, with the mean 
of the scale being 10 and the standard deviation for a 
normal population being 3.
(For further details : see WAIS-R manual (1982), P 63­
64) .
4.52 Categorv-Decision task
The computerised task employed by Thompson and Trimble 
(1981, '82 and '83) was converted to a "pen and paper"
version. The task consisted of practice conditions and 
three experimental conditions. Each of the experimental 
conditions was completed twice, and the subject was asked 
to complete all the conditions as quickly as possible.
In the practice task, the subject was presented with 
eight pairs of two by two centimetre squares on a sheet of 
paper, with one of each of the pair of squares lying 
opposite a star, (*) , sign (See figure 4a) . The subjects
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were asked to place a line through the boxes that were 
placed opposite the sign as quickly as possible.
*
Figure 4a : An example item from the
category-decision task
After the practice task, the subjects proceeded to do
the three test conditions. In all conditions, the time 
taken to complete each section was measured by the
experimenter using a stop watch.
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13.
YES
NO
j
Figure 4b: An example item
from the category-decision task, condition two.
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Condition one
The subject was told that 20 pairs of squares would be 
presented (8 pairs of squares per page, therefore, 2 1/2
pages in all) . The subject was asked, as in the practice 
task, to place a line through the square that lay opposite 
the •’*». The subject was asked to complete the task as 
quickly as possible, as the experimenter would be timing
the task.
Condition two
The subject was told that 20 objects would be 
presented (8 objects per page, therefore, 2 1/2 pages in
all) . The list of possible objects is shown in appendix 
two. With regard to each of the objects, the subject was 
asked to answer the following question; "Is the object 
presented on a shaded background ?" If the answer was "YES" 
the subject was told to place a line through the "YES" 
square, and if "NO" to place a line through the "NO" 
square. The words "YES" and "NO" were placed beneath the 
empty squares and were always presented in the same order 
i.e the top square was a "YES" square and the bottom square 
was a "NO" square. Figure 4b shows an item from the test 
with the lay-out of "YES" and "NO" squares.
The subject was shown an example of the task and was 
asked to do the task as quickly as possible .
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Condition three
2 0 objects were presented in the same manner as in 
condition two. However, on this occasion, the subject was
asked the question, " Is the object animate, i.e. either an 
animal or a plant? ". Again, if the answer was "YES" or 
"NO", the subject was told to place a line through the 
appropriate square. The subject was shown an example of the 
task and was told to complete the task as quickly as 
possible.
Conditions one to three were repeated, such that each 
subject completed the task twice. The order of presentation 
of the test conditions was varied in a Latin-square design, 
i.e for one third of the subjects the order of the 
conditions was one, two and then three; for another third 
of the subjects it was condition two, three and then one 
and for the final third of the subjects it was condition 
three, one and then two.
The times taken to complete each of the conditions and
the number of errors were recorded by the experimenter.
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Figure 4c: An example of a perceptual maze.
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4.53 Perceptual Maze task
The test material was composed of dot patterns 
superimposed on a lattice background. An example of the
task is shown in figure 4c.
As well as being shown n n example of the taak, the 
subjects were given the following instructions (written and 
verbal). The subject asn told that he/she would be 
presented with dot patterns, one at a -time , and of 
increasing complexity. In order to complete each of the 
patterns, the subject had to follow the path that completed
the maximum number of black dots. At the bottom left corner
of each dot pattern there would be a number that states the 
maximum number of dots that could be connected, on that 
particular dot pattern. The subject had completed the task 
when the specified number of dots had been joined. The 
subject:, however, had to follow two rules whilst looking 
for the path :
i. The subject had always to remain on the black path 
lines, and must not cross the white spaces.
ii. The subject must always move in a forward 
direction; thus, at any intersection, the subject could 
move on either the path to the right or to the left.
The subject began his/her path somewhere on the bottom 
line, and tried to find the correct path within two
minutes.
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Before attempting the test patterns the subjects 
completed two practice patterns; the results of these two 
tasks were not included in the analysis. If a subject 
required further explanation concerning the tasks, it was 
given at this point.
On the test patterns, the subject was allowed to fail 
one pattern, i.e. not complete one path in the allotted 
time. Hence, the test was discontinued when the subject
failed on a second pattern.
The dot patterns increased in complexity in such a way 
that the number of dots required to complete a particular 
path ranged from 5 to 15, and the number of distractor dots 
increased in proportion to the increasing number of path
dots.
If the subject began to break one of the two rules 
this was immediately corrected by the experimenter during
the task.
The times taken to complete the dot paths and the dot 
pattern at which the test was discontinued were recorded by 
the experimenter. -
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Figure 4d: Item D7 from the Benton Visual 
Retention Test.
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4.54 Revised Benton Visual Retention Test.
Version D of the Revised Benton Visual Retention Test 
was administered. The subject was told that he/she would be
shown, individually, 10 simple drawings. The subject was 
presented with each one for 10 seconds, and was then asked 
to wait for 15 seconds, before drawing the shapes from 
memory. These drawings were marked by number and type of 
errors as specified by the Benton handbook marking scheme. 
An example of one of the Benton shapes is shown in figure
4d.
4.55 The RBMT and the Rev-Osterrieth figure.
These two tasks were combined into one because the 
ability of the subjects meant that they did not normally 
require twenty minutes to complete the RBMT?, and hence, it 
was very difficult to administer the prospective items of 
the test. By combining the Rey-Osterrieth figure with the 
items of the RBMT this difficulty was overcome. Also, the 
items of the RBMT provided the distracting tasks between 
the immediate and the delayed recall of the Rey-Osterrieth 
figure. The combination of these two tasks took the
following protocol ;
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Figure 4e: A copy of the 
Rey - Osterrieth complex figure
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i) The prospective memory test items, i.e items one
to three, of the RBMT were administered. These were
presenting a portrait with a to-be-remembered name, 
hiding one of the subject's belongings, and setting
the timer.
ii) The Rey-Osterrieth figure, as shown opposite in 
figure 4e, was first copied and then immediately drawn 
from memory.
iii) Task four to twelve of the RBMT were then 
completed. These were recognition of pictures and 
photographs, immediate and delayed recall of prose, 
immediate and delayed recall of a route around the 
room, and the orientation questions. Recall of items
one to three was then tested.
iv) The Rey-Osterrieth figure was drawn from memory 
for a second time, so providing a measure of delayed 
recall of Rey-Osterrieth.
4.56 Memory Questionnaire
The questionnaire used in this study was an adaptation 
of the questionnaire devised by Sunderland et al (1983) and
consisted of 15 items.
The questionnaire was completed by the subject:, and 
the subject was asked to take a copy of the questionnaire 
away and ask a relative or close friend to independently 
complete the questionnaire on the subject's memory. Both 
the subject and the relative were asked to consider the
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subject's memory over the previous six months, and to rate 
the subject on the 15 items on the questionnaire. If a 
particular item occurred to the subject very frequently, 
the number ”4" was circled for that item, if occurring
quite often a "3", occasionally a "2", and if the item 
never happened a "1" was circled. The relative completed 
the questionnaire in the same way but always considering 
the subject's behaviour.
The subjects and their relatives were also given the 
questionnaires in a check-list form, i.e. 7 copies of the 
questionnaire numbered day one to day seven. The subject 
and the relative were asked to monitor the subject's 
behaviour over a seven day period, and to record the number 
the items that occurred to the subject on each of the seven 
days. They did this by recording a tick (or more than one 
tick, if the subject made the same error more than once) 
next to the appropriate item on that day. Hence, the 
relative's and subject's questionnaires and check-lists 
were taken home by the subject after completion of the test
session.
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CHAPTER FIVE
DUNDEE STUDY . ONE : RESULTS
5.1 Introduction
Patients and their relatives attending out-patients at 
the Dundee Royal Infirmary participated in this study. 63 
subjects (53 subjects with epilepsy and 10 controls) 
completed the test battery described in the previous 
chapter and summarised below :
1. Wais-R Vocabulary Test.
2. Wais-R Picture Completion Test.
3. Category-Decision Task.
4. Perceptual Maze Task.
5. Revised Benton Visual Retention Test:.
6. Rey-Osterreith Figure.
7. Rivermead Behavioural Memory Test:.
8. Memory Questionnaire.
Analysis of variance (ANOVA) was employed across each 
of the tests to compare the four drug groups (CBZ=14, 
VPA=13, DPH=13 and P0LYT=13) and the control (CTL) group 
(N=10) . This set of ANOVAs comprised the main body of 
results, with significant findings being further analysed 
using the Newman Keuls technique.
The Scheffe test, a conservative post-hoc test, more
suitable for comparisons in which groups differ greatly in
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size was used to compare the control group (N=10) and the 
epilepsy group (N=53), and also the monotherapy group 
(N=40) and the polytherapy group (N=13). For clinical 
interest:, two further sets of ANOVA were carried out to
compare controls versus subjects with epilepsy, and 
subjects on monotherapy versus subjects on polytherapy. 
These analyses provided a picture of the pattern of results 
for these comparisons, although the results must be 
interpreted cautiously because of the differences in sizes 
between the groups; hence the use of the Scheffe test as
described above..
The data relating to the clinical epilepsy variables 
will be described, followed by the results of the group 
comparisons.
5.2 Clinical Data
Variables assessing the type and severity of the
epilepsy disorder and its treatment were monitored for all
the subjects with epilepsy. The type of seizure, the
frequency of seizures, the age of onset and the duration of 
the condition and history of brain damage for each subject 
are shown in appendix three and the individual drug doses 
and blood serum levels are presented in appendix four.
Seizure type was classified as recorded in the 
subject's medical notes. Information on whether the subject 
suffered from more than one type of seizure; in particular,
may have suffered absence seizures was not available, in an
accessible manner, from these notes. However, it was 
noticeable that subjects did describe their experience of 
seizures as if they differed in type and severity, using 
terms such as "a mild one” or "a bad one".
Tables 5a, 5b and 5c summarise this data and are 
followed by group descriptions for each of the four drug
groups.
Table 5a : Table summarising the number of subjects in each
tvoe and frequency category of seizures.
Type of seizures Frequency of seizures
Drug (No. of subjects) (No. of subjects)
Group 1 2 3 i ii iii iv V
CBZ 5 1 7 0 1 1 4 7
VPA 7 3 3 0 2 1 2 8
DPH 10 1 1 0 2 1 0 9
POLYT 6 3 4 1 4 4 1 2
Key : Seizure type Seizure frequency
1 : Tonic-clonic i > 3 in previous week
2 : Complex partial ii > 3 in previous month
3 : Complex partial : iii > 3 in six months
(secondarily generalised) iv < 3 in six months
V None in six months.
Of the CBZ subjects, five (35.7%) were diagnosed as 
having tonic-clonic seizures, one (7.1%) as having complex 
partial seizures and seven (50%) as having complex partial 
seizures, secondarily generalised. The diagnosis of one 
subject was not available.
In terms of seizure frequency, one (7.1%) subject had 
more than three seizures in the previous month, one (7.1%)
subject had more than three seizures in the previous six
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months, four (28.6%) subjects had a seizure frequency of 
less than three seizures in the previous six months, and 
seven (50%) subjects had had no seizures in the previous
six months. The seizure frequency of one subject was
unobtainable.
Of the VPA subjects;, seven (53.8%) had tonic-clonic 
seizures;, three (23.1%) had complex partial seizures and 
three (23.1%) had complex partial, secondarily generalised, 
with the diagnosis of one subject being unobtainable.
In relation to seizure frequency, two (15.4%) subjects 
had had more than three seizures in the previous three 
months, one (7.7%) had had more than three seizures in the 
previous six months;, twt ( 11-4%) had had fewer than three 
seizures in the past six months, and eight (61.5%( had had 
no seizures in the past six months;.
In the DPH group, ten (76.9%) subjects had tonic- 
clonic seizures, one (7.7%) subject had complex-partial 
seizures and one (7.7%) subject had complex partial, 
secondarily generalised. The diagnosis of one subject was 
unobtainable.
In terms of frequency, two (15.4%) subjects had had 
more than three seizures in the past six months;, one (7.7%) 
subject had had less than three seizures in the previous
six months, and nine (69.2%) subjects had had no seizures 
in the past six months. The frequency for one subject was
unobtainable
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In the POLYT group), six (46.2%) subjects had tonic- 
clonic seizures, three (23.1%) had complex partial seizures 
and three (23.1%) hah complex partial, secondarily 
generalised. The d idgnosis of once subject was unobtainable. 
In terms of frequency, o no ( 7..%) suibbect head had more than 
three seizures in the previous week, four (30.8%) subjects 
had had more than three seizures in the previous month, 
four (30.8%) subjects had had more than three seizures in 
the previous six months, one (7.7%) had had less than three 
seizures in the previous six months, and one (7.7%) subject 
had had no seizures in the previous six months. The 
frequency for one subject was unobtainable.
In summary, most subjects had either tonic-clonic or 
complex partial seizures secondarily generalised. The 
numbers were spread evenly across the groups except for the 
DPH group which had a prreominaanc of tonic-clonic 
seizures. Most subjects had had very few seizures recently, 
although the frequency was higher in the POLYT group 
subjects, justifying the taking of more than one type of 
ACD. Only one subject had very frequent seizures, i.e more 
than three the previous week. Hence, it was not possible to 
look at the effects of recent seizures on performing the 
tests as there were insufficient data. Indeed, there were 
only two subjects who had suffered a seizure in the three
days prior to testing.
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Table 5b : Age at onset and duration of the epileptic
condition (No . of years)
Drug Group Age : Mean (S.D.) Duration : Mean (S.D.)
CBZ 22.6 (15.84) 15.9 (16.33)
VPA 22.5 (l4.72) 7.7 (4.97)
DPH 24.5 (l3.87) 13.0 (11.28)
POLYT 9.4 (9.28) 18.8 (l3.10)
Table 5b presents the mean age of onset of the 
disorder, which is very similar for the three monotherapy 
groups, both in terms in mean and standard deviations, but 
very different for the polytherapy group, with a mean age 
of onset of 9.4 years and a standard deviation of 9,28.
The duration of the condition is more variable, with 
the VPA group being the smallest (mean of 7.7 years and 
standard deviation of 4.97), the POLYT group being the 
largest (mean of 18.8 years and standard deviation of 
13.10) and the CBZ and DPH groups being similar and falling 
between the other two groups. The data for five subjects 
were unobtainable i.e not available in the medical notes.
Table 5c : Dose and blood serum concentration of medication
Drug
Group
of three monotherapy groups
Dose (mg) : Mean (S.D.) Concentration (nmol/1)
: Mean (S.D.')
CBZ 500 (23^.3) 26.1 (9.32)
VPA 1100 (633.)) 226.0 (47.93)
DPH 280 (93.)) 4486 (34.23)
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Table 5c presents the mean drug doses and serum 
concentrations for the three monotherapy groups as recorded 
at the end of the testing session. The means for each of 
the groups fell within the therapeutic optimum levels for
each of the drugs. However, in terms of individual 
subjects, two were below the optimum level in the CBZ 
group, one subject was above the optimum level in the VPA 
group), and one was below the optimum range in the DPH 
group). With regard to the serum concentration, two subjects 
were below the optimum level in the CBZ group,, and one was 
above and two below in the DPH group,. The doses for five 
subjects were unavailable i.e not recorded in the notes, as 
were the serum levels for fifteen subjects (See appendix 
four).
The POLYT group were taking a combination of ACDs, 
including the three drugs under investigation. In terms, of 
therapeutic levels, most fell in the therapeutic range for 
any one drug, with only one subject falling below the range 
for CBZ, and none being above this range. However, the data 
for four subjects were unobtainable. The data for the serum 
levels also revealed that most subjects;' concentrations 
fell within the therapeutic range, with one subject falling 
below this range in the case of CBZ and DPH and two 
subjects falling below with VPA. The data of five subjects 
were unobtainable. Interactions between the various drugs 
are possible, such that it is more difficult to know the 
therapeutic range for each of the drug combinations.
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In summary, the vast majority of subjects' drug 
concentrations, where data were available, fell within the 
recommended therapeutic range. However, it must be high­
lighted that many (N=20) serum levels were not available as 
the results from blood analyses were not entered into the
medical notes.
5.3 Quantitative Analyses
The quantitative analyses will be described in detail 
for the five groups comparisons. The results from most of 
the tests will be analysed by one-way ANOVAs comparing 
groups, and will be presented in tables. Where there was a 
within-subject factor of condition, two-way ANOVAs will be 
carried out, with a between-subjects factor of group and a 
within-subjects factor of condition. Where appropriate 
post-hoc analyses, i.e. Newman Keuls tests and Scheffe 
tests are employed.
A brief section at the end of the results will include
ANOVAs comparing the subjects with epilepsy (N=53) to the 
control subjects (N=10) and also the monotherapy subjects 
(N=40) to the polytherapy subjects (N-13). The design of 
this study renders these comparisons less orthodox because 
of the differences in the sizes of the groups and they are 
included only for clinical interest.
103
5.31 Missing data
There were no missing data points in this set 
so the issue of accommodating missing data 
comparisons did not arise.
of data,
for the
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Table 5d ; Analysis of tests of intellectual ability across
the five groups data (mean-scaled scores)
Test Subject group : Mean (S.D.)
CTL CBZ VPA DPH POLYT
Intellectual Ability 10.4 10.2 8 . -4 9.1 7.4
(Combined Score) (3.10) (2.03) (l.H) )0)13) (2.43)
Vocabulary 10.1 10.1 8.3 8.8 7.3
(3.11) (2.50) (1.84) (2.34) (2.46)
Picture 10.7 10.-4 8.5 9.3 7.5
Completion (3.45) (2..7) (2244) ) (2.86)
Table 5e : Results from the tests of intellectual ability
across the five groups
Test Five groups ) F rrtio (Df) and
significance level
Intellectual
Ability F = 3.34 P < 0.05
(Combined Score)
Vocabulary F = 2.96 ((,58) P < 0.05
Picture F = 2 . £57 ((^s) P < 0.05
Completion
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5.3 2 Comparison botween deuu and codtcol qroupr
The five groups (CBZ=14, VPA=13, DPH=13, P0LYT=13 and 
CTL=10) were anaOysed using ANOVA. Each of the tests in the 
test battery was analysed separately.
The results will be presented both to provide a 
picture of the performance of the drug groups and to 
describe the effect of conditions and bnb-pannb of the 
tests on subject performance.
5.33 Five group anaOvses of tests of
intellectual ability
A measure of intellectual ability was attained using 
the mean of the scores from the Vocabulary and the Picture 
Completion test. Three one-way ANOVAs were carried out, 
each of the two tests being analysed separately, and then a 
third analysis carried out on the combined scores. The mean 
scores and standard deviations across the five groups for 
the tests of intellectual ability are summarised in table 
5d. The CTL and CBZ group obtained the highest means, 
followed by the DPH group, the VPA group), with the POLYT 
group obtaining the lowest scores. The standard deviations 
were largest in the CTL group, smallest in the VPA group), 
and similar in size in the other three groups. The data 
were analysed using ANOVA, which revealed significant 
between group effects in all three analyses; for the 
combined scores (F 4,58 = 3.34, P < 0.05), for the
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Vocabulary task (F 4,58 = 2.96, P < 0..0) aan (fo the 
Picture Completion task (F 4,58 = 2.87, P < 0.05) (See 
table 5e).
Post hoc Analysis
As all three measures of intellectual ability were 
significantly different at the P < 0.05 level, a Newman
Keuls test was used on each set of the results. In the 
combined scores analysis, the POLYT group had significantly 
poorer performance aa thh P < 0^0 levl 0 ompaaedO oo the 
CBZ group, the CTL ggrup and the DPH goop.( There reoe no 
other significant differences between the groups.
The Newman Keuls analyses also revealed the POLYT 
group to be significantly poorer in performance (P < 0.05) 
on the Vocabulary ttes ccfiaaaV to tth CTL. aan tth CBZ 
group and poorer than the CTl group ( P < 0.05) on the
Picture Completion test. No other groups were significantly 
different.
In summary, the POLYT group performed significantly 
worse than the CTL group), and also worse than the CBZ and 
the DPH groups on some of the measures of intellectual 
ability. These results support the hypothesis that the 
POLYT group would perform significantly worse than the CTL 
and monotierapy groups.
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Scheffe test
The Scheffe test was used to compare all those 
subjects with epilepsy, i.e. the four drug groups combined
(N=53) , with the CTL group (N=10) , and also all those 
subjects on monotherapy, i.e the CBZ, the VPA and the DPH 
groups combined (N=40) were compared to the POLYT group 
(N=13), on scores of intellectual ability. No significant 
differences were found in these set of analyses;. Hence, 
these analyses supported the null-hypotheses that are no 
significant differences in performance between the CTL and 
epilepsy groups, and none between the monotherapy and 
polytherapy groups;.
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Table 5f Mean total times for the category-decision task
for the five groups
Test Subject group : Mean (S.D.)
CTL CBZ VPA DPH POLYT
Category-]Decision Task (Total time in secs)
Condition 1 17.2 18.5 20.9 23.9 25.8
(2.35) (6.24) (5.08) (9.22) (10.20)
Condition 2 20.9 22.6 27.6 28.1 32.3
(4.67) (6.83) (9-53) (11.64) (12.08)
Condition 3 24.6 23.6 31.4 29.9 34.8
(7.53) (7.18) (7.71) (9.27) (15.18)
Table 5q ANOVA of the cateqorv-decision tasks for the five
groups
Test Five groups : F ratio (Df) and
significance level
Category-Decision
Task
Effect of groups F = 3.07 (4,58) P < 0.05
Effect of condition F = 71.32 (2,116) P < 0.001
Interaction (Group F = 1.38 (8,116) P > 0.1
by condition)
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Figure 5a: Graph of mean response times of five groups in the 
category-decision task
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The category-decision task was completed twice by the
subjects and the total time to complete each set of 20
trials was recorded, as well as the number of errors.
Two subjects did not follow the procedure correctly
i.e. did not immediately turn over the pages to continue 
doing the task, on their first attempt at the task. Hence, 
the data used for the analysis were the data from the 
second attempt at the task:, which all subjects completed 
correctly. The mean total times for each of the three 
conditions of the task were compared in a two-way ANOVA 
with a main effect of groups and a within-subjects factor
of condition.
The means and standard deviations for this task are
presented in table 5f. In general, the means for the CTL 
group and the CBZ group were the fastest:, followed by the 
VPA group, the DPH group and finally the POLYT group. For 
example, the means for the five groups for condition one 
were 17.2 (CTL), 18.5 (CBZ), 20.9 (VPA), 23.9 (DPH) and
25.8 seconds (POLYT), respectively, with increasing time 
representing poorer performance as shown graphically in 
figure 5a. The standard deviations followed the same order 
with the largest standard deviations occurring in the POLYT 
group and the smallest in the CTL group). The "F" ratios, 
the degrees of freedom and the significance levels are 
presented in table 5g and reveal a group main effect (F
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4,58 = 3.07, P < 0.05) and an effect of condition (F 2,116 
= 71.32, P < 0.001) .
The number of errors was also monitored. The number of
errors was small with the majority of subjects making no
errors. Table 5h summarises the total number of errors for
each of the groups across each of the conditions. It is 
interesting to note that there was not great variability in 
number of errors across the conditions.
Table 5h : Total number of errors recorded for the five
groups in each condition of the category-decision task
Group Condition 1 Condition 2 Condition 3
CTL 1 0 0
CBZ 1 0 2
VPA 1 2 1
DPH 1 2 2
POLYT 6 5 2
The data from the error scores were not analysed 
statistically due to the small number of errors. However, 
the larger number of errors obtained by the POLYT group is 
apparent.
Post hoc Analysis
The significant findings in the category-decision 
ANOVA were further analysed using Newman Keuls test. The 
analysis of the main effect of groups revealed that the 
POLYT group performed significantly poorer compared to the 
CTL group and the CBZ group (P < 0.05). There were no other
group differences. These analyses again show some support
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for the hypothesis that the POLYT group would show 
impairments compared to other groups;.
The effect of condition was also analysed using Newman
Keuls test and revealed that all three conditions were
significantly different from each other (P < 0.01), with
the tasks increasing in difficulty from condition one to
three.
/Scheffe test
y
The Scheffe test was used to compare all those 
subjects with epilepsy, i.e. the four drug groups combined, 
with the CTL group, and also subjects on monotherapy to the 
POLYT group), on the results from the category-decision 
task:. No significant differences were found in this set of 
analyses. Hence, these analyses support the null-hypotheses 
i.e. that there are no significant differences between the
groups.
In summary, the results revealed poorer performance by 
the POLYT group compared to the CTL and CBZ group). There 
were also significant effects of conditions but no test
condition by group interactions.
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Table 5i: Mean scores on the RMBT and memory
questionnaire for the five groups 
Test Subject group : Mean (S.D.)
CTL CBZ VPA DPH POLYT
Rivermead Behavioural 
Memory test
Screening Score 10.3
(1.42)
Profile Score
Prose Recall
66.9 
(5.67)
Immediate : Raw 9.45
score (2.62)
Delayed : Raw 8 r 45
score (1.88)
10.6 9 r 7 9.9 8.5
(1.16) (1.55) (1.77) (2.44)
67 ) 0 62 ) 1 64.9 58.3
(8.47) (8.63) (7.30) (9.52)
9.68 7.89 8.70 6.46
(3.89) (3.27) (2.66) (2.98)
8.25 6.85 7.26 5.73
(3.51) (3.67) (2.47) (3.55)
Memory Questionnaire 23.4 29.4 29)6 27.4 31.9
(Raw scores) (8.46) (8.04) (10.99) (13.85) (11.31)
Table 5~ ANOVA of the RMBT and the memory questionnaire
for the five groups
Test F ratio (Df) and significance level
Rivermead Behavioural 
Memory test
Screening Score F = 2 r 57 (4,58) P < 0.05
Profile Score F = 2.50 (4,58) P = 0.051
Prose Recall F = 1.89 (4,58) P > 0.1
Effect of Condition F = 43.23 (1,116) P < 0 r 001
Group by condition F < 1
Memory Questionnaire F < 1
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Figure 5b: Graph of mean screening scores for five groups on
the RMBT
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5.35 The Rivermead Behavioural Memory Task (RMBT) and
Memory Questionnaire
These two tests were included in the battery to
provide a measure of memory impairments related to everyday
life.
The RMBT produced two scores for each of the groups. 
The profile score was obtained from the sum of the raw 
scores on each of the sub-components of the RBMT, and these 
raw scores were converted to the screening scores. The RMBT 
contains, as one of its sub-components, a prose recall 
task. This standardised verbal memory task has been 
analysed individually as a comparison to the visuo-spatial 
memory tasks in the test battery.
The profile and screening scores were analysed by two 
separate one-way ANOVAs, whereas prose recall was analysed 
by a two-way ANOVA with a main effect of groups and a 
within-subjects factor of immediate versus delayed recall..
The pattern of means across both the screening and the 
profile scores revealed the CBZ group obtaining the higher 
scores, followed by the CTL group, the DPH group, the VPA 
group and finally the POLYT group (see table 5i and figure 
5b) . The standard deviations were once again largest for 
the POLYT group, followed by the VPA and DPH group and 
smallest for the CBZ and the CTL group (See table 5i) . The 
ANOVA revealed a significant between groups difference in 
the screening score analysis (F 4,58 = 2.57, P < 0.05) and
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a trend in the profile score (F 4,58 = 2.50 P = 0.052) (See
table 5j)
Post hoc Analysis
Newman Keuls analysis was carried out on the screening 
data and showed the POLYT group performing significantly
worse compared to the CTL group (P < 0.05). No other
significant differences found. This result supported the 
hypothesis that the POLYT group would perform worse than
the CTL group.
yScheffe test
y
The Scheffe ttst was used to compare all those 
subjects with epilepsy and the CTL group), and also subjects
on monotherapy to the POLYT group, on the screening score 
results. No significant differences were found in this set 
of analyses, thus supporting the null-hypotheses i.e. that 
there are no significant differences between the groups.
The prose recall analysis revealed a similar pattern 
of means and standard deviations to the screening and 
profile scores, bbu the NOOAP revealed no group 
differences. There was, not surprisingly, an effect of 
condition (F 4,58 = 43.23, P < 0.001), with subjects
performing less well on the delayed recall part of the 
task. There was no group by condition interaction.
The memory questionnaire scores that were obtained 
from the subjects at th< time o< testing were analysed
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using a one-way ANOVA, which revealed an "F" ratio of less 
than one, and so no further analysis was carried out.
Only 33 (58%) of subjects returned the postal 
questionnaires and check-lists. Hence, there were not 
sufficient questionnaires completed by relatives, nor 
enough seven day check-lists to include in a between-groups 
analysis, and so, no analysis was carried out on these
data.
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Table 5k Mean scores on the visuo-soatial tasks for
the five groups
Test Subject group : Mean (S.D.)
CTL CBZ VPA DPH POLYT
Perceptual Maze 3.8 3.9 3.2 3.3 2.7
Task (1.99) (1.77) (1.57) (1.79) (1.11)
Benton Visual retention test
Score 8.1 7.1 7.3 6.2 5.8
(2.03) (2.40) (2.81) (2.54) (3.65)
No.errors 2.40 4.07 4.23 7.00 6.39
(3.03) (4.58) (5.20) (6.47) (6.53)
Rey-Figure
Part 1 35.4 34.8 33.9 32.7 31.7
(1.08) (1.16) (3.57) (5.15) (5.73)
Part 2 25.0 24.9 23.7 22.5 20.5
(5.02) (6.30) (9.32) (8.65) (9.39)
Part 3 25.7 23.2 24.6 20.6 19.8
(4.23) (7.09) (8.39) (10.37) (8.88)
Table 51 ANOVA of the visuo-soatial tasks for
Test
the five groups
F ratio (Df) and significance level
Perceptual Maze Task F = 1.14 (4,58) P > 0.1
Benton revised visual 
Score
retention test
F = 1.34 (4,58) P > 0.1
No.errors F = 1.49 (4,58) P > 0.1
Rey-Figure
Effect of Group F = 1.20 (4,58) P > 0.1
Effect of Condition F = 163.0 (2,116) P < 0.001
Interaction
(Group by Condition)
F < 1
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5.36 Visnc-spatial tasks
Three tasks requiring visuo-spatial cognitive 
processes were included in the battery. All three produced 
a similar pattern of means and standard deviations. The CTL
group and the CBZ tended to have the better mean scores and 
the smaller standard deviations, with the VPA and the DPH 
groups falling in the middle, and the POLYT group obtaining 
poorer means and larger standard deviations. These means
and standard deviations are summarised in table 5k. Each of
the three tests was analysed using ANOVA; a one-way ANOVA 
for the Perceptual Maze tasks scores, two one-way ANOVAs 
for the Benton Visual Retention task, (one for the scores 
and one for the number of errors as it was possible to 
score a high number of errors on any one of the ten trials;) 
and a two-way ANOVA for the Rey-Osteoreoth figure, with a 
within groups factor of conditions. None of these analyses 
revealed any significant differences between the groups 
(See table 51) . There was, not surprisingly, an effect of 
condition in the Rsy-Osterreith figure task (F 4,58 = 
163.0, P < 0.001), i.e the subjects found the complex 
figure more difficult to draw from memory, than to copy, 
but there was no group by condition interaction.
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5.36 Summary I
I
In general, the CTL and CBZ group means were in 
direction of better performance than the OPA and DPH means 
which in turn were better than the POLYT group). Th^ 
standard deviations, however, were in the opposite 
direction with increasing standard deviations corresponding 
with lower performance means.
There were significant impairments for the polytherapy 
group compared to the CTL and CBZ groups on the tests of 
intellectual ability, the Rivermead behavioural memory test 
screening score (with a trend obtained on the profil^ 
score), and on the category-decision task. No group by 
condition interactions were obtained. No significant 
differences were found on the visuo-spatial tasks, nor oh 
the memory questionnaire. Hence, there was some support for 
the hypothesis that the POLYT group would show impairments 
compared to CTL group and some of the monotherapy groussi.
IHowever, there was no support for the hypotheses concerning 
differences between the monotherapy groups themselves, and 
in comparison to the CTL group, as no significant 
differences were obtained between these groups.
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Figure 5c: Graph of spread of individual mean response times for 
condition two of the category decision task for five groups
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Figure 5d: Graph of the spread of Rey-Osterreith figure scores 
for five groups
Drug Group
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5.4 Further analysis
The comparisons between the groups using ANOOA yielded 
few significant differences between the five groups, with 
the exception of the POLYT?. However, there were consistent 
patterns of data. The CTL and CBZ groups consistently 
obtained higher mean scores compared to the OPA and DPH 
groups, and these two groups consistently obtained higher 
mean scores than the POLYT group. It was also noticeable 
that the groups with the lower mean scores tended to have 
larger standard deviations. This pattern is shown on the 
category-decision task, for example on condition one the 
mean times and standard deviations (shown in brackets) for 
the CTL, CBZ, OPA, DPH and POLYT groups were 17.2 s (2.35), 
18.5s (6.24), 20.9s (5.08), 23.9s (9.22) and 25,8s (10.2) 
respectively. Figures 5c and 5d show graphically the spread 
of scores on both the category-decision task and the Rey-
Osterreith task.
On many of the tests, the analysis using ANOOA 
supported the null-hypothesis i.e. that ACDs have no 
effects on cognitive functioning and there are no 
significant differences between the drug and CTL groups. 
However, as ANOOA compares the amount of the variance 
across the groups to that within the groups, these large 
standard deviations would have reduced the possibility of 
finding between-group differences.
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Subj
Table 5m Ranked mean Z-scores for subiects
RankDrug Z-sco:
across test batterv
Z-scorere Rank Subj Drug
18 CBZ 1.49 1 29 VPA -0.55 3349 CTL 0.92 2 31 DPH -0.57 3408 CBZ 0.89 3 10 VPA -0.58 3515 CBZ 0.88 4 2 5 CBZ -0.59 3650 CBZ 0.80 5 09 VPA -0.65 3745 POLYT 0.75 6 41 POLYT -0.77 3856 CTL 0.54 7 64 DPH -0.82 3940 CTL 0.37 8 65 DPH -0.83 4052 DPH 0.20 9 27 CTL -0.85 4157 CTL 0.19 10 26 DPH -0.88 4244 DPH 0.16 11 53 VPA -1.03 4342 VPA 0.16 11 13 VPA -1.04 4412 CBZ 0.15 13 67 VPA -1.09 4561 DPH 0.15 13 34 POLYT -1.09 4523 CBZ 0.14 15 16 CTL — 1.11 4728 CTL 0.14 15 20 CBZ -1.17 4846 CTL 0.12 17 55 POLYT -1.26 4821 CBZ 0.11 18 30 VPA -1.38 5035 CTL 0.08 19 47 CBZ -1.54 5151 CTL 0.08 19 60 DPH -1.54 5117 VPA 0.04 21 06 DPH -1.73 5314 CBZ 0.01 22 4 3 POLYT -1.83 5439 VPA — 0.01 23 59 POLYT -2.08 5554 VPA -0.03 24 36 POLYT -2.39 5622 CBZ -0.19 25 48 VPA -2.52 5758 DPH -0.24 26 68 POLYT — 2.60 5811 VPA -0.25 27 33 POLYT — 2.66 5932 POLYT -0.27 28 19 CBZ -2.74 1907 CBZ — 0.40 29 63 POLYT -2.76 6324 POLYT — 0.46 30 66 POLYT -3.87 6262 DPH -0.53 31 38 DPH -4.80 6337 DPH -0.54 32
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Given that there were large standard deviations on 
some tests for some of the drug groups, are there 
individuals within the drug groups who could be identified 
as out-liers compared to the CTL group? If so, who are 
these individuals and can any reasons be identified as to 
why they performed as out-liers?
In order to answer these questions, the z-scores for 
each of the subjects on each of the tests were computed 
using the standard deviations of the CTL group). The mean of
the of z-scores for the tests was used to rank the
performance of each subject on the tests. Table 5m shows 
the mean z-score across the tests for each subject and the 
rank order of the subjects, with rank 1 obtaining the 
highest z-scores and rank 63 the lowest.
The range of z-scores was from 1.49 to -4.80, with 21 
subjects obtaining a mean z-score above zero and 42 
subjects obtaining an mean z-score below zero. The lowest 
z-score obtained by a control subject was -1.11 which was 
ranked at 47. Hence, 16 epilepsy subjects obtained lower z- 
scores than the lowest scoring control subject and eight of 
these subjects scored z-scores that were more than double 
that of the lowest control subject in the direction of poor 
performance, i.e. larger than -2.22. These subjects are 
identified as out-liers.
One possible way to reconcile this observation with 
the lack of significant differences in the ANOVAs, is to 
suggest that although the majority of subjects did not show
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significant impairments on the test battery, such that 
there were no overall group differences, there were a 
number of clinical subjects who did perform very poorly on 
the battery of tests.
One possible reason for the poor performance of some 
clinical subjects is explored by looking at the eight 
subjects who performed poorly across the tests compared to 
the CTL subjects. The clinical characteristics of these 
subjects will be described to explore possible avenues why 
these subjects performed so poorly.
5.41 Details of individual subjects
Of the subjects on monotherapy, three subjects were 
identified as out-liers on the z-score analysis. The 
clinical details of these three subjects are described
below:
Subject number 48 was a 52 year old woman who suffered 
from complex partial, secondarily generalised seizures. The 
first seizure occurred when she was 47 years old, i.e the 
duration of the disorder was five years, but she had 
suffered no seizures in the past six months. This subject 
was taking OPA, and although the dose was not recorded in 
the medical notes her serum level at the time of testing 
was 399 jmol/1, which is at the low end of the therapeutic 
range.
Subject number 3 8 was a woman aged 5 0 years, for whom 
epilepsy was diagnosed when she was 47. This individual
suffered from generalised tonic-clonic seizures but she had
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suffered none in the previous six months. She was taking 
200 mg of DPH daily and the serum level of her medication 
at the time of testing was 62 jirnol/1, which is in the 
middle of the therapeutic range.
Subject number 19 was a 52 year old woman. The details 
of her epilepsy could noo be found aa her medical notes 
were missing. However, she reported having suffered no 
seizures recently, and her serum level of CBZ at the time 
of testing was 31 pmol/l which is in the middle of the 
therapeutic range.
Five subjects performing as out-liers were identified 
in the POLYT group. The clinical details of these subjects
will be described.
Subject number 33 was a 22 year old woman who suffered 
from gnnrralised omnic-clonic seizure3. The first seizure 
occurred when she was thirteen years old, and hence the 
duration of the disease was nine years. The subject still 
suffered seizures but these occurred at a frequency of less 
than three per six months. The subject was on daily doses 
of 600 mg DPH and 1500 mg VPA and had serum levels at the 
time of testing of 44 jmol/l DPH and 205 jarnoo/l VPA, which 
are well within the therapeutic range for these ACDs.
Subject number 3 6 was a 3 8 year old woman who had 
suffered complex partial seizures since the age of nine 
years. This subject still suffered from regular seizures 
which occurred at a frequency of more than three per month. 
She was on daily doses of 325 mg DPH and 60 mg
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IPieinobarbitonG, Unfortunately, the serum levels of the 
medication at the time of testing were not available.
Subject 59 was a 34 year old man who had suffered 
generalised tonic-clonic seizures for three years. This 
subject still suffered from regular seizures at a frequency 
of greater than three per month. This subject was on a 
combination of CBZ and Clobazam. The dose of CBZ 700 mg and 
the serum level at the time of testing was 41 ttmol/1 which
is in the middle of the therapeutic range. The dose and
serum levels of the clobazam were unavailable.
Subject number (53 was a 2 0 year old woman who had 
suffered from complex partial seizures from early 
childhood. She had not suffered from any seizures in the 
past six months. This subject took CBZ (400 mg daily) and 
phenobarbitone (60 mg) daily and her serum levels for these 
two drugs at the time of testing was 13 yimol/l and 41 
2imol/1 respectively, both of which are at the low end of 
the recommended therapeutic range.
Subject number 656 had suffered from complex prrtial 
seizures for a number of years (her medical notes did did 
provide more prreiie onforrnation io 2hn the af onsot of 2er 
condition). She was still suffering from regular seizures 
i.e. more than three per week. Her medication consisted of 
1000 mg of CBZ and 800 mg of VPA daily.. The serum levels of 
these drugs at the time of testing was 49 yumol/1 and 408 
yumol/1 respectively. Hence, the level of CBZ was at the top
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of the therapeutic range whereas the OPA was at the lower 
end of the therapeutic range.
The clinical details of these subjects does not point 
any one clinical factor that might throw some light as to
why these individuals performed so poorly on the test 
battery. They showed a range of presentations in terms of 
seizure type, duration of disorder and frequency of recent 
seizures. The subjects on POLYT tended to suffer from 
higher seizure frequencies, so justifying the need for
POLYT.
The ACD doses and serum levels tended to be well
within the recommended therapeutic ranges.
One interesting factor is that seven of the eight
individuals were female.. 3 0 of the 53 subjects with
epilepsy in this study were female, although it is still 
somewhat surprising that so many of this group of out-liers 
were female. There is, however, a large amount of clinical 
data that is unknown with regard to these individuals, for 
example the possibility of cerebral damage or the presence 
of interseizure activity, both of which may be related to 
cognitive performance.
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Table 5o Mean scores for the goileniv versus CTL groups
(Mean scores combined across conditions of tests)
Subject Group : Mean (S.D.)
Test CTL Epilepsy
Intellectual Ability (Age-scaled score)
(Combined score) 10.2 (3.11) 8.8 (2.34)
Category-decision Task (in secs)
(Combined score) 21.6 (4.96) 26.5 (10.21)
Rivermead Behavioural Memory Test
Screening Score 10.3 (1.42) 9.7 (1.88)
Sunderland and
Harris Questionnaire 23.4 (8.46) 29.4 (10.93)
Perceptual Maze Task
(No. mazes completed) 3.8 (1.99) 3.3 (1.61)
Revised Benton Retention task
(No. correct) 8.1 (2.03) 6.6 (2.87)
Rey-Figure
(Combined Score) 28.9 (4.32) 26.1 (7.34)
Table 5d Results from the guileusv vs CTL groups adaavsli
Test Two groups : F ratio (Df) and
CTL versus Epilepsy significance level
Intellectual Ability 
(Combined score) F = 2.70 (1,61) P > 0.1
Category-decision Task 
(Combined Score) F = 3.37 (1,61) P 0.072
Rivermead Behavioural Memory Test
Screening Score F = 2.88 (1,61) P > 0.1
Sunderland and
Harris Questionnaire F = 2.69 (1,61) P > 0.1
Perceptual Maze Task F < 1
Revised Benton
Retention Test F = 2.48 (1,61) P > 0.1
Rey-Figure F = 1.62 (1,61) P > 0.1
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5.5 For Clinical 2Clinica i terest2 versut
clinical suMe^s
The performance on the tests of the subjects with 
epilepsy (N=53) was compared to the CTL group (N=10) using 
ANOVA. Most of the analyses were one-way ANOVAs with a 
between-groups factor of epilepsy versus non-epilepsy. For 
those tests with different conditions, two-way ANOVAs were 
carried out with a between groups factor of epilepsy versus 
non-epilepsy and a within-groups factor of condition.
Table 5o contains the means and standard deviations
for the combined mean scores for the two groups across all 
the tests. (Note that as there were no group by condition 
interactions found in the monotherapy versus polyrhfrapy 
analyses, for those tasks where there were more than one 
condition, the combined means and standard deviations 
across all conditions are presented).
The results of the ANOVA analyses, in terms of "F" 
ratios, degrees of freedom and levels of significance 
across these three tests are presented in table 5p
Comparing the CTL group to all the subjects with 
epilepsy combined as one group produced a pattern of 
results in which the means of the CTL group were generally 
the direction of better performance compared to the 
clinical group. The standard deviations were generally 
larger for the clinical group. However, the differences 
between the means, when analysed by ANOVA, were not 
significant, with only the category-decision task showing a
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trend i.e P < 0.1, in the direction of impaired performance 
of the clinical group. There were no significant group by
condition interactions.
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Table 5g Mean scores for the tests for the monotherapy
versus polytherapy groups 
(Mean scores combined across conditions of tests)
Subject Group : Mean (S.D.)
Test MONOT POLYT
Intellectual Ability (Aeessaaeed score)
(Combined score) 9.26 (2.15) 7 .39 (2.3))
Category-decision Task (in secs)
(Combined scores) 25.1 (8.62) 31 .0 (12.63)
Rivermead Behavioural Memory Test
Screening Score 10.0)8 (1.5)) 8 .54 (2.4))
Memory Questionnaire 28.88 (10.0)) 31 .00 (H.D)
Perceptual Maze Task 3.4 (l.?) ) 2 . 7 (1.1))
Revised Benton Retention Task
(Score) 6 . 9 (2.5)) 5 . 8 (2.5))
Rey-Figure 
(Combined Scores) 26.8 (15.3) ) 24 . 0 (7.2))
Table 5r Results of the monotherapy versus polythsrapv
analvsis
Test F ratio (Df) and significance level
Intellectual Ability
(Combined Score) F = 6.06 (1,51) P < 0.05
Category-decision Task
(Combined score) F = 4.3.0 (1,51) P < 0.05
Rivermead Behavioural Memory task
Screening Score F = 7..3 (l/51) P < 0.01
Memory Questionnaire F < 1
Perceptual Maze Task F = 2..3 (1,51) P > 0.1
Revised Benton Retention Task
(Score) F = 1.21 (1,51) P > 0.1
Rey-Figure
Effect of Group F = 1.51 (1) P > 0.1
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5.6 For clinical Interest : Monotherapy versus
Pslvre.frapv groups
The subjects with epilepsy wer e divide2 into two 
groups, those on monotherapy (N=40) and those on 
polytherapy (N=13). The performance of the two groups was 
analysed using ANOVA (a one-way ANOVA, with one factor of 
groups, for those tests without conditions and a two-way 
ANOVA with factors of groups and conditions, for those 
tests with conditions).
The monotherapy group had means in the direction of 
better performance, and also smaller standard deviations 
than the pslytherapy group). The means and standard 
deviations are presented in table 5q. (Note that as there 
were no group by condition interactions found in the 
monotherapy versus polytherapy analyses, for those tasks 
where there oere more than one oudtrtlon. he 2 combined
means and standard deviations across all conditions are
presented).
The results were analysed by ANOVA and several of the 
comparisons produced significant findings. The polytherapy 
group portomed oignificantly worse on the combined 
intellectual ability score (F 1,51 = 6.06, P < 0.05), on 
the category-decision task (F 1,51 == 4.10, P < 0.05) and on 
the Rivermead Behavioural Memory Test screening score (F 
1,51 = 7.38, 2 o 0.01). However, neither the memory
the visuo-spatial tasks showedquestionnaire nor
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significant differences. Table 5r presents the group effect 
”FW ratios, degrees of freedom and significance levels.
5.6 Summary
A number of interesting features and results arose 
through the course of this study. These points will be 
summarised below with further discussion taking place in 
the main discussion chapter (see chapter eleven) :
1. The number of subjects in the five groups was 
smaller than anticipated, in spite of the fact that the 
study ran for 18 months. Identifying suitable subjects in a 
busy hospital setting was not as straight-forward as was 
anticipated at the out-set.
2. The test battery was easy to run, and the data easy 
to collect, which was reflected in the lack of missing data 
points. The only exception to this were the postal check­
lists and questionnaires, which were removed from the 
analysis.
3. The clinical information concerning the subjects 
with epilepsy revealed a set of subjects that had a long 
duration of epilepsy but who had reasonably well-controlled 
seizures. There was only one subject, in the POLYT group 
who reported getting three or more seizures in a week and a 
small number reported getting several in one month (again 
mostly in the POLYT group).
4. The analysis of results did not produce a great 
number of group differences and hence, tended to support
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the null-hypotheses that the subjects with epilepsy were 
not impaired, irrespective of the ACD taken. Where 
differences were found they tended to show poorer 
performance by the POLYT group. The tests that did reveal 
these differences were the tests of intellectual ability, 
the RMBT and the category-decision task. Neither the visuo- 
spatial tasks nor the memory questionnaire revealed 
differences between the groups.
5. A further analysis using mean z-scores was carried 
out, and showed a number of subjects with epilepsy 
performing very poorly. However, the clinical information 
available did not indicate a possible reason for these poor 
levels of performance.
The findings of this study and their implications will
be discussed in chapter eleven.
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CHAPTER SIX
COGNITIVE FUNCTIONING : THEORY AND APPLICATION
6.1 Introduction
The literature on the cognitive impairments associated 
with ACDs has been described in chapter three. Turning to 
this literature, what can be gleaned from the published 
work as to the nature of these impairments?
Trimble and Thompson (1983) made the following 
distinction between :
"Cognitive function, traditionally measured 
by psychological tests and reflective of an 
individual's ability to deal meaningfully with 
information in their world, and behaviour, which 
reflects more a person's success, or otherwise, 
in handling tnrerrfreoual relationships." S55.
Taking this viewpoint, they developed a battery of 
tests that included measures of memory, attention, 
retention of new information, speed and accuracy of 
perceptual registration, decision-making and manual speed. 
Unfortunately, Thompson and Trimble did not discuss the 
rationale behind these categories of cognitive function. 
Furthermore, they did not consider a particular skill that 
may underpin, or affect performance in another area, for 
example perceptual registration may underpin category-
decision tasks.
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Andrewes, Toralinsc^n, Elwes and Reynolds (1984) used 
the two terms of cognitive function and mental function
inter-changeably and claimed that the tests chosen for
their assessment were :
"Tests chosen for their ability to isolate
particular cognitive functions according to
theoretical research." P23
However, the particular cognitive functions isolated 
were not specified. Hence, our understanding of the precise 
nature and extent of these impairments is hampered by the 
different types of assessments employed. The lack of a 
theoretical framework and justification for the tests used 
makes for poor understanding of the results obtained; for 
example, terms such as "memory" and "attention" are often 
used to describe what certain tests are measuring. It is 
difficult to know what these concepts mean in terms of 
either psychological theories and/or relevance to everyday 
functioning. To avoid this pitfall, it is necessary for 
researchers to employ robust psychological theories and the 
appropriate experimental paradigms.
Difficulties in choosing appropriate theories of 
cognition are numerous. The extensive and diverse 
literature on cognition poses problems for the applied 
clinical researcher. There is a large range of terminology 
and types of experimental paradigms, but a lack of 
encompassing theories. Eysenck (1977) compiled the
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following list of terms describing memory phenomena, which 
illustrates this point :
"We have iconic, echoic, active, working, 
acoustic, articulatory, primary, secondary, episodic,
semantic:, short-term, intermediate-term and long-term 
memories, and these memories contain tags, traces, 
images, attributes, markers, concepts, cognitive maps, 
natural-language mediators, kernal sentences, rational 
rules, nodes, associations, propositions, higher-order 
memory units, and features."P4,
Nevertheless, researchers investigating the effects of 
aging and of neurological damage on cognitive functioning 
have successfully employed theories and paradigms in the 
applied setting. Examples of such work will be described 
later in relation to choosing appropriate paradigms for the 
study described in chapters seven and eight of this thesis.
Regardless of the poorly specified rationale for the 
tests used in the ACD literature:, some the tests have 
produced some interesting findings. Researchers' 
interpretations of their findings can provide guidance for 
choosing appropriate models and paradigms from the 
cognitive psychology literature:.
Dodrill and Troupin (1977) compared CBZ and DPH, and 
identified certain types of tasks as being sensitive to 
different drugs. They interpreted their findings in the 
following way :
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"Those tasks with clearly significant differences 
between drugs primarily involved higher level complex
skills, requiring mental manipulation and t;hey always
favoured carbamazepine. Furthermore, there was a
strong tendency for these differences to become
apparent only on our most complex and demanding
measures ."P1027.
Thompson and Trimble (1983) made the following
observations •
"Impairment of performance seemed to be related
to the demands of the task.....the degree of slowing
on the decision-making test appeared to be related to 
the type of decision required with slowing being most 
marked for the more difficult category judgements....
.......These decrements of concentration and
mental slowing seem likely to be related to the poorer 
immediate recall for pictures and words. The 
presentation of memory stimuli was experimentally 
paced such that a reduction in attentional capacity or 
slowing would probably interfere with the adequate 
registration of stimulus items."P232.
Finally, Andrewes et al (1986) concluded that :
"The memory tasks showed the greatest differences 
between the groups."P131
From these interpretations, the following areas of 
cognition appear to be sensitive to the effects of ACDs
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i. Attentional capacity, as identified by task 
demands and complexity.
ii. Recent memory function, with particular 
regard to types of material.
The following discussion on cognitive functioning will 
concentrate on those theories that take memory and/or 
attentional capacity as a central theme, and also those 
paradigms that explore aspects of task demands and 
complexity.
6.2 Cognition Functioning ; Memory and Attention
6.21 Models of memory
Memory and attention are seen as the corner-stones of 
our ability to process information. Although closely 
linked, for the purpose of describing the theories under­
pinning these terms, they will be discussed as separate and 
independent entities.
The concept of memory has been influenced greatly by 
three theoretical models. Firstly, there was the ’’multi- 
store" approach of Atkinson and Schriffin (1968 and 1971). 
This model is now viewed as simplistic and is unable to 
explain neurological data of patients with intact long-term 
memory but poor short term memory (Shallice and Warrington, 
1970). The second model was the "depth of processing" model 
(Craik and Lockhart, 1972), incorporating the concept of a 
continuum of depth of processing of information. However, 
this framework is not supported by experiments on normal
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subjects investigating the recency effect, nor by 
neuropsychological data which again tended to support the 
view of a dichotomous framework of long and short term 
memory (Baddeley, 1978).
The third approach is the "working memory" model
(Baddeley and Hitch, 1974). This robust model is supported 
by much experimental data and has also been used with some 
success in applied settings. Hence, a more detailed over­
view of the model will be described.
6.2 2 Workingr Memory Model
In 1974, Baddeley and Hitch set about constructing a 
model of memory that described how memory operated. The 
result of their deliberations was the concept of working 
memory. The working memory model included both a 
phonologically-based short-term memory similar to those of 
the old store models, named the articulatory loop, but also 
other components, notably the visuo-spatial scratch pad and 
a central executive. Baddeley and Hitch perceived the 
working memory system as :
"a system that allowed several pieces of
information to be held in the mind at the same time
and intmryelated."pl69
The model implied a system for the temporary holding 
of information during a range of cognitive tasks. Such a 
system could then be employed to read or understand a
spoken sentence, or to carry out a reasoning task. This
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general working memory system had a limited capacity, and 
hence a broad range of tasks would absorb a considerable 
amount of this capacity, and compete with the performance
of other tasks.
To develop the model, they took as a starting point 
the component common to all short-term memory systems, that 
of a limited capacity, which is frequently measured using 
the digit span task. In the seventies, a number of 
experiments were carried out investigating the amount of 
residual memory available when performing, concurrently, a 
span task and another type of task, for example a verbal 
reasoning task. Although, performing a six digit span task 
considerably slowed performance on the reasoning task, 
there were still processes available to perform the 
reasoning task. It appeared that short-term memory 
processes and the processing required for the reasoning 
task over-lapped but were not entirely dependent on one 
limited capacity system. What other components made up this 
system and could these components be isolated from the rest 
of the system? Two such systems identified were the 
articulatory loop and the visuo-spatial sketch pad.
6.23 The Articulatory Loop
The articulatory loop is the term given to that part 
of the system that deals with short-term storage of items
that are encoded and rehearsed in an acoustic manner. The
capacity of the loop is often measured by a span task and
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temporally is in the range of 2.5s i.e subjects can recall 
what they can say in 2.5s. Baddeley (1966) revealed that on
many occasions subjects used the process of sub-vocal 
phonological rehearsal in order to prevent a trace from
decaying; this rehearsal process is located in the 
articulatory loop. If this path of maintaining information 
is blocked by, for example, making the subject repeat a 
word aloud (a process known as articulatory suppression), 
then recall is impaired. The articulatory loop seems also 
to be involved in reading abilities, as shown by reading 
tasks in which the subject is asked to spot text errors. 
Articulatory suppression inhibits this process. Hence, it 
seems likely that the articulatory loop acts as a checking 
mechanism for preserving the order of information.
The acoustic nature of the loop explains why 
performance of the loop is detrimentally affected by items 
that are phonemically similar or of longer spoken duration 
(Baddeley, Thomson and Buchanan, 1975). Subsequent data, 
investigating the word length and phonological similarity 
effects, have led to a revision in the original 
articulatory model, as described in the next paragraphs.
As predicted by the original model, both the 
phonological similarity and the word length effects are 
abolished by articulatory suppression, when the to be 
remembered material is presented visually. However, if this 
material is presented auditorily, a clear word length 
effect and phonological similarity effect are still
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observed (Baddeley et al. 1975). There is, nevertheless, 
one subtle and important difference between these two 
effects. If material is presented auditorily, and 
suppression is continued throughout input and output of the 
material, the word length effect is abolished (Baddeley, 
Lewis and Vallar, 1984, experiment 4). Under the same 
experimental conditions, the phonological similarity effect 
is still present:, though somewhat reduced (Baddeley et al. 
1984, experiment 1-3).
The revised model of the articulatory loop consists of 
two parts, an articulatory process for maintaining 
information by the process of rehearsal, and a phonological 
store that feeds into this articulatory control process. 
The phonological store is directly accessible by auditory 
presentation or by articulatory coding of visually coded 
material. Hence, the phonological similarity effect appears 
to be a product of this system, remaining present:, with 
auditory presentation, even if articulatory suppression 
occurs throughout input and recall. The word length effect 
appears to be more a product of the articulatory process, 
being time-based and requiring verbal rehearsal to be
maintained.
6.24 Visuo-soatial sketch pad and other visual sub­
systems . •
Another sub-system of the working memory system is the 
visuo-spatial sketch pad which can generate and manipulate
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visuo-spatial images, (Baddeley and Lieberman, 1980). This 
storage system can be disrupted by concurrent spatial 
processing, particularly where eye-movements and other 
bodily movements are involved (Quinn and Ralston, 1986). 
Philips and Christie (1977a and b) described a different 
type of visual system, that could be described as a visual 
pattern-based store that is maintained by active rehearsal 
of the pattern. It is not clear to what degree the visuo- 
spatial sketch pad and more visual stores are distinct 
components of a working memory system, or indeed if there 
are other types of visual stores not yet identified.
Far less work has been carried out in this area than 
in the verbal storage of information. Logie (1986) 
described a number of experiments in an attempt to identify 
experimental tasks that were primarily tasks using the 
visuo-spatial sketch pad and thus made minimal demands on 
either the central executive or the articulatory loop. He 
pointed out that in some of the earlier tasks, for example 
the "Brooks task" and the tracking tasks, the tasks are 
difficult to do and are therefore likely to be making use 
of the central executive. Ideally, Logie wished to identify 
visuo-spatial tasks that were the equivalent to 
articulatory suppression.
Logie carried out a number of experiments using 
variations in pattern-matching and picture presentation 
tasks which were used as secondary tasks that may affect
recall of a primary task. The primary tasks either involved
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learning a list of words by rote rehearsal or by visual
imagery mnemonics. Hence, there was the possibility that 
the introduction of secondary tasks would differentially 
affect the performance on the primary tasks. The results of 
these experiments revealed that it was possible to obtain 
selective disruption on the visual mnemonic task by 
presentation of unattended pictures, whereas there was 
selective disruption of the rote rehearsal task by 
presentation of unattended speech. Hence, this set of 
experiments provided some paradigms for investigating the 
visuo-spatial sketch pad, separate from the other systems 
in working memory.
6.25 Central Executive
Baddeley and Hitch (1974) thought that there must be 
an overall controlling mechanism that they called a 
"central executive". This central executive was seen as the 
core of the working memory system and was thought to embody 
much of the attentional mechanism. The central executive is 
served by other systems designed to do specific tasks. 
These include the articulatory loop and the visuo-spatial 
sketch pad.
As the central executive is perceived as central to 
the working memory model, it may have seemed odd not to 
have discussed this component earlier;. However, theories of 
working memory have paid scant attention to this component
and, until relatively recently, have chosen not even to
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speculate on the characteristics of the central executive.
Nevertheless, Baddeley has begun to develop his own view on
the nature of the central executive. He has described two
approaches in formulating ideas on the nature of the 
executive in his book "Working memory" (1985).
The first approach was to postulate that any process 
that was part of working memory but was outside particular 
"slave" systems, must fall within the realms of the 
executive. However, as the boundaries of the slave systems 
are not clearly defined, and as we do not know how many 
slave systems are yet to be discovered, this approach does 
not provide any clear idea of the nature of the central
executive.
The second approach was to look at the executive as a 
type of supervisor or scheduler for the working memory 
system,, which would relate directly to the control of 
attention. With this approach in mind, Baddeley turned to 
the literature on attention, hoping to be able to integrate 
concepts of memory and attention. Unfortunately, he found 
that many models of attention concentrated entirely on 
aspects of perception, and not on aspects of planning or 
scheduling of tasks. One model that Baddeley did find 
useful was the Norman and Shallice (1980) model of 
attention to action. A component of the model is the 
supervisory attentional system, with a limited capacity, 
that could be used in tasks that involve planning or 
decision-making, or where novel or poorly learned sequences
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of acts were involved. The other major component of the
Norman and Shallice model is the concept of a large
selection of semi-automatic series of actions (schemata), 
that would be triggered into action on the presentation of
particular stimuli. An example, of a well-learned and 
complex schemata is that associated with the skill of
walking.
In Baddeley's view/, such a model can account frr much 
of the experimental data atttibuued to thh central 
executive in working memory tasks. The model can be 
illustrated by its application to experiments using dual 
task paradigms. When the primary tasks includes tasks of 
reasoning, learning or comprehension and the secondary task 
is a span task, the effects are not as dramatic as 
expected. It could be postulated that partfs) of the 
primary tasks are already part of schemata, and hence not 
affected by the competition wlit tth span task for the 
limited capacity supervisory system.
The model may also be of value in interpreting data 
from applied fields of neuropsychology and aging. For 
example, older adults appear reasonably unimpaired on 
standard measures of short term memory, but have problems 
when completing more complex tasks, manipulating and/or 
time-sharing between information, for example, in d^ho^c 
listening tasks (Broadbent aan Grrgory, 1965). Hence,
applying the Norman and Shallice model to conceptualise the
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central executive, these types of results could be viewed
as deficits of the central executive.
In summary, the working memory model can be divided 
into a number of components, two of which are the verbal
and visuo-spatial short term stores. There is a controlling 
mechanism, or central executive, that may be similar to 
that of the supervisory attentional system of the Norman 
and Shallice (1980) model of action.
By following the developments in the memory literature 
with regard to short-term memory, the point is now reached 
where there is at least some tentative integration of 
memory and attentional components of cognition. However, 
the complex model of Norman and Shallice does not provide 
paradigms for measuring attentional capacity, nor provide 
ways of investigating the effects of task complexity. To do 
this, it is necessary to study some of the literature on 
attention.
6.26 Models of Attention
Attention has often been regarded as synonymous with 
consciousness and/or concentration. It is generally 
considered to be a mechanism by which a individual can 
select a portion of appropriate information. The 
information can be selected for various reasons, including 
relevance and also novelty to the individual.
Research on attention has provided the distinction
between focused and divided attention. The research on
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focused attention has concentrated on the selection
mechanisms of attention, what information is attended to 
and what happens to the unattended information. Divided 
attention research has been primarily concerned with 
performance limitations, i.e. the processing limitations 
and the capacity of attentional systems.
Attention can thus be investigated at different 
levels, at a perceptual level or at a more cognitive level. 
Wickens (1980) compared two useful metaphors that capture 
the essence of this distinction. The first metaphor 
described attention as a type of searchlight 
(Wachtel,1967). Thus, in focused attention this searchlight 
focuses on that topic on which one is momentarily 
concentrating. The second metaphor for attention is as a 
resource (Norman and Bobrov,, 1975) , which emphasises
attention as having a certain capacity which can be used on 
one or more tasks and can therefore be divided. Hence, in 
divided attention tasks attention as a resource is 
investigated.
The literature considering attention as a resource 
provides a useful framework in considering the effects of
ACDs for four reasons :
1. Provides a framework for measuring attentional 
capacity.
2. Provides ways of linking memory and attention 
together (as in the Norman and Shallice model).
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3. Attempts to clarify issues surrounding task 
difficulty.
4. Provides methodologies, most notably dual-task 
paradigms and a discussion of the costs and 
benefits of these methodologies.
Perceiving attention as a resource has its origins in 
the theorising of researchers such as Moray (1967), who 
proposed that attention was similar to a general purpose 
computer, in that it had a limited processing capacity. 
Tasks differing in difficulty would make differing demands 
on this capacity. Hence, as the difficulty in one task 
increases, the capacity to maintain performance on another 
task decreases. Kahneman (1973) developed this view-point, 
in particular, he viewed attention as a flexible, shared 
processing resource with limited availability. Kahneman 
also proposed that physiological correlates, for example 
heart rate, could be suitable indices of resource 
mobilization. Two key elements in Kahneman's (1973) 
theorising were :
"the allocation policy and the evaluation of 
demands on the limited capacity. The evaluation of 
demands is the governor system that causes capacity 
(or effort) to be supplied as needed by the activities
that the allocation policy has selected."Pll
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This type of theorising is similar to hhat of Norman 
and Shallice's Supervisory AtOdntifnal System, and 
consequently to the central executive of working memo^y^.
The concept of resource is often translated 
experimentally in terms of "difficulty", with the rationale 
that more difficult tasks require greater amounts of 
resources. However, there are many examples of tasks 
interfering primarily via structure i.e. by the stages, 
codes or modalities of processing required, rather than by 
difficulty per Se. Wickens (1976) found that performance on 
a manual tracking task was more impaired by a concurrent 
task requiring subjects to maintain constant pressure on a 
stick, than by an auditory signal detection task that the 
subjects perceived as being the more difficult secondary 
task. As well as this type of data, there is evidence for 
structural effects in the phenomena of task "difficulty 
insensitivity”, in which secondary tasks interfere with 
some primary tasks but fail to do so with others.
Kahneman's (1973) theory had cccoutded or r type 
of data by proposing that aathough tlie^ireB wwa one 
undifferentiated pool of resources, there were also 
"satellite" structures, for example, ears, hands, or voice, 
that produced structural interference.
Two elements of this typp of single rosource 
theorising have been challenged by a number of researchers 
including Allport (1980). The first area of conhenOton is 
that instead of one resource pool of attention there may be
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several distinct pools, of which different tasks make 
differing demands on these pools. The second and related 
area is the necessity of conceptualising an overall 
governor or controller system. In Allport's view, the 
experimental data supports the requirement for several 
distinct resources, and Allport is not convinced that the 
behavioural data demands the necessity for an overall 
controlling mechanism. An alternative and influential way 
of accounting for the data is that of multiple resource 
theories according to Allport (1980). These theories argue 
that instead of one pool of undifferentiated resources, 
there are several with different capacities and uses. This 
framework had been argued very strongly by Navon and Gopher 
(1979), using performance operating characteristics (POCs) 
to describe dual-task performance data.
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Stages ■>
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\
Figure 6a: The proposed structure of processing resources
by C. D. Wickens (1980)
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What are these different resources and how are they 
related? Not all the issues concerning aOtentional 
resources are resolved, but Wickens (1980) on consideration 
of a large portion of the literature produced a useful 
diagrammatic representation of the different groups of 
resources along three dimensions, as shown in figure 6a. 
Any particular task could demand different resources along 
any of the three dimensions of stages, modalities or 
processing codes. -
With regard to stages, the evidence cited by Wickens 
(1980) pointed to different resource pools, one for 
perceptual and central-processing aspects of a task and 
another for response selection and execution of a task. 
Hence, secondary tasks affecting only perceptual or 
central-processing of a primary task will have little 
effect on success in responding to the primary task, 
whereas those affecting response selection and execution of 
a task will have a marked effect on the primary task.
In the case of modalities, according to Wickens, there 
is strong evidence that it is much easier to perform 
concurrent cross-modal tasks that use, for example, the 
visual and auditory modalities, than to perform concurrent 
tasks that use the same modality.
Finally,, when considering processing codes, there is a 
large amount of evidence for separate verbal and spatial 
coding, examples of which were cited earlier in the
157
discussion of working memory^. The relative ease with which 
tasks requiring vocal and manual responding can be 
performed, as opposed to concurrent tasks requiring the 
same type of responding, supports the view that outputs are
also divided in terms of verbal and spatial codes, with 
vocal outputs using verbal resources and manual outputs 
using more spatial resources.
Performance along these dimensions has primarily been 
investigated using the dual-task technique. This technique 
has also been extensively used in the investigation of the 
working memory model. The basic task is for the subject to 
maintain adequate performance on a primary task whilst 
simultaneously performing a secondary task. An example from 
investigations into working memory is where the primary 
task is a verbal reasoning task and the secondary task is a 
verbal digit span task. As these two tasks are competing 
for at least some of the same resources there is a
decrement in performance on the primary task when the 
secondary task is introduced.
Using this technique has some obvious benefits :
1. One can investigate resource capacity, by loading 
the secondary task, so that residual capacity is used 
up and the subject begins to have difficulties 
maintaining performance on the primary task.
2. One can investigate the effects of varying task 
difficulty (an area identified as interesting in the
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ACD literature), by increasing the complexity of the 
secondary task.
3. One can investigate the nature of the attentional 
resources which are tapped, particularly as one
secondary task can be applied across many different 
types of primary tasks.
There are disadvantages with the technique. A 
problematic area is the strategies used by the subject to 
perform the two tasks, particularly if the subject 
concentrates on the secondary task, so treating it as the 
primary task. When using this technique good instructions 
for the subject are very important.
6.3 Adapting tdcptinues co tqe setlith sepplng
One of the major aims of this theoretical chapter is 
to find ways of adapting theoretical ideas into paradigms 
appropriate for investigating the effects of ACDs on 
cognitive functioning. The following text describes in 
detail two paradigms that may be of value in this sphere.
Morris (1984 and 1986) noted that memory impairments 
are often one of the earliest signs of dementia. He was one 
of the first researchers to use the working memory 
framework and dual-task paradigms to investigate the memory 
impairments of individuals with mild senile dementia of an 
Alzheimer type (SDAT).
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In his first set of studies, Morris (1984) compared a 
SDAT group and a matched group of elderly controls on tasks 
investigating performance of the articulatory loop. He 
found that although performance was significantly poorer 
for the SDAT group, the articulatory loop was functioning 
normally because this group showed normal word length and 
phonemic similarity effects indistinguishable from
controls.
In a second set of studies, Morris investigated the 
hypothesis that the differences in performance of normal 
elderly and the SDAT groups were due to impairments in the 
central executive. The tasks employed were variations of 
the Brown-Peterson task. The basic procedure was as
follows:
1. The subject was presented with a t^gram (a set of 
three consonants) to be remembered for a designated
interval.
2. The subject was asked to perform a secondary task 
during the retention interval.
3. The subject was asked to recall the three items of 
the trigram in the correct order.
The trigrams were presented visually by means of cards
i.e a set of three consonants per card, for three seconds, 
and both the retention intervals and the secondary tasks 
were varied. The SDAT group (N=12) and the normal elderly
control group (N=12) completed 96 experimental trials,
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comprising six trials for each of four conditions over the 
four retention intervals (0, 5, 10, and 20s). The four 
conditions differed according to what was required of the 
subjects in the retention interval :
1. Unfilled retention interval in which the 
subjects were asked to concentrate solely on 
remembering the trigram. However, subjects were asked
not to use vocal rehearsal.
2. Articulatory suppression in which the subject 
was asked to repeat aloud, at a steady rate, the word 
"the”, for the duration of the retention interval.
3. Digit reversal in which the experimenter 
presented pairs of digits and the subject was asked to 
reverse the digits, for the duration of the retention
interval.
4. Digit addition in which the experimenter 
presented pairs of digits which the subject was asked 
to sum, for the duration of the retention interval.
The number of articulations, digit reversals and 
additions were monitored by the experimenter. Performance 
was measured in terms of mean percentage of items recalled 
in the correct serial position for each delay period. 
Overall the SDAT group was clearly impaired. The 
differences between the groups seemed to increase with
increasing task complexity and retention interval. However,
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as the zero interval condition was included in these
analyses, and most subjects from both groups performed at 
ceiling, this obscures the effects of interval delay. It is 
possible that the significant results were due to different 
performances for zero retention interval and having any
retention interval, and that increasing the delay made 
little difference in the ratio of performance between the 
two groups. This view is supported by an analysis of the 
digit reversal and digit addition conditions which showed 
parallel performance for the two groups with increasing 
delay.
One very interesting finding was that concurrent 
articulation caused a significant decrement in performance 
when compared with the unfilled condition in the SDAT 
group), but not in the elderly control group. This is an 
important result, supporting the original hypothesis, i.e. 
that dementia results in a decrement in processing 
resources of the central executive. Normally, articulatory 
suppression would not take up enough of the resources to 
interfere very much with the primary task of remembering 
the t^grans. However, if the SDAT group has a depleted 
central executive, the simple task of articulatory 
suppression will consume a greater proportion of these 
resources and so less will be available for the primary 
task of remembering the trigrams.
However, another possible explanation is that the SDAT 
group are more prone to interference effects and the
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articulations may produce abnormal interference. To 
discount this possibility, Morris carried out a third 
experiment, similar to the one just described, but with two 
conditions, articulatory suppression and tapping (in which 
the subject was asked to tap repeatedly on the testing 
table). The hypothesis for this experiment was that if the 
non-verbal tapping task produced a differential impaired 
performance for the SDAT group, it would be difficult to 
argue that such a task produced abnormal interference. The 
results revealed that the SDAT group, unlike the elderly 
controls, showed a significant decrement in performance in 
both the tapping and articulatory suppression conditions.
The overall conclusion from these set of experiments 
is that very simple atshiacting tasks produced substantial 
forgetting in the SDAT groups. TThee eesuets ree 
interpreted by Morris ass evidence in support of a depleted 
central executive. However, the interpretation is derived 
by a process of elimination. As the articulatory loop is 
thought to be functioning normally and it would be 
difficult to explain the results in terms of structural 
interference, therefore it must be a central executive 
deficit. The studies do not attempt to investigate the 
central executive per Se, which may be due to difficulties 
in investigating a concept that is still rather vague.
The executive ii geene-ra ll ccdtedvsd of as a 
controlling and scheduling device for distributing 
resources, and therefore tasks requiring scheduling and
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changing direction of resources would presumably require a 
large amount of central executive functioning.
Weber, Burt, and Noll (1986) devised a task that 
required switching of resources between memory and 
perceptual attention. This type of switching might be 
required in a task such as reading and could be described 
as a task requiring extensive use of the central executive. 
Weber et al, devised a paradigm that allowed measurement of 
the switching time between perception and memory. The 
subjects for the study were 14 undergraduates who followed 
the following basic procedure of four experimental 
conditions.
1. Three consonants were presented visually and 
immediately recalled on clearing the screen (time to 
recall consonants was measured).
2. The subject was asked to read aloud as quickly as 
possible three consonants as they appeared on the 
screen (time to read consonants was measured).
3. Two sets of consonants are presented, first a set 
to be remembered, followed by a perceptual set (as in 
condition 2). The subject said the first of the 
perceptual consonants followed by the first of the 
memory items, followed by the second of the perceptual 
consonants etc. Hence, the subject recalled six 
consonants alternating between perception and memory 
and the total time to recall the six items was
measured.
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4, Sets of six consonants were presented to be either 
read aloud or recalled immediately.
The study followed this basic design, producing times 
for components of perception, memory recall and switching 
from perception and memory. The number of items presented 
was also increased, hence more resources were required for 
the perceptual adi memrrp sspctse oi hhe Cssse and less was 
available for the switching task so, producing significant 
increases in the switching times.
Weber et aC (1986) interpreted P ie susss is cs 
revealing a depletion in central executive resources, such 
that as the list lspggh irinceased, hie monTey and 
perceptual aspects of the task required more resources, 
leaving less resources in the central executive, resulting 
in slower switching times.
Both the Morris (1984 and 1986) studies and the Weber 
et al, 1986 study are examples of ways of investigating 
resources using the theoretical framework of working 
memory. They have been described in detail as they provide 
tasks that will bp incorporated into the test battery 
designed for the Glasgow study described in the next 
chapter.
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6.4 Summary
This chapter has endeavoured to integrate the iesutts 
and interpretations found in the ACD literature, with 
aspects of theorising and research into cognition. The ACD 
literature indicated those areas of cognitive psychology 
research on which to focus. The cognitive psychology 
literature provided theoretical frameworks for 
understanding cognition, paradigms for investigating sub­
components of cognition, and high-lighted' some of the 
inherent problems in transferring some of this work to the 
applied setting.
Interweaving these two lines of research has lead to 
the identification of working memory and aOtdntionat 
resource theory, as appropriate avenues to form the 
theoretical under-pinning of batteries of tests to 
investigate the effects of ACDs on cognitive functioning. 
It has also high-lighted the usefulness of dual-task 
paradigms as a possible methodology for investigating this
area.
A battery of tests based on the contents of both this 
chapter and chapters two and three is described in chapter 
seven. The results obtained in this study are described in 
chapter eight.
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CHAPTER SEVEN
STUDY.TWO ; MEASURING COGNITIVE FUNCTIONING USING A
NEW TEST BATTERY
7.1 : Aims of chapter
The aims of this chapter are two-fold. Firefly, the 
rationale for a new battery of tests based on the 
theorising in chapter six will be explained. Secondly, the 
methodology of how this battery of tests was employed to 
investigate the effects of anticonvulsant drugs on 
cognitive functioning will be described.
The second of these aims can be further elaborated :
1. To use psychometric tests based on a theoretical 
framework, to identify the nature of the cognitive 
impairments of persons taking anticonvulsant medication.
2. To design a study that, although primarily a 
between-groups design, could also incorporate within- 
subject comparisons, made possible when some of the 
subjects changed medication for clinical reasons.
3. To use a computerised battery of tests so that
a) tasks requiring accurate and rapid timing could be 
included,
b) a larger amount of data could be collected than in 
the more conventional "pen and paper" tests, and,
c) possible experimenter bias would be minimised.
4. To follow up the work already begun in this area at
the Glasgow Western Infirmary.
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7.2 Introduction
The study was carried out ct the Glasgow Western 
Infirmary, and involved 92 subjects with epilepsy and ten
control subjects. Suitable clinical subjects were 
identified by consultant pharmacologist Dr.M.J.Bro^dj.^. They 
were divided into four groups on SOp basis of their 
medication. A baSSery of tests was administered So SOp five 
groups of subjects (including one control group). Whenever 
possible, She subjects completed She battery of tests on 
three occasions, and any changes in medication or seizure 
frequency were monitored. Therefore, a mixture of bhSween- 
group and within-group comparisons were carried out.
The facilities at the Western Infirmary were such ShaS 
there was good serum level monitoring of She anticonvulsant 
medications of subjects involved in She study. There was 
also access to relevant medical information, including 
details of EEG reports and computerised tomography (CT) 
scans. BBC microcomputers were available for administering 
tasks and collecting data.
7.21 Hypotheses
The Oypotheses being investigated in Shis study were 
based on the information presented in chapters two, three 
and six. They were as follows ;
1. Subjects with epilepsy would be significantly
impaired on She test battery compared So the control
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group). This hypothesis is supported by the infoimation 
presented in chapter two and also by the work of 
Brodie et al. (1987) which had been carried out at the
Western Infirmary,
2. Within the clinical subject population, the 
subjects on anticonvulsant medication would be more 
impaired than untreated subjects with epilepsy. This 
hypothesis is supported by the information presented 
in chapter three, which described the detrimental 
effects of anticonvulsant medication on cognitive 
functioning.
3. Within the subject groups on monotherapy, those on 
the drug DDH ouldS cows moos impaired performance, 
particularly in comparison to those on CBZ and VHA, 
This hypothesis is supported by the work of Thompson 
and Trimble (1981, '82 and '83) which showed that the 
number of impairments associated with CBZ and VHA to 
be far fewer than with DHH.
4. From the discussion presented in chapter six, it is 
hypothesized that the impairments of performance will 
best be interpreted in terms of a depletion in 
cognitive resources and working memory. Hence, it is 
predicted that the pattern of impairments will be 
generalized across different resources and modalities, 
and will bb ggidnee w^e ttak complexity increasss. 
Hence, performance will decline in proportion to test 
condition difficulty. Also, on the dual-task memory
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tests it is predicted that different secondary tasks 
will impair the performance of the primary tasks to
different degrees;, as a function of the type of 
primary task (verbal, spatial or visual) as proposed 
by the working memory model.
7.3 Subjects
7.31 Criteria for subject inclusion.
The criteria for subject inclusion was the same as in 
study one (chapter four) , with regard to age of subjects 
(16 to 55 years), lack of gross brain pathology and/or 
neurosurgery, no other medication apart from 
anticonvulsants, medication in the optimum therapeutic 
range, and no evidence of psychiatric symptomatology.
Additional criteria were that the subjects should have
an abnormal EEG but a normal CT scan.
The subjects with epilepsy were either taking CBZ, 
VPA, DPH or were not on any medication for their epilepsy 
(i.e. an untreated group), UT). The control (CTL) group were 
persons either known to the clinical subjects or persons 
working in the hospital., matched for age and numbers of 
males and females in the groups.
Consent for the subjects to participate in the study 
was obtained by Dr.M.J.Brodie.
The matching of subjects with epilepsy on features of 
their epileptic condition followed the same protocol as in
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chapter four, with regards to types and frequency of 
seizures, age at onset and duration of their epilepsy.
7.32 Subjects identified
Possible subjects were identified by Dr. M.J. Brodie. 
Forms containing details about each subject's epilepsy were 
already in use at the clinic and provided relevant 
information on the variables of age, type of epilepsy, 
frequency of seizures, family history of epilepsy, presence 
of neurological damage (as seen on a CT scan) and EEG data 
This information was employed in the screening of subjects 
to match groups.
Control subjects who neither took anticonvulsant 
medication nor had epilepsy were identified amongst the 
hospital staff and volunteers (friends and relatives of 
subjects with epilepsy).
Hence, five experimental groups were identified :~
1. Subjects with epilepsy taRincg CBZ monotherapy.
2. Subjects with epilepsy taking VPA monotherapy.
3. Subjects with epilepsy taking DPH monotherapy.
4. Subjects with epilepsy taking no anticonvulsants
(untreated group, UT)
5. Control group of subjects (CTL)
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Table 7a : Details of subject arouDs for studv 2
Drug No. of No. of subj. Age Sex
Group subj ects post screen (mean/SD) (M/F)
CBZ 28 21 25.2 (5.37) 8 / 14
VPA 17 16 27.4 (10.48) 4 / 12
DPH 20 15 34.3 (10.91) 11 / 5
UT 2 8 22 22.6 (5.24) 8 / 14
CTL 11 10 27.2 (4.10) 5 / 5
TOTAL 102 84
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The original sample of 102 subjects consisted of 91 
subjects with epilepsy and 11 control subjects. However, 
for the between-group analyses, the data for 2 0 of the 
subjects were excluded for the following reasons :
i. Abnormal CT scan or other indication of .rain 
damage (N=ll).
ii. Normal EEG in the case of eslbjects with 
epilepsy (N=5).
iii. Incomplete data (N=3), of whom one was a 
control subject.
iv. Os datUaetfnes thers hans nttUonnuteaoees
(N=l).
Two subjects are represented twice in the analyses
because they were included in the medicated and non- 
medicated groups. This arose because they actually began 
taking medication during the period of testing.
Hence, the final numbers of subjects in the epilepsy 
data sets were 74 and in the control data sets were 10. 
The subjects with epilepsy were made up of 52 subjects 
taking anticonvulsant medication and 22 not taking any 
anticonvulsant medication, the latter group being 
designated the untreated epileptic group (UT). Of those 
52 subjects on medication, 21 were taking CBZ, 16 were
taking VHA and 15 were taking DHH.
Table 7a table provides a summary of the details of 
the subjects included in the final analysis. The mean age 
of four of the subject groups was within five years of 
each other i.e from 2 2.6 to 2 7.4 years, but the mean age 
of the DHH group was somewhat older (34.3 years). The DHH
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group was also different to the other groups in the 
numbers of male and female subjects in the group. This 
group had double the number of men in the group compared 
to female subjects, a ratio of eleven to five, whereas 
the other groups had either similar numbers of male and 
female subjects or had more female subjects in the 
groups.
The clinical data for each of the groups will be 
described in the results chapter under the heading of 
clinical data.
7.4 Rationale for tests used in the test battery
The test battery was based largely on the 
theoretical framework of working memory and resource 
theory as described in chapter six and to a lesser degree 
was based on tests similar to those used in other 
studies, for example, by Thompson and Trimble (1981). The 
amount of testing was agreed with Dr.M.J.Brodie as being 
at a level that would not be too taxing for his patients.
A battery of tests incorporating dual-task paradigms 
was designed to investigate aspects of working memory and 
resource theory. Thus, the test battery included 
psychometric tests of intellectual abilities and mood, 
tests of motor skill of increasing complexity, and tests 
of verbal, visual and visuo-spatial working memory, which 
also increased in difficulty. These memory tests were 
specifically intended to test the "resource depletion" 
hypothesis. Tests of rapid decision making and attention­
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switching were included to investigate the "central
executive" in the working memory model.
The detailed rationale for each of the tests is 
described in this section, whereas the procedure for
administering the tests is described in section 7.6
7.41 Wechsler Adult Intelligence Scale-Revised
(WAIS-R) Wechsler (1981).
The Vocabulary and the Picture Completion sub­
components of the WAIS-R were administered based on the 
same rationale as in chapter four.
7.42 Multiple Affect Adjective Check-list (MAACL).
Zuckerman and Lubin
The aim of including this questionnaire was to 
ensure that the groups of subjects were matched on 
various aspects of their mood. The MAACL is quick to 
administer, requiring the subject to consider their mood 
at that particular time, and specifically measures levels 
of anxiety, depression and hostility. The MAACL has been 
used both for evaluation and research (Sweetland and 
Keyser,198 3) .
7.43.Motor tasks.
Two tapping tasks were included in the battery of
tests. Both were based on tasks used by other researchers 
in the area, for example, Brodie et al (1986). The 
reasons for including such tasks have been discussed by 
Hindmarch (1980):
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"The rate of finger tapping is one of the simplest 
of human motor activities and has been widely used 
to measure drug changes in motor performance."H196
7.44 Reaction time tasks
A simple reaction time task was employed to provide 
a measure of subject performance on a perceptual input 
and motor output task, following the theoretical 
framework as described by Wickens (1980). This simple 
task did not require the memory or decision-making 
components of a working memory system. However, the task 
was made more complex by combining the simple reaction 
time task with he s motor tapping task, so investigating 
the effects oo task complexity on subject performance. As 
perceptual and motor performance are often part of memory 
and attention based tasks, the simple reaction time and 
motor tasks can separate out these different aspects of 
subject performance.
7.45 Digit Span
The Digit Span task, presented and recalled 
auditorily, is s reliable measure of the articulatory 
loop system in the working memory model. The inclusion of 
the digit span in the WAIS-R battery means that normative
data is available for this edee.
7.46 Memory tasks ; Ver-loal. visual and spatial
tasks
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Three types of working memory tasks were included to
explore the performance of subjects using different parts 
of the working memory system. All three tasks had a 
primary memory task and secondary tasks that were either 
verbal, visual or motor in nature.
The verbal memory task was based on the Brown- 
Peterson task, as adapted by Morris (1984) . The visual 
task was based, in part, on the Revised Benton Visual 
Retention task (1963) and involved recalling complex 
shapes as described in chapter four.
The spatial task was designed by the author, as 
suitable, easy to use, spatial tasks investigating the 
working memory model were unavailable in the literature. 
The work of Logie (1986) only came to the attention of 
the author, after the design of the task included in this 
battery of tests. The author wished to include a measure 
of spatial memory that fulfilled the following 
requirements :
a. A task that measured memory for spatial location, 
but did not involve skilled performance that would 
make extensive use of the "central executive", as 
based on the literature discussed in chapter six.
b. A task that was quick to administer within a test 
battery. Hence, instructions should be easy to 
follow and carry out.
c. A task that could be combined with the same
secondary tasks as used with the verbal and visual 
memory tasks;.
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Given these requirements, the type of tasks used by 
Brookes (1967), for example, matrices of numbers in 
different locations, and the tasks developed by Baddeley 
and Lieberman (1980) involving tracking, did not fulfil 
these criteria. These tasks were difficult to do, 
involving complicated procedures and a level of skilled 
performance.
The scoring on all three memory tasks gave a minimum 
score of zero and a maximum of six on each condition. The 
exact nature of the scoring on the spatial task was based 
on the performances of five pilot subjects on the test.
7.47 Category-Decision task
This task as employed by Thompson and Trimble (1981, 
'82 and '83) was particularly sensitive in detecting 
differences between subjects on different anticonvulsant 
drugs. The task is a time-based measure requiring the 
subject to respond rapidly to a question concerning the 
colour or category of an object presented visually. The 
task requires rapid decision-making and could thus be 
seen as a "central executive" task in the working memory 
framework. The task also increases in complexity, hence 
testing the effects of task complexity on subject 
performance.
The task is computerised, and therefore, differs 
from the category-decision task in chapter four.
7.48 Attention-switching task
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This task was adapted from that used by Weber et al 
(1986) and involves the subject switching from a 
primarily perceptual task to a memory task. Hence, the 
switching of resources between the two tasks could be 
seen as requiring extensive use of the "central 
executive" in the working memory model.
This group of tests was administered in the study 
using the following procedure:
7.5 Protocol for studv two
The tests were completed by all the subjects and are
summarised as follows :
1. WAIS Vocabulary and Picture Completion tasks.
2. MAACL.
3. Finger tapping tasks.
4. Simple reaction time (SRT) with three 
conditions.
5. Short term memory span (Digit Span).
6. Trigram memory task..
7. Visual memory task.
8. Spatial memory task.
9. Category-Decision task.
10. Attention-Switching task:.
This protocol was completed (where possible) by each 
of the subjects on one or more occasions at intervals of 
approximately eight weeks.
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In order to minimize the effects of fatigue on tasks 
completed at the end of the testing session, the order of 
presentation of the tasks was varied and balanced across 
the groups, with equal numbers of subjects completing the 
heste in the following orders :
Order one : 1, 5, 9, 10, 3, 4, 6, 2, 7, 8.
Order two : 1, 5, 9, 10, 3, 4, 7, 2, 8, 6.
Order three : 1, 5, 3, 4, 9, 10s 8 , , z 7 .
Order four : 1, 5, 6, 7, 9, 10, 2 , 4 .
Order five : 1, 5, 7, 8, 2, 6s 3, 4, 9, 10.
Order six : 1, 5, 8, 6, 2, 7, 3, 4, 9, 10 .
The subjects also completed the MAACL and were asked 
when they had had their last seizure and the nature of 
that seizure. After completing the whole battery, those 
subjects taking medication provided 20ml blood samples 
which were subsequently aonlysdd for blood serum levels 
of anticonvulsants.
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7.6 Procedure for studv two
7.61 WAIS sub-components
This test was administered as in study one (chapter 
four) following instructions in the WAIS-R manual,.
7.62 Multiple Affect Adjective Check-list (MAACL).
Each subject was presented with a list of 132 
adjectives describing mood and feelings. The subject was 
asked to read the lists of words quickly and to place a 
cross (X) in the boxes next Iso all those worcds ahat 
described his/her mood and feelings at that time or, if 
appropriate, on that day. The subject was asked to 
identify all the appropriate words, even though some of 
them may seem very sirnlaar . The questionnarre was 
subsequently marked giving scores on three scales for 
anxiety, depression and hostility.
7.63 Motor task.
This task was divided into two parts.
a) The subject was asked to tap using the index 
finger of his/her hand (the hand was specified by the 
experimenter) on a response key for a period of 60s. The 
subject tapped as quickly as possible for the whole 
period and was asked not to stop tapping, once started.
b) The subject was asked to tap on two response keys 
alternately. The response keys were placed 17.5cm aptat. 
Again the subjects only used one finger of the specified
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hand and continued tapping as quickly as possible for the
60s.
The hand specification was balanced across the
groups. The number of taps and the inter-tap interval 
were recorded on the BBC microcomputer.
7.64 simple reaction time (SRT)
This task was divided into three conditions;. In all 
three conditions;, the primary task remained the same i.e 
the subject was asked to press the space-bar on the 
microcomputer as soon as he/she saw an orange light 
(cursor) appear in the middle of the blank screen. The 
light disappeared when the space bar was pressed. Before 
the cursor appeared it was preceded by a warning signal 
(a bleep produced by the microcomputer) and the bleep- 
cursor interval was varied (0.5 to 2.0s). The subject 
completed 10 practice trials and 20 experimental trials;. 
The microcomputer recorded the response times to the 
onset of the light i.e. the time from when the cursor 
appeared to when the subject pressed the space bar.
Each of the three conditions had a different 
secondary task to be carried out by the subject;, using 
their other hand, whilst simultaneously responding to the 
light:
i) No distractor condition (Trials = 20)
ii) The distractor task was the single key tapping
task as carried out in section 7.63(a) (Trials =
20) .
182
iii) The distractor task in this condition was the 
alternate key tapping task as carried out in section
7.63 (k>) (Trials = 20)
Io all three conditions there were practice
conditions to ensure that the subjects understood the
tasks.
7.65 Digits Span task
Both forward and backward digit spans were measured 
using the ascendiog staircase method. The procedure and 
lists of digits followed the WAIS-R Digit Span teet.
7.66 T^qram task
In this task there were five conditions. In all 
conditions, the primary task remained the same. This 
consisted of the subjects being presented with sets of 
three randomly generated consonants (trigrams) for five 
seconds, via the BBC microcomputer screen.
The subject was then told to wait for a ten seconds 
interval and after ten seconds the subject was asked to 
verbally recall the letters. The experimenter typed io 
the subject's responses. In each of the five conditions 
the subject was presented with two practice trials and 
six experimental trials.
The secondary (distractor) tasks were presented in 
the ten second waitiog intervals. The five conditions
were as follows :
i) There was oo secondary task, so the subject
could concentrate solely on recall of the trigra!!.,
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although the subject was not allowed to verbally 
rehearse the trigram; however, covert rehearsal 
could still be taking place.
ii) The subject was asked to carry out articulatory 
suppression, i.e. the subject was asked to repeat 
aloud the word "the" during the ten second waiting 
interval, at a steady rate of approximately two 
articulations per second. The experimenter 
demonstrated the method of articulation before the 
subject commenced the practice trials. The subject 
began each period of articulation by saying aloud 
the word "the" at the beginning of each ten second 
interval. The number of articulations were counted 
by the experimenter pressing the space bar as the 
subject articulated the word "the". Hence, the
number of articulations were recorded on the
computer.
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Figure 7a: Two examples of visual distractor shapes.
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iM) The subject was asked to count backwards io 
multiples of threes beginning at 101 during the ten 
second waiting interval. Before commencing the 
practice trials, the experimenter demonstrated the 
method of countiog backwards. The experimenter also 
said the first number, i.e. the last number from the 
previous trial, from which to start the counting at 
the beginning of each ten second interval.
iv) The subject was asked to copy on to paper some 
simple shapes that appeared on the screen during the 
ten second interval. Two of the shapes presented are 
shown opposite io figure 7a, The subject was told to 
continue drawing for the whole ten second interval, 
but that it was not necessary to finish all the 
shapes io the ten second interval. The same 
distracting tasks were presented in all the 
experimental trials.
v) The distracting task in this cooditioo was a 
tapping task, in which the subject was asked to tap 
alternately on two response keys at a steady rate of 
approximately two taps per second, using the index 
finger of Cis/Cer preferred hand. The experimenter 
demonstrated the tapping rate before the subject 
commenced the practice trials.
The subject had to recall the trigraos perfectly 
before the experimenter scored a "1" on the
computer, otherwise the subject scored a "0"'.
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Figure 7b: An example of a primary task
item in the visual task.
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7.67 Visual task
The visual task was similar to the trigram task in 
its method of presentation. The primary task was always 
presented via the computer screen. It consisted of an 
abstract shape being presented on the screen for five
seconds. There was then a ten second waiting period, 
after which the subject was asked to draw the shape from 
recall. There was a selection of eighteen types of shape, 
each of which could be shown at four different angles;. 
Hence, there were 72 possible stimuli. The types of 
shapes that could be presented in any set of six trials 
were balanced such that the six shapes in any set of 
trials were different (not just the same shape seen from 
a different angle), and were regulated in the number of 
lines contained in the shapes. An example of the type of 
shapes presented is shown opposite in figure 7b. There 
were two practice trials and six experimental trials in 
each of the conditions;. In this task there were four 
conditions, which varied in the nature of the secondary 
(distracting) task. The subject was always asked to 
concentrate on recalling the shape presented in the
primary task. The four conditions were as follows :
i) Three wae ne secondare task ane hnnee •tee
subject was able to concentrate on recalling the
primary shape after the ten second interval..
ii) The subject was presented with distracting 
shapes in the ten second interval as in the trigram 
task (section 7.66, condition iv) . Again, the
subject was asked to copy the presented distractor
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shapes for ten seconds, and after this interval to 
try to draw the primary task shape.
iii) In this condition, the secondary task was the 
articulation of the word "the", (see section 7.66, 
condition ii).
iv) In this conditinn , the secondary task was the 
tapping task (see section 6.66, condition v).
The primary shapes were scored by the experimenter. 
The shape had to be accurately recalled in order to be 
scored as correct, although the size of the shape was not 
of importance. The number of distractor shapes drawn in 
condition (b) was recorded by the expeiimetter, whereas 
the number of artiuulitinns ndd tee taps eree rcordeed yy
the computer.
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Figure 7c: Example of the spatial task, a) on presentation, and b) on recall.
a) b)
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7.68 Spatial task
This task was also similar to the trigetm task. The 
primary task consisted of a large white square, 15cm by 
15cm., being presented on the computer screen for five 
seconds. On each trial, somewhere within the large white 
square appeared three small, 1.5cm by 1.5cm, red squares 
for the five seconds period. During the presentation 
period, the subject was asked to concentrate on the 
position of the red squares. An example of the type of 
stimulus is presented opposite in figure 7c. After the 
post stimulus presentation waiting interval of ten 
seconds, a 15cm by 15cm width grid appeared on the screen 
containing one of the previously presented red squares. 
The subject was asked to point to the position of the two 
missing red squares. After the subject had pointed to two 
squares on the grid, the experimenter pressed the space 
bar, upon which the screen showed the correct position of 
the missing stimuli squares by filling two squares of the 
grid in yellow. If the subject had correctly pointed to 
the position of tHe missing squares, the subject received 
one point for each of the correct squares. Hence, the 
maximum score was two points, which was scored by the 
experimenter. If, however, the subject pointed to one of 
the adjacent squares to the correct one he/she received a 
score of 0.5 inste^ed od one and if the subject pointed at 
other squares ht/sht received zero. Hence, the minimum 
score is zero and the maximum score was twelve, which was 
subsequently divided by two, to provide a score out of 
six. Again, there were two practice trials and six
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experimental trials;. The four ecoddtioos were as follows
i) There e es s o d distractor ann so the subject 
could concentrate on recalling the locations of the 
red squares.
ii) The secondary task was the tapping task (as in 
section 7.66, condition v).
ooo) The secondary task was concurrent articulation
(as in neseitn n.76, ccodntion ii).
iv) ThT e .seconda t tas wwa ith enawStd ef ihrper
(as in n iaeitn n .6(5, c cnnntitn Wo))
The performance on the secondary tasks was recorded 
as in trigram task (see section 7.66).
7.69a Caieqory-Drcision task.
The stimuli for this task were chosen from a 
selection of 43 digitized images presented via the 
computer screen. The list of images is presented in 
appendix two. The stimuli were the same objects that were 
used in the "pen and paper" version of this task, used in 
the Dundee study and described in chapter four. The 
images on the screen could be presented coloured red or 
green, and categorized as animate or inanimate.
There were three conditions in this task and 20 
experimental trials for each of the conditions :
i) The STheesu wec ewksi so detoere to dit .theec 
of the object on the image, which was either "red" or 
"green". In this condition, one of the response keys was
labelled "red" and the other was labelled "grred". The
192
subject saw the prompt word "colour" on the computer 
screen, followed by either a red or green object:.
ii) The subject was asked to respond to whether the 
image presented was either "animate" or "inanimates". The 
prompt word for this condition was the word "animate", 
and again the keys were labelled appropriately.
iii) The subject was randomly asked about the colour 
of the object or whether the object was "animate", with 
presentation of appropriate prompt words. The number of 
"colour" questions and "animate" questions was equal,
i.e. ten trials of each.
In each condition, a word acting as a prompt for the 
appropriate responses, i.e what colour or whether animate 
or not, was flashed on the screen for 500ms, followed 
500ms later by the image. The subject was asked to make 
the appropriate response by pressing one of the response 
keys as quickly as possibles. Each of the keys was 
labelled using cards stating green, red, animate, 
inanimate and green/inanimate and red/animate depending 
on the condition of the task. The response times, i.e. the 
time between the appearance of the image on the screen 
and the subject responding on the key, was recorded by 
the computer'. The subject was allowed to place his/her 
index fingers on the left and right response keys and 
these keys were labelled clearly for appropriate 
responding in each of the conditions. Both the order of 
presentation of the conditions and the responses assigned 
to the two response keys were balanced across the groups. 
For conditions (i) and (ii) there were three practice
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trials and for condition (iti) there were five practice 
trials. All practice trials were completed before the 
experimental trials began. If a subject appeared not to
understand the nature of the task, further practice 
trials and explanations were given by the experimenter.
7.69b Attention-Switching task
The stimulus materials for this task were t^granis 
of letters as used in the trigram task (see section 
7.66). There were three conditions, each containing two 
practice trials and ten experimental trials. If, however, 
the subject did not appear to understand the task, he/she 
was given extra explanations and practice trials by the 
experimenter. After the subject recalled the t^granis, 
the experimenter immediately pressed the space bar on the 
computer, and the response time, i.e. the time from 
presentation of appropriate response cue to the pressing 
on the space bar was recorded on the computer. Errors in 
recall were monitored by the experimenter, and the 
subject had to recall all letters in the correct order 
before being scored as correct. The three conditions were
as follows :
i) A trigram appeared on the screen. The subject 
was asked to read the trigram as soon as it appeared 
on the screen. After the subject had read the 
trigram, the experimenter pressed the space-bar (a 
reading task).
ii) The subject was presented with a taogaam on
the screen for four seconds. After another four
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second waiting interval an asterisk appeared on the 
screen. On seeing the asterisk (*) , the subject was 
asked to recall the trigram as quickly as possible
(a working memory task). After recall, the 
experimenter immediately pressed the space-bar and 
another trigram appeared.
in) A trigram to be memorised was presented on the 
screen for four second as in condition (i) . After 
four seconds, another different tetgeam was 
peesented on the screen. When this second trigram 
appeared, the subject was asked to recall as quickly 
as possible the first letter of the memorised 
trigr-am, and then to say the first letter of the one 
on the screen. He/she then recalled the second 
letter of the memorised trigram followed by the 
second letter on the screen etc. When the subject 
had said all six letters the experimenter pressed 
the space-bar.
When all the tasks had been completed, those 
subjects taking anticonvulsant medication were asked to 
provide a 20ml blood sample.
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CHAPTER EIGHT
GLASGOW STUDY : RESULTS
8.1 Introduction
Subjects completed the test battery after attending 
the epilepsy clinic:. The test battery was completed by 102 
subjects, of who e 1 1 oomplete d hh e test battery on one 
occasion, 35 on two occasions, 34 on three occasions and 2 
subjects on four occasions. The sum total of completed test 
sessions was 211. Most of the analyses of these data were
carried out on the results from the session one data.
The repeated testing of some subjects allowed for 
within-subjects analyses, to investigate performance across
sessions. This was carried out on a small number of 
subjects who had had changes in their medication between 
the testing sessions, and also it was used to investigate 
the effects of recent seizures on test performance. 
Practice effects on the test battery were analysed using 
the data of subjects who completed the tests on three
separate occasions.
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Where possible, all subjects completed the test 
battery described in chapter seven which is summarised
below:
1. WAIS Vocabulary and Picture Completion tasks.
2. MAACL (Mood Affect Adjective Check-list)
3. Finger tapping tasks.
4. simple reaction time tasks.
5. Digit span.
6. Trigram memory task.
7. Visual memory task.
8. Spatial memory task.
9. Category-Decision task.
10. Attention-Switching task.
The data obtained were analysed primarily by analysis 
of variance (ANOVA), with a between-subjects factor of drug 
groups and, where appropriate, a within-subjects factor of 
condition and/or session (two-way ANOVA).
The main body of analysis was the comparisons across
five groups (CTL N=10, UT N=22, CBZ N=21, VPA N=16 and DPH
N=15). The results from these analyses will be described in
detail, including post hoc analyses (using Newman Keuls and
Scheffe tests) where indicated. 
yThe Scheffe test was employed to compare the CTL group
(N=10) to the group with epilepsy (N=74) , and also the ACD 
ygroup (N=3 2) to the Non-ACD group (N=52) . The Scheffe test 
is a conservative post-hoc test, which allows for the
combining of different subject groups to form new groups
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and is suitable for comparisons between groups that differ 
greatly in size.
The data from the 71 subjects who completed the test 
battery on more than one occasion allowed for the -following 
within-group comparisons (across test sessions) to be
carried out :-
a. Change in level of ACD, i.e high versus low blood 
serum concentration of ACD (N=16 and consisted of CBZ N=9
and DPH N=7).
(Note, four subjects changed from higher to lower 
levels of medication, whereas twelve subjects changed from 
lower to higher levels of medication)
b. Presence of recently occurring seizure i.e. seizure 
occurring in previous two days, versus no recent seizure 
i.e. none in previous 14 days, (N=8)
c. Comparison of subject performance on the test 
battery across three sessions to identify practice effects, 
(N=23). These subjects had no changes in seizure frequency
or medication.
Before describing the ANOVAs, the data pertaining to
the clinical characteristics are described.
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Table 8.2a Summary of clinical data across four crroups
Drug
T/C
(No
Type of 
Seizures 
C/P C/Psg
. of Subj.)
with epilepsy
Seizure Age at
frequency onset (yrs)
123 mean (SD)
(No. of Subj.)
Duration
(yrs)
mean (SD)
CBZ
(N=21)
9 4 8 8 8 5 17.0 (7.8) 8.1 (7.
VPA
(N=16)
7 2 7 5 3 8 16.8 (10.4) 10.5 (11.'
DPH
(N=15)
7 2 6 5 5 5 22.8 (15.3) 12.3 (11.
UT
(N=22)
11 4 3 3 11 5 18.2 (6.7) 4.2 (6.
Key : T/C : tonic-clonic; C/P : complex partial
T/Psg : complex partial, secondarily generalised
: Frequency 1 : high frequency
: Frequency 2 : medium frequency
: Frequency 3 : low frequency
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8.2 Clinical data
Variables assessing the degree and severity of the 
epileptic condition were monitored across the subject 
sample. The type of epilepsy, the frequency of seizures,
the age of the subject at the onset of the condition and 
the duration of the disease are summarised for each subject 
in appendix five.
Table 8.2a summarises these variables for the four 
clinical groups (three drug groups and one untreated 
group).
The identified seizure type was that diagnosed by the 
Consultant neurologists in the medical notes. The 
information on the frequency of seizures was provided by 
the subject. There is the possibility that the seizure 
events described by the subject, for example "a dizzy 
spell" may not correspond to the single type of seizure 
identified using the medical notes. Hence, there is no 
screening of minor seizures, for example, absence seizures, 
in the frequency data.
Of the CBZ subjects, nine (42.8%%) werd aiagnos rd as 
having tonac-clonac ss o i zizres, oorr (19.0%) as having
complex partial seizures and eight (353.9%) as having
complex partial, secondarily generalised seizures. In terms 
of frequency of seizures, eight (38.9%) had more than three 
seizures in past six months, with eight subjects having 
more frequent seizures and five having less frequent 
seizures. The mean ago of onset of the condition for the
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CBZ group was 17.0 years with a standard deviation of 7.8 
years, and the mean duration of the disease was 8.1 years 
with a standard deviation of 7.4 years;.
The DPH subjects revealed a similar pattern in terms 
of types of seizures, with seven (43.8%) being diagnosed 
with todoc-clodic seizures, two (12.5%) with complex 
partial and six (37.5%) with complex partial, secondarily 
generalised. In terms of frequency, five subjects had a 
seizure frequency of greater than three in past six months, 
with five subjects having more frequent subjects and five 
having fewer seizures. The mean age at onset of epilepsy 
was 22.8 years with a standard deviation of 15.3 years, and 
the mean duration of the condition was 12.3 years with a 
standard deviation of 11.6 years.
The VPA group revealed seven (43.8%) subjects 
diagnosed with todoc-clonic seizures, two (12.5%) with 
complex partial seizures and seven with (43.85) complex 
partial, secondarily generalised. In terms of frequency, 
three subjects had a frequency of more than three seizures 
in the past six months;, five had more frequent seizures 
than this, and 8 had fewer seizures. The mean age at onset 
of epilepsy was 16.8 years, with a standard deviation of 
10.4, and the mean duration of the condition was 10.5 
years, with a standard deviation of 11.9.
In the UT group 11 (55%) were classified as having 
tonoi-clonic seizures, four (20%) as having complex partial
seizures, three (15%) as complex partial, secondarily
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generalised, one (5%) as having absence seizures and two
were of uncertain type. In terms of seizure frequency, 11 
had a frequency of more than three seizures in the past six 
months, three had had more frequent seizures than this, and
five had had fewer seizures. The frequency of one subject 
was unknown. The mean age at onset of epilepsy was 18.2 
years with a standard deviation of 6.7 years, and the mean 
duration of the condition was 4.17 years with a standard 
deviation of 6.0.
Inspection of the three drug groups revealed that most 
subjects had either tonic-clonic seizures or complex 
partial seizures, secondarily generalised. Few subjects had 
complex partial seizures alone. In comparison, the 
untreated clinical group had a greater proportion of tonic- 
clonic seizures and fewer complex partial, secondarily 
generalised.
In terms of seizure frequency, most of the drug group 
subjects fell in the high and medium frequency ranges, but 
most of the untreated group were in the medium frequency 
range. The age of onset was similar across the CBZ, the VPA
and the UT group, but was later for the DPH group. In terms 
of duration, the UT group had a smaller duration of the
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disease than the drug groups.
In summary, tho throo drug groups were reasonably
well-matched on tho epilepsy variables, but the UT group 
were somewhat different both in terms of seizure typo 
(fewer complex partial, secondarily generalised) and a 
lower seizure frequency.
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Table 8.2b Blood serum concentrations of anticonvulsant
drucs for the three drucf crroups
Drug group Concentration (mg/ml) No. Subjs. outside
Mean (SD) therapeutic range
CBZ (N=21) 9.3 (2.81) 3 above range
2 below range
VPA (N=16) 91.3 (36.9) 7 above range
3 below range
DPH (N=15) 25.8 (13.5) 10 above range
2 below range
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The blood serum concentrations of the anticonvulsant
medications were monitored for the three drug groups. The 
individual subject drug data is presented in appendix six. 
The data for the three drug groups are summarised in table 
8.2k). The mean concentration of CBZ for the CBZ group was 
9.25 mg/ml, with a standard deviation of 2.81. Three 
subjects were above the optimum serum levels as designated 
by Davidson (198 3) and two were below. The mean 
concentration of the VPA group was 91.3 mg/ml, with a 
standard deviation of 36.9. Seven subjects were above the 
optimum serum level and three were below. The mean 
concentration of the DPH group was 25.97 mg/ml, with a 
standard deviation of 13.5. Ten subjects were above the 
optimum serum level and two subjects were below this level.. 
There were, therefore, many subjects falling above the 
optimum serum level of medication particularly in the VPA 
and the DPH groups.
8.3 Quantitative analyses 
Drug groups versus untreated group versus control
group comparisons
The main analyses comprised of between-groups ANOVAs 
across the five groups (CTL, N=10, UT, N=20, CBZ N=21, VPA
N=17 and DPH N=16) , with a within-subjects factor of 
conditio n. The analyses used the test data from session
one.
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The porformanco of subjects on the different tests and
conditions is doscribod to allow the reader to evaluate tho
pattorn of porformanco on each of tho tests.
Tho data from tho analyses will be presented in tables
which will contain the means, standard deviations, "F"
ratios, degrees of freedom and level of significance for
each of the individual ANOVAs.
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Table 8.3a Numbers of subjects in analyses
CTLTest Total No. CBZ VPA DPH UT
Intellectual
Ability
84 21 16 15 22 10
Motor Task 84 21 16 15 22 10
Reaction time 
Task
84 21 16 15 22 10
Digit Span 84 21 16 15 22 10
Trigram task 84 21 16 15 22 10
Visual task 83 21 16 15 21 10
Spatial task 82 21 16 15 20 10
Distractor tasks
1. Articulations 84 21 16 15 22 10
2. Counting 
backwards
84 21 16 15 22 10
3. Shapes 83 21 16 15 21 10
4. Tapping 84 21 16 15 22 10
Category- 
decision task
58 20 9 8 11 10
Attention- 61 20 9 11 11 10
switching task
207
8.31 Missing Data
Missing data points were treated in one of two ways in
the analyses. If a subject did not complete a particular 
test:, that subject's data were removed from the analysis 
completely. However, if a result from any individual trial 
was not recorded because of either experimenter error or 
technical reasons, the subject was given the mean score for 
the whole data set for that missing trial data point. The 
number of data points treated in this way was small, for 
example in the trigram task, the data of only three 
subjects out of a total 420 sets of data i.e. 84 subjects 
each completing five conditions of the tests, were treated 
in this way. In giving the mean trial score to missing data 
points, there is a small reduction in the probability of 
obtaining significant differences between the groups.
Unfortunately, due to an error in the computer 
programme for the category-decision and the attention­
switching tasks, the correct response times for a large 
portion of data were not recorded. Hence, the data set for 
these two tests was reduced by approximately a third of the 
original data set.
The number of subjects included in each test analysis 
is presented in table 8.3a, showing a much reduced data set
for the category-decision and attention-switching tasks. A 
complete data set consisted of 84 subjects.
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8.32 Mood Affect Adjective Check-List (MAACL)
The results from the MAACL provided measures of
anxiety, depression and hostility. The data from the MAACL 
was non-parametric and was therefore analysed using
Wilcoxon signed ranks test.
The five drug groups were compared across the three 
mood variables. They were not significantly different on 
any of the three variables (all significance levels were P 
> 0.1) Hence, the subjective feelings of negative mood
states did not differ significantly across any of the 
groups, and no further analysis was carried out on this
data .
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Table 8.3b : Mean scaled scores for the tests of
Intellectual ability across the five groups 
Test Subject group : Mean (S.D.)
CTL UT CBZ VPA DPH
Intellectual Ability 9.15 7.91 8.93 7.78 9.33
(Combined score) (1.69) (1.98) (1.96) (1.94) (2.32)
Vocabulary 9.70 8.27 9.24 7.81 9.47
(2.72) (1.98) (2.24) (1.70) (2.60)
Picture Completion 8.60 7.55 8.62 7.75 9.20
(1.80) (2.40) (2.59) (2.75) (1.72)
Table 8.3c Summary of ANOVA for the five groups on tests
of Intellectual ability
Test "F" ratio (Df) and significance level
Intellectual Ability
(Combined score) F = 1.56 (Df 4/79) P > 0.1
Vocabulary F = 1.79 (Df 4/79) P > 0.1
Picture Completion F = 1.23 (Df 4/79) P > 0.1
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8.33 Tests of intellectual ability
Table 8.3b summarises the mean scaled scores and
standard deviations across the five groups for the tests of 
intellectual ability. On the combined scores (mean of 
Vocabulary and Picture Completion), the DPH group had the 
highest mean (9.33), followed by the CTL group (9.15), then 
CBZ (8.93), the UT group (7.91) and finally the VPA group 
(7.78). The DPH group also had the largest standard 
deviation with the CTL group having the smallest.
Table 8.3c presents the "F" ratios, degree of freedom 
and levels of significance of the results of the three one­
way ANOVAs across the five groups on the tasks of 
intellectual ability. There were no significant differences 
on these tests between the five groups. Therefore, any 
significant differences between groups, on further tests, 
should indicate specific cognitive impairments and not 
simply lower intellectual ability.
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Table 8.3d Mean total number of taps on motor tasks and
mean response times on reaction time tasks for
the five groups
Subject group : Mean (S.D)
Test CTL UT CBZ VPA DPH
Motor tasks : Total No. of taps
Condition one (no distractor)
a) Single tapping 320.6 280.6 314.0 286.4 293.3
(37.6) (55.7) (64.3) (61.3) (40.7)
b) Double tapping 161.7 138.5 162.2 146.4 153.7
(25.6) (36.2) (35.6) (30.5) (32.0)
Condition two (with simple reaction time task)
a) Single tapping 288.9 234.9 281.1 253.8 273.1
(66.5) (59.1) (59,5) (72.8) (52.4)
b) Double tapping 153.3 125.1 149.0 135.9 146.8
(36.1) (37.3) (35.6) (29.1) (33.0)
Reaction time tasks (in msec)
Condition one 261.9 301.9 340.8 331.6 335.4
(No tapping) (30.6) (61.1) (157.1) (81.5) (101.6)
Condition two 292.2 345.7 394.1 381.8 350.6
(Single tappi ng) (44.1) (65.7) (203.0) ( 107.0) (90.3)
Condition three 369.3 411.1 460.4 524.0 468.8
(Double tapping) (52.0) (81.4) (198.3) (324.5) (120.1)
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8.3 4 Motor tasks and Reaccion Time tasks
The motor task consisted of two simple tapping tasks 
c) tapping one key for 60 seconds with the same finger and 
b) tapping two keys, alternately, for 60 seconds with the 
same finger?.
The simple reaction time task consisted of the subject 
responding as quickly as possible to an orange cursor 
appearing on the computer screen.
The tasks were first carried out separately. The two 
tasks i.e reaction time task and motor tasks, were then 
carried out simultaneously. Dual-task methodology was used, 
whereby the subjects were asked to maintain their 
performance on the reaction time task i.e. the primary 
task, whilst endeavouring to carry out the tapping tasks 
i.e the secondary tasks. The subjects were first asked to 
complete the reaction time task with a secondary task of 
tapping on a single key with their free hand, and were then
asked to carry out the reaction time task with a secondary
task of tapping alternately on two keys with their free
hand.
The response times in the reaction time tasks were
measured in milliseconds and the tapping tasks were
measured in the total number of taps recorded in 60
seconds.
Table 8.3d summarises the means. and standard
deviations for the tapping rates and response times across
the conditions. The pattern of means across the tapping
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tasks revealed higher tapping rates for the CTL group),
followed in general by the CBZ group, the DPH group, the 
VPA group and lastly, the UT group. There was no obvious 
pattern in the standard deviations, with the exception of
the CTL group having smaller standard deviations.
The effect of making the motor task more difficult, by 
introducing two keys to be pressed alternately, 
dramatically reduced the tapping rate compared to the 
original single tapping rate. The rate of tapping also 
slowed (by approximately 10%) when the tapping tasks were 
used as secondary tasks, with the reaction time tasks.
The mean response times in the reaction time task 
produced a consistent pattern of means in which the CTL 
group had the fastest response times, followed by the UT 
group, followed by the three drug groups. In general, the 
CTL group and the UT group also had smaller standard 
deviations compared with the three drug groups.
The effect of combining the reaction time task with
the motor tasks served to slow down the reaction time
tasks; for example, in the control group, the mean response 
time in condition one (no tapping task) was 261.9 ms, the 
mean response time in condition two (with single key
tapping) was 292.2 ms and in condition three (with double 
key tapping) the response time was 369.3 ms.
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Table 8.3e Summary of ANOVAs across five groups for the
motor and reaction time tasks
Test "F" ratio (Df) and significance level
Motor tasks
Effect of Group F — 2.14 (Df 4/79) P = 0.083
Effect of Condition F = 70.05 (Df 4/79) P < 0.001
Effect of Keys F = 786.00 (Df 4/79) P < 0.001
Interactions
Group by Condition F < 1
Group by keys F < 1
Group by condition F < 1
by keys
Reaction time tasks
Effect of Group F = 1.86 (Df 4/79) P > 0.1
Effect of Condition F = 43.26 (Df 4/79) P < 0.001
Interaction F < 1
(Group by Condition)
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The "F" ratios, degrees of freedom and the levels of 
significance are presented in table 8.3e, for the two-way 
ANOVAs of the tapping and reaction time tasks. In both sets 
of analysis there was a within-subjects factor of condition
as well as the between-groups factor. The analyses revealed 
no significant group effects, although there was a trend in 
the motor task (F (4,79)= 2.14, P = 0.083). The effect of 
condition, i.e. the addition of the dual task, was highly 
significant in both motor and reaction time tasks, as was 
the effect of keys in the tapping task. For all these 
effects the level of significance was less than 0.001. 
These significant effects show that response times and 
tapping rates slowed as tasks became progressively more 
complex.
There were, however, no significant interactions
between group and condition. Hence, increasing the task 
complexity did not have a larger detrimental effect on any 
one group's perform^ar^c^^.
The analysis of the results for the reaction time 
tasks was repeated using corrected means for each subject, 
i.e. those individual response times that were more than
three standard deviations from the mean score of the total
subject sample were removed from each subject's score, and 
a new mean response time was computed. Analyses were also 
carried out using the uncorrected and corrected median 
scores. The same findings were obtained regardless of which 
particular analysis was carried out, with all "F" ratios
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being more than one, but all significance levels being less
than 0.1.
In summary, the results on these motor and perceptual 
tasks revealed no significant group differences, although
there was a trend in the tapping tasks. There were 
significant effects of condition but no group by condition 
interactions. Hence, the lack of significant differences 
between the groups supports the null-hypotheses i.e. of 
there being no significant differences in performance 
between the control and clinical groups, and no significant 
differences between the clinical groups.
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Table 8.3f Mean scaled score for digit span and mean
score correct for triqrams for the five groups 
Test Subject Groups : Means (S.D)
CTL UT CBZ VPA DPH
Digit span 12.00 11.87 11.00 10.98 10.13
(2.24) (2.19) (2.82) (2.95) (3.44)
Trigram task
Condition one 6.00 5.82 5.76 5.50 5.87
Control (0.00) (0.40) (0.44) (0.73) (0.35)
Condition two 5.70 4.91 5.10 4.63 5.47
Articulations (0.48) (1.11) (1.34) (1.71) (0.99)Condition three 3.90 2.77 3.38 2.50 3.67
Counting in "3s" (1.45) (1.69) (1.56) (1.90) (1.88)
Condition four 5.80 5.50 5.15 5.00 5.67
Shapes (0.42) (0.74) (1.06) (1.03) (0.49)
Condition five 5.90 5.27 5.62 5.00 5.60
Tapping (0.32) (0.83) (0.67) (1.27) (0.51)
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8.35 Verbal Memory Tasks
The two verbal memory tasks were the digit span and 
the trigram task. Table 8.3f summarises the means and 
standard deviations for the five groups. In the digit span
task the CTL group obtained a higher mean score than the 
other groups, followed by the UT group, the CBZ group, the 
VPA group), and the finally the DPH group). The UT group and 
the CTL groups had smaller standard deviations than the 
three drug groups.
In the trigram task, the CTL group once again obtained 
the highest mean scores, the next highest was the DPH 
group, followed by the CBZ group, the UT group and finally 
the VPA group (see figure 8a) . The control group also had 
smaller standard deviations, but this may have been due to 
ceiling effects in some conditions. However, in condition 
three where few ceiling effects were observed, the CTL 
group still obtained the smallest standard deviations, 
followed by the CBZ group, the UT group), the DPH group and 
finally the VPA group.
Surveying the means across the five conditions of the 
trigram task, one observes that the highest mean scores 
were obtained with the no distractor condition, the next 
highest mean scores were with the tapping distractor task, 
followed by the drawing shapes condition, then with 
articulatory suppression, and the lowest mean scores were
obtained with the counting distractor task; for example, in
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Table 8.3a ANOVA of diait snan and ariaram data for the
five arouDS.
Test "F " ratio (DF) <and significance level
Digit Span (Groups) F = 1.80 (Df 4/79) P > 0.1
Trigram task
Effect of groups F = 3.25 (Df 4/79) P < 0.05
Effect of Condition F = 110.01 (Df 4/316) P < 0.001
Interaction
(Group by condition)
F < 1
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the CTL group the means for these five conditions were 6.0, 
5.9, 5.8, 5.7 and 3.9 respectively.
The digit span task results were analysed by a one-way 
ANOVA, with a between-subjects factor of groups. No
significant group effect was found on this analysis.
The trigram task was analysed by a two-way ANOVA, with 
a between-subjects factor of groups and a within subjects 
factor of condition. Main effects were found for groups (F 
(4,79) = 3.25, P < 0.05), and for conditions (F (4,316) =
110.01, P < 0.001). However, there was no significant group 
by condition interaction (see table 8.3g).
Post hoc Analvses
The main effect of groups on the trigram task was 
further analysed using Newman Keuls test:. This analysis 
revealed a significant difference (P < 0.05) between the
CTL group and the VPA group, with the VPA group performing 
more poorly. No other group comparisons were significant.
Table 8.3h : Summary of Newman Keul comparisons for
triaram conditions
CTL Tapping Shapes Artie. Counting
CTL P< 0.05 P <0.05 P< 0.01 P< 0.01
Tapping N. S P< 0.05 P< 0.01
Shapes P< 0.05 P< 0.01
Artie. P< 0.01
Counting
The effect of condition was also analysed using a 
Newman Keuls test. The control condition, i.e no
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distractor, produced significantly higher scores compared 
to both the articulatory suppression and the counting
distractor conditions at the P < 0.01 level. The control
condition was also significantly higher scoring compared to 
the tapping and drawing shapes condition at the P < 0.05 
level. The counting condition was significantly impaired at 
the P < 0.01 level compared to the articulatory
suppression, the tapping and the drawing shapes conditions. 
The articulatory suppression condition was significantly 
lower scoring, at the P < 0.05 level, compared to the 
tapping and the drawing shapes conditions. These 
comparisons are summarised in table 8.3h.
The Newman Keuls analysis supported the hypothesis 
that the verbal distractor tasks interfered to a greater 
degree on the performance on the primary trigram task 
compared to the visual and motor secondary tasks. The 
visual and motor distractor conditions did, however, have 
an effect on performance compared to the control condition, 
with significantly lower scores being obtained on the 
primary task in these conditions.
Two further group comparisons were made (for clinical 
interest) using the Scheffe test.
1. CTL group (N=10) versus the group with epilepsy 
(N=7 4)
2. ACD group (N=52) versus non-ACD group (N=32)
Neither of these two analyses revealed significant
differences between the groups.
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Table 8.3i Mean score correct for the visual and spatial
tasks for the five qroups
Test Subject Groups : Means (S.D)
CTL UT CBZ VPA DPH
Visual task
Condition one 5.30 5.05 5.00 4.57 4.93
Control (0.68) (1.05) (0.95) (1.26) (0.99)
Condition two 5.20 5.10 4.71 4.19 4.42
Articulations (0.79) (0.94) (0.96) (1.17) (1.29)
Condition three 3.60 3.38 3.62 2.75 3.13
Shapes (1.90) (1.23) (1.24) (1.29) (1.77)
Condition four 5.00 4.48 4.52 3.63 4.67
Tapping (1.16) (1.24) (1.21) (1.45) (1.29)
Spatial task
Condition one 4.33 4.01 4.20 3.92 4.40
Control (0.89) (0.56) (0.74) (0.95) (0.64)
Condition two 4.13 3.57 4.01 3.08 3.55
Articulations (0.97) (0.92) (0.99) (1.00) (0.97)
Condition three 2.93 2.53 2.66 1.93 2.68
Shapes (0.99) (0.99) (0.83) (0.89) (1.29)
Condition four 3.95 3.35 3.47 2.82 3.55
Tapping (0.89) (1.00) (1.10) (1.24) (0.89)
Table 8.3i ANOVA of visual and soatial task for the five
Test
croups
"F" ratio (DF) and significance level
Visual task 
(Effect of Group)
F = 2.12 (Df 1/78) P = 0.082
Effect of Condition
Interaction
(Group by Condition)
F = 71.10
F < 1
(Df 3/234) P < 0.001
Spatial task
(Effect of Group)
F = 2.94 (Df 1/78) P < 0.05
Effect of condition
Interaction
(Group by Condition)
F = 76.47
F < 1
(Df 3/234) P < 0.001
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Figure 8b: Graph of the spatial memory task for five groups in 
study two
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8.36 Non-verbal memory ttsks
Table 8.3i summarises the means and standard
deviations for the two non-verbal primary memory tasks 
across the five groups. The maximum scores on both the
visual and the spatial memory tasks were six, and a number 
of subjects achieved the maximum scor e o n some of the
conditions.
The CTL group obtained the highest mean score on the 
visual memory task, followed by the UT gropp, the CBZ 
group, DPH group and finally the VPA group; for example the 
means on the condition one for the groups were 5.30, 5.05, 
5.00, 4.93, and 4.57 respectively. The size of the standard 
deviations will have been affected by the ceiling effects 
obtained in some conditions. Looking across the conditions 
there was no observable pattern in hhe sizes oo the
standard deviations.
Surveying the means across the four different 
conditions, one finds a consistent chterrp, wtth the 
highest being obtained in the no distractor condition, the 
next were in the articulatory suppression condition, 
followed by those in the tapping task, with the smallest 
means being obtained in the drawing shapes condition.
The means and standard deviations of the spatial 
memory task is also summarised in table 8.3i. There was a 
less clear pattern of size of means, although generally the 
CTL group obtained higher means than the other groups. 
There were fewer maximum scores on the spatial task and
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generally lower scores than on the visual task. Once again 
there was no clear pattern of size of standard deviations. 
Indeed, the standard deviations appeared to be of a more 
similar size in all five groups (see figure 8b).
Surveying the effects of condition on the mean scores, 
a similar picture was revealed for the spatial task as for 
the visual task. Again, there was a consistent order of the 
means, with the highest scores being obtained by the no 
distractor condition, followed by the articulatory 
suppression, followed bb tte tapping condition and the 
lowest mean scores were obtained by the drawing shapes 
condition. Hence, on both primary tasks, the shape drawing 
distractor task produced the lowest means in the primary
task data.
Both the v^siaa ann tth spatial task were analysed 
using two-way ANOVAS, with a between-subjects factor of 
groups and a wittin-subjects factrr of condition. Main 
effects of groups were found in the spatial task (F 1,78 = 
2.94, P < 0.05) and a trend was observed in the visual 
task, (F 1,78 = 2.12, P < 0.1). There were also effects of 
conditions for both tasks, F 3,234 = 71.10, P < 0.001 for 
the visual task, and F (3/234) = 76.47, P < 0.001 in the 
spatial task (see table 8.3j).
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There were no significant interactions between groups 
and conditions. Hence, increasing task difficulty did not 
affect the performance differentially, across the five
groups.
229
Table 8.3k Newman Keuls analysis of condition for the
visual and the soatial tasks
1. Visual Task
CTL
Artic.
Tapping
Shapes
CTL Artic. 
N.S.
Tapping
P < 0.01
P < 0.05
Shapes
P < 0.01 
P < 0.01 
P < 0.01
2. Spatial Task
CTL Artic:. Tapping Shapes
CTL P < 0.01 P < 0.01 P < 0.01
Artic. P < 0.01 P < 0.01
Tapping p < 0.01
Shapes
230
Post hoc Analyses
The main effect of groups on the spatial task was
further analysed using the Newman Keuls test. The 
performance of the VPA group was significantly poorer than 
the CTL group performance on the spatial task (P < 0.05). 
There were no other significant differences.
The effect of condition for both the tasks was
analysed by Newman Keuls test.
In the visual task the control condition performance 
was significantly better hean the tapping and the drawing 
shapes condition (P < 0.01). The articulatory suppression
performance was also significantly better than the tapping 
task (P < 0.05) and the drawing tasks (P < 0.01) . The
tapping task produced significantly better performance 
compared to the drawing shapes task (P < 0.01), as shown in
table 8.3k.
The effects of conditions in the spatial task were 
analysed using Newman Keuls test, which revealed that 
comparisons between conditions were all significantly 
different at the P < 0.01 level. The best performance on 
the primary spatial task was in the control condition 
followed by the articulatory suppression condition, the 
tapping task condition, and finally the visual condition. 
Table 8.3k summarises these findings.
The Newman Keuls analysis supported the working memory 
model and hence the design of the tasks, i.e. that the
visual and spatial tasks would be more greatly affected by
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the tapping and the drawing shapes secondary tasks than by 
the verbal articulatory suppression condition. In addition,
the trigram task was significantly more affected by the 
articulatory suppression condition compared to either the 
tapping or drawing shapes conditions (see section 8.35). 
However, the pattern of performance on the visual and 
spatial primary tasks could not be differentiated by the 
performance of the primary tasks, on the tapping and shape
conditions.
Two further comparisons, the CTL subjects (N=10) 
versus the subjects with epilepsy (N=74) and the ACD ((N=52) 
versus the non-ACD ((N=3 2) were made on both the two tasks 
using the Scheff^ test. Neither of the analyses revealed
significant differences between the groups.
In the three memory tasks (trigrams, visual and
spatial) the subjects were requested to' perform the
secondary (distractor) task at a specified and constant
rate across all three tasks. The following section presents 
the analyses of the performance of the groups on each of
the secondary tasks across each of the memory tasks.
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Table 8.31 Mean Number of distractor tasks per second
across the three memory tasks for the five groups.
Test Subject Groups : Means (S.D)
CTL UT CBZ VPA DPH
Articulations
A) Trigrams 2.27 2.26 2.75 2.50 2.39
(0.54) (0.80) (0.83) (1.05) (0.86)
B) Visual 2.46 2.30 2.71 2.30 2.44
(0.61) (0.72) (0.85) (0.81) (0.79)
C) Spatial 2.52 2.34 2.59 2.38 2.26
(0.89) (0.84) (0.82) (1.08) (0.90)
Counting backwards 0,53 0.45 0.44 0.34 0.47
(Trigram task:) (0.21) (0.17) (0.15) (0.22) (0.18)
Shapes
A) Trigrams 0.19 0.18 0.20 0.16 0.17
(0.06) (0.06) (0.05) (0.04) (0.07)
B) Visual 0.18 0.18 0.19 0.14 0.15
(0.05) (0.06) (0.07) (0.04) (0.07)
C) Spatial 0.19 0.17 0.19 0.14 0.15
(0.05) (0.07) (0.06) (0.04) (0.07)
Tapping
A) Trigrams 2.03 1.87 2.19 2.21 2.12
(0.36) (0.52) (0.44) (0.65) (0.53)
B) Visual 2.01 1.85 2 . 17 1.90 2.01
(0.39) (0.66) (0.42) (0.63) (0.49)
C) Spatial 1.95 1.76 2 . 11 1.79 2.05
(0.35) (0.59) (0.50) (0.57) (0.58)
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8.37 Distractor tasks
The subjects were required to carry out secondary 
distractor tasks in the different conditions of the memory 
tasks. The aim was that the performance on the secondary 
tasks should be constant across the tasks and the subject 
groups, and that any trade-off in performance should only 
occur in the primary memory tasks. This section assesses 
the extent to which the subjects were successful at 
maintaining secondary task performance.
The rate of articulatory suppression requested by the 
experimenter was two items per second. In general, the 
subjects achieved this as they performed at a rate of 
between 2 and 2.5 items per second as shown by the mean 
scores in table 8.31. This rate was maintained across the
different memory tasks and across the five groups.
The counting backwards in threes condition only 
applied in the trigram memory task. It was more difficult 
to specify a rate of performance in hhis task, as the rate 
depended on the ability of the subject to count backwards
in threes. The order of the means on this task revealed 
that the CTL group obtained the highest rate of counting, 
followed by the DPH group), the UT group, the CBZ group and 
finally the VPA group.
In the shapes condition, it was also more difficult to 
specify a rate of drawing. Nevertheless, a consistent rate 
of drawing was obtained across the three memory tasks, with 
the CTL group and the CBZ group drawing at perhaps a
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marginally higher rate compared to the other three groups 
(see table 8.33.)
The subjects were instructed to tap at a rate of two 
taps per second in the tapping condition on the memory
tasks. In general, the groups were all able to tap at a 
rate close to this requested rate. However, across the 
three memory tasks the rate of tapping varied in a 
consistent manner, with faster mean tapping rates being 
obtained on the trigram task, followed by the visual task, 
and slowest tapping rates being obtained by the spatial 
task; for example the CTL group means were 2.03, 2.01 and 
1.95 respectively. (See table 8.31)
In terms of standard deviations, few obvious patterns 
of results were obtained. In general, the control group had 
smaller standard deviations compared to the other groups,
but this was not a wholly consistent pattern.
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Table 8.3m ANOVA of the secondary tasks for the five
Test "F" ratio
arouDS
(DF) and significance level
Articulations : 
Effect of Group F < 1
Effect of Task F < 1
Interaction 
(Group by Task)
F = 1.74 (Df 8/158) P = 0.092
Counting backwards 
Effect of Group F 2.04 (Df 4/79) P = 0.094
Shapes ;
Effect of Group F 2.01 (Df 4/79) P > 0.1
Effect of Task F = 10.98 (Df 2/158) P < 0.001
Interaction 
(Group by Task)
F < 1
Tapping :
Effect of Group F = 1.10 (Df 4/79) P > 0.1
Effect of Task F 4.17 (Df 2/158) P < 0.05
Interaction
(Group by Task:)
F < 1
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The distractor tasks were analysed using ANOVA and the 
results are summarised in table 8.3m. The articulatory 
suppression, shape drawing and tapping distractors were 
each analysed using a two-way ANOVA with a between-subjects
factor of groups and a within-subjects factor of primary
task.
There were no main fffects frr iihhrr ggruus or 
condition in the articulatory suppression. However, there 
was a trend in the gooupr yr ^tractorr ^emcti^r (F 
8,158 = 1.74, P < 0.1).
There were no main effects of groups in either the 
shapes drawing or the tapping distractor tasks. However, in 
both, there was an effect of task for the shape drawing 
distractor (F 2,158 = 10.98, P < 0.001), and for the
tapping distractor (F 4,158 = 4.17, P < 0.05). There were 
no group by distractor interactions.
The counting backwards distractor was analysed by a 
one-way ANOVA which revealed a trend towards a significant 
effect of groups (F 4,79 = 2.04, P < 0.1).
Post hoc Aialises
Although subjects were asked to maintain a iptaiint 
performance on the tPignaiOrss, there were effects of 
primary task for both the tapping (P < 0.05) and the 
drawing shapes (P < 0.001) dis^a^ors. These effects were 
analysed using Newman Keuls test:.
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The performance on the shape drawing distractor was 
significantly reduced on the visual task (P < 0.01) 
compared to the performance of this distractor on the 
trigram task. The performance on the tapping distractor, on 
the other hand, was significantly reduced on the spatial 
task compared to the trigram task (P < 0.01). There were no 
other significant differences.
This analysis supports the view that there is a
difference in mode of operation in the spatial task
compared to the visual task, and that the difficulty of
combining motor and spatial tasks resulted in a reduced
level of performance in the motor tapping distractor 
compared to the control condition. Likewise, the difficulty 
of performing on the primary visual task and the secondary 
shape drawing task resulted in reduced performance in the 
secondary drawing task compared to performance of the 
drawing shapes distractor on the trigram task.
In summary, the three dual-task memory tests showed 
some differences in performance, particularly between the 
CTL and the VPA group. There were several effects of 
condition as expected from the design of the tests. 
However, there were no interactions between group and
condition of test.
This set of results, obtained from using working 
memory tasks, supported a model of working memory with 
separate verbal and vseuo-spahial systems, and indeed to 
some degree indicate the possibility of separate visual and
238
spatial systems. Howe^^^, there was no clear evidence that 
ACDs impair performance on these tasks, nor indeed that 
epilepsy per Se results in impairments on these tasks.
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Table 8.3n Mean response times for the categorv-decision
and attention-switching tasks in milliseconds, for the five
groups.
Test Subject group : Mean (S.D)
CTL UT CBZ VPA DPH
Category-decision task (N=58)
Condition one 552.9 551.9 540.8 731.1 682.0
(175.5) (204.8) (145.3) (263.6) (209.6)
Condition two 657.8 732.0 806.8 853.9 814.2
(114.4) (220.0) (270.5) (390.8) (305.3)
Condition three 904.3 930.9 1027.4 1397.9 1126.3
(337.7) (478.3) (486.1) (481.8) (498.5)
Attention-switching task (N=60)
Condition one 1514.0 
(324.8)
1372.1 
(242.3)
1492.0 
(490.9)
1726.1 
(458.9)
1541.9 
(382.6)
Condition two 1579.1 1534.8 1647.6 1874.0 1634.1
(227.8) (316.3) (350.6) (383.9) (415.8)
Condition three 4895.6 5108.2 5361.2 5109.4 4803.4
(932.8) (1308) (1586) (1794) (1450)
Table 8.3d ANOVA of categorv-decision and attention-
switching tasks for the five groups
Test "F" ratio (Df) and significance level
Category-decision task 
Effect of Group F = 1.91 (Df 4/53) P > 0.1
Effect of Condition F = 43.26 (Df 2/106) P < 0.001
Interaction
(Group by Condition)
F < 1
Attention-switching task 
Effect of Group F < 1
Effect of Condition F = 362.64 (Df 2/110) P < 0.001
Interaction F > 1
(Group by condition)
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8.38 Category-Decision and Attention-Switching tasks
The means and standard deviations for the category- 
decision and attention-switching tasks are presented in 
table 8.3n. Each of the means presented is the mean group 
response time in milliseconds.
The pattern of means in the category-decision task 
revealed that the CTL group generally had the fastest 
response times, followed by the UT group, the CBZ group, 
the DPH group with the VPA group having the slowest times; 
for example, in condition three the times were 904.3, 
930.9, 1027.4, 1126.3, and 1397.4 milliseconds, 
respectively. The standard deviations were generally 
smaller for the CTL group but of a similar size for the 
other groups.
The means of every group consistently increased across 
the three task conditions; for example, the CTL group means 
were 552.9, 657.8 and 904.3 respectively.
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Table 8.3a Mean percentage of errors on category-decseion
Group
task for five groups
Mean percentage error score (%)
Condition 1 Condition 2 Condition 3
CTL 3.0 0.0 14.0
UT 0.0 0.0 19.0
CBZ 0.5 1.0 14.0
VPA 2.2 1.1 22.2
DPH 0.0 1.0 10.0
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The mean percentage error scores across the three 
conditions in the cahegory-dhcision task for the five 
groups are presented in table 8.3q The pattern of means 
revealed very few errors in the first two conditions, with
more errors in the third condition. Many subjects had zero 
errors across all conditions, and with such small numbers 
of errors the data were not analysed ehahsehscally. The 
pattern of means was consistent, with for all five groups 
obtaining similar error scores.
The pattern of means for the attention-switching task 
revealed that the CTL group and the UT group had faster 
response time means than the three drug groups. Hence, in 
condition two the mean response times for the CTL, UT, CBZ, 
VPA and DPH groups were 1579.1, 1534.8, 1647.6, 1874.0, and 
1634.1 ms. Also, the standard deviations were smaller for 
the CTL and UT group compared to the other three groups.
Surveying the mean scores across the conditions for 
all five groups, the mean scores consistently increased 
across the conditions, with the final condition producing 
mean response times more than double those in condition
one.
The mean phrcenhsgh errors for each condition for each 
of the five groups are summarised in table 8.3r. The mean 
error percentages were very low in condition one and 
gradually increased across conditions. Again many subjects
had no errors in any of the conditions and the errors
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scores were of a similar size across all subject groups. 
Thus, no further analysis was carried out on the data.
Table 8.3r Mean percentage error scores for attention­
switching task for five groups
Group Mean percentage error score (%)
Condition 1 Condition 2 Condition 3
CTL 2.2 11.6 12.1
UT 3.1 7.3 15.9
CBZ 3.0 6.0 11.2
VPA 3.9 5.6 14.0
DPH 4.4 10.0 17.0
The response time data for both tasks were analysed 
using two-way ANOVA, with a between-subjects factor of 
groups and a within-subjects factor of condition. Table 
8.3p presents the results of this analysis and reveals that 
there were no significant main effects of groups. There 
were main effects of condition for the category-decision 
task (F 2,106 = 43.26, P < 0.001) and for the attention 
switching task (F 2,110 = 362.64, P < 0.001). There were no 
group by condition interactions. Henc^, increasing task 
complexity did not have a greater detrimental effect on any 
one group performance.
Post hoc analvses
The Newman Keuls test was used to investigate the 
effect of condition for these two tasks. On the category- 
decision task, all the conditions were significantly
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different from each other (P < 0.01) with the conditions
becoming increasingly difficult, i.e condition one (that of 
colour) was the easiest, followed by condition two (that of 
animate/inanimate), with condition three (colour or 
animate/inanimate) being the most difficult.
In the attention-switching task, condition three 
(requiring the switching of attention from perception to 
memory) was significantly more difficult than conditions 
one (reading task) and two (memory task) at the P < 0.01 
level. Hence, these results were as expected in the design
of the tests.
8.4 Summary
Although not totally consistent, the following 
pattern of means and standard deviations emerged. In 
general, the CTL group obtained means in the direction of 
better performance and also had smaller standard deviations 
compared to the other four groups. Of the three drug 
groups, the VPA group performed less well compared to the 
CBZ and DPH groups which performed in a similar fashion. 
Interesting ly, the means of the UT group for some of the 
tasks, were in the direction of poorer performance when 
compared to the CBZ and DPH groups but better than the VPA
group.
The ANOVAs revealed a number of trends and significant 
findings. On the memory tasks, i.e the trigram and spatial
tasks, the CTL group performed significantly better than
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VPA group at the 0.05 level. There were trends i.e. P < 
0.1, for the main effects of group on the visual memory 
task and the motor task. There were no significant group 
differences in the distraction tasks or the response hsme
tasks.
Hence, this set of results predominantly supported the 
null-hypotheses i.e. no significant differences were shown 
between the drug groups themselves and in comparison with 
the untreated epilepsy group, and in most of the analyses 
the epilepsy groups were not significantly different when 
compared with the control group.
The analysee of the effects of condition supported the 
view that the tests varied in difficulty as expected by the 
design of the test battery. One interesting finding was the 
change in performance of subjects in the distractor 
conditions in the memory tasks. The subjects had been asked 
to maintain a constant performance on the distractor tasks. 
However, it transpired that the subjects showed reduced 
performance on the visual (^irawing shapes) secondary task 
when the primary memory task was of a visual nature and 
also showed reduced performance on the motor (tapping) 
distractor task when the primary task was a spatial memory 
task. This pattern of reduced performance supported the 
theoretical view that there is more interference between 
motor and spatial tasks and also more interference between 
two visual tasks, as discussed in chapter six.
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The hypothesis in relation to task difficulty i.e. 
that as the tasks became more difficult, there would be an 
increasing "number of significant differences between the 
five groups, was not supported.
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Figure 8c: Graph of the spread of individuals’ mean scores on
S.R.T. for five groups in study two
Group
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Figure 8d: Graph of the spread of individuals’ scores in 
condition five of the trigram task for the five groups in study 
two
Percentage of 
subjects with this 
score
Number of 
trigrams 
correct
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8.5 Further analysis of the data
The between-group comparisons revealed few significant 
differences between the five groups. However, the patterns 
of means across the whole test battery were consistent. The
CTL group obtained higher means than the CBZ group, 
followed by the UT and DPH groups, with the VPA group 
obtaining the lowest means. It was also noticeable that the 
standard deviations tended to become larger in the opposite 
direction, so the groups with lower performance mean scores 
tended to have the larger standard deviations. On the 
reaction time task, in condition one, the means and 
standard deviations (shown in brackets) for the five groups 
i.e. the CTL, UT, DPH, VPA and CBZ groups were 2 61.9ms 
(30.6), 301.9ms (61.1), 331.6ms (81.5), 335.4ms (101.4) and 
340.8ms (157.1), respectively. To further illustrate this 
point, figures 8c and 8d show graphically the range of 
scores obtained on the reaction time task and the trigram 
task for the five groups.
On many of the tests, the null-hypothesis was 
supported, i.e. there were no significant differences 
between the groups. However, as ANOVA compares the variance 
within the groups to the variance across the groups, the 
large standard deviations would have reduced the 
possibility of obtaining significant between-group
differences.
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Table 8.5a Ranked mean z-scores for subjects
across test battery
Subj Drug Z-score Rank Subj Drug Z-score Rank
403 CBZ 1.38 1
4 69 UT 1.31 2
491 CTL 1.21 3
409 UT 1.08 4
419 UT 0.99 5
438 UT 0.81 6
478 CTL 0.79 7
425 VPA 0.76 8
458 UT 0.69 9
484 DPH 0.62 10
475 DPH 0.50 11
488 UT 0.50 11
400 CBZ 0.39 13
401 CBZ 0.37 14
461 CBZ 0.37 14
428 CBZ 0.36 16
423 CTL 0.34 17
471 UT 0.33 18
436 CTL 0.31 19
426 DPH 0.28 20
416 DPH 0.27 21
410 CBZ 0.27 21
411 VPA 0.26 23
402 UT 0.22 24
404 CBZ 0.20 25
481 CTL 0.18 26
448 CBZ 0.10 27
429 UT 0.09 28
418 UT 0.05 29
518 CBZ 0.03 30
413 CBZ 0.01 31
486 CTL -0.04 32
499 UT -0.16 33
461 UT -0.17 34
432 VPA -0.18 35
479 VPA -0.21 36
421 DPH -0.24 37
447 VPA -0.28 38
487 DPH -0.31 39
408 DPH -0.33 40
433 DPH -0.33 40
477 DPH -0.35 42
4 07 VPA -0.37 43
461 CBZ -0.37 43
474 DPH -0.39 45
483 UT — 0.41 46
464 VPA -0.42 47
493 UT -0.42 47
495 DPH -0.50 49
453 CBZ -0.55 50
446 DPH -0.67 51
439 CBZ -0.74 52
4 66 CTL -0.76 53
444 UT -0.78 54
4 52 VPA -0.79 55
455 CBZ -0.81 56
450 UT -0.88 57
473 CTL -0.91 58
462 DPH -0.92 59
430 CBZ -0.95 60
476 CTL -0.99 61
498 UT -1.00 62
496 UT -1.07 63
445 VPA -1.10 64
467 VPA -1.11 65
433 CBZ -1.20 66
470 VPA -1.23 67
427 VPA -1.35 68
463 UT -1.52 69
417 CBZ -1.55 70
496 CBZ -1.55 70
456 CBZ -1.74 72
468 DPH -1.74 72
442 VPA -1.80 74
449 CBZ -1.81 75
431 UT -1.83 76
435 DPH -2.01 77
485 VPA -2.02 78
497 DPH -2.14 79
454 UT -2.45 80
492 VPA -2.50 81
4 59 VPA -2.83 82
472 UT -3.09 83
434 CBZ -3.61 8 4
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Given the large standard deviations, ar e there 
subjects who could be identified as out-liers compared to 
the control ssujects? If there are out-liers, are there 
clinical variables that may indicate reasons for the poor 
performance of those subjects?
To answer these questi^s, , the z-scores of each 
subject on each test were computed using the standard 
deviation of the control group. The mean of the z-scores 
across the tests was then obtained for each subject. The 
mean z-scores were ranked with 1 being the highest mean z-
score and rank 84 the lowest. Table 8.5a shows the mean z-
scores for the 84 subjects across the test battery.
The range of mean z-scores was from 1.38 to -3.61. The 
lowest average z-score for a control subject was -0.99. 
This subject was ranked 61; hence, there were 2 3 epilepsy 
subjects with mean z-scores below this control subject z- 
score. Indeed, there were eight subjects who had a score 
more than double this z-score in the direction of poorer 
performance, i.e. larger than -1.98 These subjects were 
identified as out-liers. The eight subjects consisted of 
three subjects on VPA, two on DPH, one on CBZ and two 
untreated epilepsy subjects. Hence, this analysis did not 
indicate that ACDs may produce cognitive impairments, as 
there were out-liers in the UT group.
One possible explanation for the occurrence of the 
large number of out-liers may be the presence of factor(s)
relating to the epilepsy and its treatment, that could
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impair the performance of some subjects. For instance,
could seizure frequency be related to subject performance? 
The clinical details pertaining to the eight individuals 
identified as out-liers will be described to provide a
picture of the characteristics of the subjects obtaining
very poor results.
One subject on CBZ : Subject No. 434
This subject was a 19 year old woman, for whom 
epilepsy had been diagnosed one and a half years 
previously. She suffered from generalised tonic-clonic 
seizures at a frequency of at least three seizures per 
month. She was taking 800 mg of CBZ daily and her serum 
level of medication at the time of testing was 10.9 mg/ml 
which is at the higher end of the recommended therapeutic
range.
Three subjects on VPA ; Subject No.s 442 459 and 492
Subject 459
This 51 year old woman was diagnosed as suffering from 
epilepsy at the age of 37 (duration of the disease was,
therefore, fourteen years). Her diagnosis was complex 
partial, secondarily generalised seizures and her seizure 
frequency was category three, i.e greater than three in the 
past six months, but less than three per month. This lady 
took 800 mg of VPA per day and her VPA serum concentration 
was 66 mg/ml, which is in the middle of the therapeutic
range.
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Subject 485
This 31 year old wnman had fuffered from complex 
partial seizures for three years. Howe^^f^, she had suffered 
no seizures in the previous six months. This subject was on
a daily dose of 800 mg of VPA and had a serum level of 48 
mg/ml at the time of testing. This level of anticonvulsant 
medication is at the low end of the therapeutic range.
Subject 492
This 2 . yyer old rnmn .as deaggosdU aa suffering from 
epilepsy at tte aae d sdxXeee (disdead duration was, 
therefore, seven years). Hu was diagnosed with complex 
partial, secondarily generalised seizures, and his seizure 
frequency was category five, i.e. none in the previous six 
months. He was on a dose of 500 mg of VPA per day and his 
VPA serum concentration was 101 mg/ml, which is high and 
falls just above the optimum therapeutic range.
These three brief subject profiles do not point to any 
one factor as a possible reason for their poor performance 
on the battery of tests as many other subjects performing 
in the normal range of the tests had emiilar. case
histories.
Two subjects on DPH : Subject . No.s . : 435. and 497
Subject 435
This 23 year old woman had suffered from generalised 
tonic-clonic seizures for eleven years. Hence, the duration 
of the disease was nine years. She had a seizure frequency
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of‘three, i.e. she had suffered more than three seizures in 
the past six months. She was on a daily dose of 425 mg DPH 
and had a serum level of 47.4 mg/ml at the time of testing.
This level of DPH is more than double the maximum
recommended therapeutic level.
Subject 497
This 57 year old man suffered from complex partial 
seizures, secondarily generalised. He suffered his first 
seizure at the age of seventeen and therefore, the duration 
of the disorder was 40 years. His seizure frequency 
category was three, i.e. he had suffered more than three 
seizures in the past six months. He was on a daily dose of 
375 mg DPH and had a serum level at the time of testing of 
13.5 mg/ml, which is in the middle of the therapeutic
range.
Two subjects in the UT group : Subject No.s 454 and
472
Subject 454
This 23 year old woman had suffered complex partial 
seizures identified as originating from the temporal lobe 
(left or right temporal lobe not identified). She had 
suffered the seizures for four years and had a seizure 
frequency category of three, i.e she had had more than 
three seizures in the past six months.
Subject 472
This 27 year old man had suffered generalised tonic-
clonic seizures for the previous eight years. He had a
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seizure frequency of two, i.e. he had suffered more than 
three seizures in the previous month.
Looking at the performance and clinical details of
subjects did not point to any one factor as the reason for 
some subjects' poor performance, although a very high serum 
concentrations of DPH may be indicated as a possible factor 
for one of the subjects. Further analyses were carried out 
to try to identify relevant factors, other than drug group, 
which may have affected subject performance. These analyses 
comprised of the following :
1. Pearson correlations to investigate the 
relationship between the performance of subjects on the 
battery of tests to factors associated with their epilepsy
and medication.
2. A within-group analysis of those subjects who had 
changes in their anticonvulsant medication between testing
sessions (N=16).
3. A small within-group analysis was carried out on 
eight subjects who completed the test battery on one 
occasion, and for whom a seizure had recently occurred near 
one testing session and there had been no recent seizure
occurrence near another testing session.
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Table 8.6a : Significant Pearson correlation coefficients
for epilepsy subjects
Anx Hos Dpn Age S.ty S. fre Ons Dur
Anx .578** .585**
Hos 578** .548**
Dpn
Age
585** .548**
.550**
S.ty
S. fre -.298*
-.298*
-.307*
Ons .550** -.541**
Dur
Voc
Pcom
RT
Mot
TG
S3
SP
SH
-.307* -.541**
Key : * = p < 0.01 , ** = p < 0.001,
(-) denotes negative correlation 
Anx : Anxiety, Hos : Hostility, Dpn : Depression, 
S.ty : Seizure type, S.fre : Seizure frequency,
Ons : Onset, Dur : Duration, Voc : Vocabulary,
Pcora : Picture Completion, RT : Reaction time,
Mot : Motor task, TG : verbal memory task,
S3 : Counting backwards, SP : Spatial memory task, 
SH : Visual memory task.
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Table 8.6b : Sianificant Pearson correlation coefficients
for epilepsy grouD (continued).
Voc Pcom RT Mot TG S3 SP
Anx
Hos
Dpn
Age
Con
Dose
S.ty
S. fre
0ns
Dur
Voc .409** .402* . 593** .3 39*
Pcom
RT
Mot
.409** .401* . 324*
TG .402* .401* .413*
S3 .593** .413*
SP . 339* . 324*
SH
Key ; * = p < 0.01, ** = P < 0.001
(-) denotes negative correlation.
Anx : Anxiety, Hos : Hostility, Dpn : Depression,
S.ty : Seizure type, S.fre : Seizure frequency,
0ns : Onset, Dur ; Duration, Voc : Vocabulary,
Pcom : Picture Completion, RT ; Reaction time.
Mot : Motor task, TG : verbal memory task,
S3 ; Counting backwards, SP : Spatial memory task,
SH : Visual memory task.
Dose : Dose of ACDs, Con : Serum Concentration of ACDs.
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8.6 Relationships between epilepsy and cog nitive
performance variables
To investigate the strength of possible relationships 
between epilepsy and test performance variables, sixteen 
variables were identified, and the Pearson product moment 
correlation was used to measure the inter-relationships. 
The three drug groups were treated as one epilepsy group 
(N=52) in the first analysis. The sixteen variables 
identified were taken from the clinical and performance 
data as analysed in the ANOVAs. They consisted of levels of 
anxiety (Anx), hostility (Hos), depression (Dpn) (data from 
the MAACL), age of subjects (Age), type of seizure (S.ty), 
frequency of seizures (S.fre), age at onset of the disease 
(Ons) , duration of the disease (Dur), Vocabulary score 
(Voc), Picture Completion score (Pcom), simple reaction 
times (RT) , motor task scores (Mot), verbal (trigrams) 
(TG), spatial (SP), and visual memory task scores (SH). The 
correlation analysis produced a matrix of correlation 
coefficients which identified significant correlations at
the P < 0.01 and P < 0.001 levels.
The significant correlations are shown in tables 8.6a
and 8.6b. The mood variables all intercorrelated between
themselves at the P < 0.001 level, revealing that subjects 
who tended to identify many mood indicating words in one 
area of the MACCL, also identified them in the two other
areas of the MAACL.
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Several of the epilepsy variables also 
intercorrelated. Seizure type and seizure frequency type 
correlated negatively at the P < 0.01 level. Hence, those 
subjects with generalised tonic-clonic seizures tended to 
have a lower frequency of seizures compared to those 
subjects with a diagnosis of complex partial secondarily 
generalised seizures. Seizure frequency also correlated 
negatively with duration of disease (P < 0.001). Hence, 
those subjects with a smaller duration of the disease 
tended to have a higher frequency of seizures. Duration 
also correlated with age of onset (P < 0.001) and onset 
correlated with age itself (P < 0.01) as would be expected.
However^, none of the epilepsy variables correlated 
with any of the test performance variables. Some tasks 
correlated significantly with each other including 
Vocabulary, Picture Completion, verbal memory task, spatial 
memory task and counting backwards. However, motor 
performance, reaction times and the visual memory task did 
not correlate with any other variables.
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Table 8.6c : Sianificant Pearson correlations for the three
druq qroupS
Subject groups : 1:CBZ, 2:VPA and 3:DPH
Anx Hos Dpn Age Con Dose S.ty S.fre 0ns Dur
Anx 1. . 650*
2. .730*
3. .838** .810**
Hos 1,
2.. 730*
3.. 838** .740*
Dpn 1. . 650*
2 .
3..810** .740*
Age 1.
2 .
3 . . 667*
Con 1. . 879**
2. .922**
3. .753*
Dosel.
2 . 
3 .
S.tyl. 
2 .
3 .
s.frl.
2 .
3 .
.879** 
. 922** 
. 753*
. 554*
. 554*
0ns 1. -.783**
2 .
3 . . 667* -.690**
Dur 1 . . 783*
2 .
3 . -.690*
Key : * = P < 0.01, ** = P < 0.001
(-) denotes negative correlation.
Anx : Anxiety, Hos : Hostility, Dpn : Depression,
S.ty : Seizure type, S.fre : Seizure frequency.
0ns ; Onset, Dur : Duration,
Dose : Dose of ACDs, Con : Serum Concentration of ACDs.
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Table 8.6d : Significant Pearson Correlation Coefficients
for the three drug groups (continued)
Subject groups : 1:CBZ, 2:VPA and 3:DPH
Voc Pcom RT Mot TG
Voc 1.
2 .
3 .
Pcornl.
2 .
3 .
RT 1.
2 .
3 .
Mot 1 .
2 .
3 .
TG 1.
2 .
3 .
S3 1.
2 .
3 .
SP 1 .
2 .
3 .
SH 1.
2 .
3 .
Key :
556*
777**
* =
S3
. 556*
.777**
-.770 **
SP SH
-.770 **
Voc
RT
TG
SP
P < 0.01, ** = P < 0.001 
) denotes negative correlation.
: Vocabulary, Pcom : Picture Completion, 
Reaction time. Mot : Motor task, 
verbal memory task, S3 : Counting backwards, 
Spatial memory task, SH : Visual memory task.
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The clinical group was divided into the three ACD
groups and the correlation analyses were repeated on these
smaller groups. Two extra variables of drug dose and serum
concentration of anticonvulsant were added to the matrices.
The large number of variables compared to the small number 
of subjects per group render these analyses less sensitive 
and fewer significant correlations were observed per drug 
group compared to the combined epilepsy group. The 
significant correlations are summarised in tables 8.6c and 
8.6d. Again there were no significant correlations between 
the epilepsy variables and the performance variables. 
Hence, these comparisons are not included in the tables.
It is interesting to note that there were no 
correlations between the two drug measures and the epilepsy 
variables and the performance variables. The smaller number 
of significant correlation coefficients makes it difficult 
to identify any patterns of individual drug group 
correlations.
In summary, the correlation matrices do not indicate 
any one epilepsy or drug variable to be of significance in 
relation to test performance. However, it must be borne in
mind that as this analysis had few data points relative to 
the number of correlations computed, one is less confident 
about the lack of findings.
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Table 8.7a Changes in medication over sessions
Session (1, 2, 3 or■ 4) and concentration (mg/ml)
Subject Concentration High Low Difference
CBZ 417 (1) 10.6 (2) 5.8 4.8401 (2) 4.1 (3) 1.2 2.9471 (2) 9.2 (1) 0 9.2448 (2) 12.7 (1) 9.6 3.1413 (2) 8.2 (1) 0 8.2418 (4) 10.1 (1) 0 10.1456 (3) 21.9 (2) 10.6 11.3461 (3) 5.4 (1) 0 5.4496 (2) 8.2 (1) 0 8.2
DPH 435 (1) 47.4 (3) 24.3 23.1487 (2) 19.1 (1) 14.9 4.2446 (3) 34.6 (1) 23.1 11.5421 (2) 16.8 (1) 12.6 4.2468 (1) 40.8 (3) 18.8 22.0420 (3) 29.7 (1) 26.1 3.6497 (2) 15.7 (1) 13.5 2.2
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8.7 Changes in medication
Sixteen subjects changed dose and hence serum
concentration of their anticonvulsant medication during the 
course of the study. Performance on the test battery could
thus be compared across high and low concentrations of 
anticonvulsant medication. Table 8.7a shows the changes in
blood serum concentrations of anticonvulsant medication in 
different testing sessions. For nine of the subjects the 
changes involved CBZ and for seven of the subjects the 
changes involved DPH.
The mean change in level of blood serum concentration 
for the CBZ subjects was 7.02 mg/ml with a standard 
deviation of 2.89, and for the DPH subjects the mean change
was 10.1 mg/ml with a standard deviation of 8.34.
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Table 8.7b Mean total Number of taps in motor task and
mean response times in reaction time tasks across chances
in medication
Subject group : Means (S.D.)
Test All Subjects, N = 16 CBZ, N = 9 DPH, N = 7
Motor tasks L
All
227.7 (44.1)
CBZ
232.7 (46.0)
DPH
222.6 (45.3)
(Combined) H 209.2 (42.4) 214.5 (35.8) 202.4 (51.5)
All CBZ DPH
Reaction time tasks
Condition 1 L 363.4 (107.6) 336.6 (89.1) 398.0 (126.1)
H 361.4 (111.9) 320.6 (82.5) 413.4 (128.5)
Condition 2 L 379.1 (98.0) 373.7 (93.3) 386.0 (110.9)
H 387.3 (94.8) 354.2 (81.9) 429.9 (98.8)
Condition 3 L 463.6 (138.0) 426.9 (148.1) 510.9 (117.2)
H 506.9 (156.7) 456.7 (124.4) 571.7 (179.0)
Key : L : Low and H : High ACD concentration
Table 8.7c ANOVAs of motor task and reaction time task for
drug changes across sessions 
"F” ratio, degrees of freedom and significance level
Motor tasks Combined F = 2.96 (1/15) P > 0.1
(Group Effect) CBZ F < 1
DPH F = 2.29 (1/6) P > 0.1
Reaction time task :
CombinedI ;
Effect of change F 2.24 (1,15) P > 0.1
Effect of condition F = 17.24 (2,30) P < 0.001
Change by condition F = 2.81 (2,30) P = 0.076
CBZ :
Effect of change F < 1
Effect of condition F 6.65 (2,16) P < 0.01
Change by condition F = 2.69 (2,16) P = 0.098
DPH :
Effect of change F = 8.85 (1,6) P < 0.05
Effect of condition F = 12.08 (2,12) P < 0.01
Change by condition F < 1
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8.71 Motor and Reaction time tasks
A within-group ANOVA was carried out on the motor test 
performance of the sixteen subjects combined into one 
group, and then two further ANOVAs were carried out on the
drug groups (CBZ and DPH).
The mean tapping rate scores (summed across
conditions) for the motor task in the high and low 
concentrations groups are shown in table 8.7k), The high 
concentration group had lower mean tapping rates, but the 
ANOVA revealed no significant effects of drug changes 
(shown in table 8.7c). There were also no significant 
interactions of drug change by condition, so these results
have not been included in table 8.7b or 8.7c
Three within-group ANOVAs were carried out on the 
reaction time data (on the combined group and separately on 
the CBZ and the DPH groups) . The pattern of means of the
combined scores and the CBZ scores revealed no consistent
pattern between high and low drug conditions. However, the 
DPH group did reveal slower response times in the high drug 
condition. Indeed, the ANOVAs showed no significant main 
effects of change of drug levels, either for the combined 
group or for the CBZ group alone, but the ANOVA on the DPH 
group did reveal a main effect of drug change with slower 
response times in the higher drug concentration condition 
(F 1,6 = 8.85, P < 0.05).
The effects of condition were highly significant as 
would be expected as the tasks increased in complexity (see
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section 8.34). There were no significant drug change by
condition interactions, although there were trends in the 
combined group (F 2,30 = 2.81 P < 0.1) and in the CBZ group 
(F 2,16 = 2.69, P < 0.1).
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Table 8.7d Mean scaled score for digit span and mean score
correct for trigram task for low vs high medication
comparisons.
Subject group : Means (S.D.)
Test All Subjects N =16 CBZ N = 9 DPH N = 7
Digit Span L
All
10.13 (2.36)
CBZ
10.00 (2.34)
DPH
10.29 (2.56)
H 10.31 (2.94) 9.33 (2.87) 11.57 (2.70)
All CBZ DPH
Trigram task
Condition 1 L
H
5.94
5.86
(0.25)
(0.34)
5.89
5.80
(0.33)(0.44) 6.006.00
(0.00)
(0.00)
Condition 2 L 5.13 (1.15) 5.22 (1.09) 5.00 (1.29)
H 4.63 (1.67) 5.00( (1.58) 4.14 (1.77)
Condition 3 L 3.06 (2.08) 3.89 (2.09) 2.00 (1.63)
H 2.69 (1.89) 3.56 (1.74) 1.57 (1.51)
Condition 4 L 5.38 (0.81) 5.22 (0.97) 5.57 (0.53)
H 5.25 (1.00) 5.56 (1.01) 4.86 (0.90)
Condition 5 L 5.38 (0.62) 5.33 ((0.71) 5.43 (0.53)
H 5.19 (0.83) 5.44 (0.73) 4.86 (0.63)
Key : L : Low and H : High ACD concentration
Table 8.7e ; ANOVAs of low vs high drug groups for digit
span and trigram tasks
Subjects (High vs Low) : ”F” ratio and 
Combined level of
CBZ Significance
DPH
Digit Span
Combined F < 1
CBZ F = 2.29 (1/8) P > 0.1
DPH F = 2.21 (1/6) P > 0.1
Trigram task : Combined
Effect of Change F = 3.10 (1/15) P = 0.098
Effect of Condition F = 32.64 (4/60) P < 0.001
Change by condition F < 1CBZ
Effect of Change F < 1
Effect of Condition F = 9.98 (4/32) P < 0.001
Change by condition F < 1
DPH
Effect of Change F = 5.17 (1/6) P = 0.063
Effect of Condition F = 41.98 (4/24) P < 0.001
Change by condition F < 1
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8.72 Verbal Memory Tasks
The analysis of the trigram tasks revealed some 
interesting findings and a detailed summary of the results 
for the memory tasks is presented, including the means and
standard deviations for each condition and the "F" ratios
and significance levels for the main effect and 
interactions (see tables 8.7d and 8.7e)
The trigram task revealed a pattern of consistently
higher means across all conditions for the low
concentration condition. The ANOVA for the combined drug
groups showed a trend in the direction of increased
medication showing poorer performance. The ANOVA for the 
DPH group also showed a similar trend (F (1,6) = 5.17, P =
0.063). There were no significant findings or trends found
in the CBZ group analysis.
There was a marked effect of task condition, which was 
not unexpected as the same result was obtained in section 
8.35, and hence no further analysis was carried out on the 
condition effect. There were no medication change by 
condition interactions.
The digit span task did not reveal any pattern in the 
means, and therefore, not surprisingly, there were no 
significant findings in the ANOVA analysis.
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Table 8.7f Mean score correct for the visual and spatial
tasks for low vs high medication comparisons
Subject group ; Mean (S.D.)
Test Subjects N = 16 CBZ N = 9 DPH N = 7
All CBZ DPH
Visual task 
Condition 1 L 4.94 (1.06) 5.44 (0.73) 4.29 (1.13)
H 5.13 (0.96) 5.33 (0.87) 4.86 (1.07)
Condition 2 L 3.25 (1.18) 3.89 (1.05) 2.43 (0.79)
H 2.88 (1-54) 3.89 (1.17) 1.57 (0.79)
Condition 3 L 4.80 (1.07) 5.33 (0.71) 4.14 (1.07)
H 4.44 (1.53) 5.00 (0.70) 3.71 (1.25)
Condition 4 L 4.38 (1.36) 5.00 (0.87) 3.57 (1.51)
H 4.36 (1.22) 4.67 (1.12) 4.00 (1.63)
All CBZ DPH
Spatial task 
Condition 1 L 4.17 (0.75) 4.11 (0.88) 4.25 (0.60)
H 3.91 (0.88) 3.97 (0.96) 3.82 (0.83)
Condition 2 L 3.65 (1.18) 3.75 (1.24) 3.54 (1.17)
H 3.56 (0.95) 3.72 (0.99) 3.36 (0.92)
Condition 3 L 3.92 (0.91) 4.06 (1.03) 3.75 (0.78)
H 3 .42 (1.08) 3.72 (1.09) 3.03 (1.04)
Condition 4 L 2.56 (0.87) 2.83 (0.73) 2.21 (0.96)
H 2.30 (0.92) 2.64 (0.78) 1.86 (0.94)
Key : L : Low and H : High ACD concentration
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Table 8.7q Anovas of low vs hiah drug qroups
Subjects (High vs Low/) : "F" ratio and
Combined level of
CBZ Significance
DPH
Visual task : Combined
Change F < 1
Condition F = 29.79 (3/45) P < 0.001
Change by condition F = 1.75 (3/45) P > 0.1
CBZ
Change F < 1
Condition F = 11.78 (3/24) P < 0.001
Change by condition F < 1
DPH
Change F < 1
Condition F = 21.86 (3/18) P < 0.001
Change by condition F = 4.50 (3/18) P < 0.05
Spatial task : Combined
Change F = 7.11 (1/15) P < 0.05
Condition F = 24.04 (3/45) P < 0.001
Change by condition F = 1.21 (3/45) P > 0.1
CBZ
Change F = 2.46 (1/8) p > 0.1
Condition F = 8.86 (3/24) p < 0.001
Change by Condition F < 1
DPH
Change F = 4.76 (1/6) p = 0.071
Condition F = 17.78 (3/18) P < 0.001
Change by condition F < 1
Figure 8e: Graph of scores in the spatial memory task for high 
and low levels of medication in study two
Mean number 
correct
Condition
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8.73 Visual memory Tasks
Tables 8.7f and 8.7g summarise means, standard 
deviations and the within-group ANOVAs for the visual and 
the spatial memory tasks for subjects changing medication.
The means for the visual memory tasks displayed no 
consistent pattern. There was no main effect of medication 
change. The effect of condition was highly significant, at 
the P < 0.001 level, showing the same picture of increasing 
task difficulty as described in section 8.36. No further 
analysis was carried out on the condition effect. There was 
no medication change by condition effect for either the 
combined group or the CBZ group, but there was a change by 
condition effect for the DPH group (F (3,18) = 4.50, P < 
0.05) (see table 8.7c)
Post hoc Analysis
The drug change by condition interaction (P < 0.05) in 
the visual task in the DPH group was analysed by the Newman 
Keuls test:. This test revealed that in the low drug 
concentration, condition four, i.e drawing shapes as a 
distractor, resulted in significantly worse impairment 
compared to the other three conditions (P < 0.01). In the 
high drug condition, the same poor performance in condition 
four compared to the other three task conditions was 
present to an even stronger degree (P < 0.001). Also, there 
were trends (P < 0.1) for the performance in conditions two
and three towards poorer performance compared to condition
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one (no distractor). There is therefore some tentative 
evidence that as the task became more difficult, the 
performance of the high drug group became more impaired.
The spatial task revealed a consistent pattern of
means across all conditions, with the low concentration 
group producing the higher means (see figure 8e). The three 
within-group ANOVAs revealed a significant effect of 
medication change for the combined drug group (F (1,15) = 
7.11, P < 0.05) in the direction of better performance in 
the low concentration drug group). The analysis of the CBZ 
group alone did not produce a significant effect of change, 
whereas the DPH group produced a trend in the same 
direction as the combined group (F (1,6) = 4.76, P < 0.1).
This result suggests that higher levels of medication 
may impair subjects on working memory tasks.
Although, the effects of conditions were present, as 
in section 8.36, there were no medication change by 
condition interactions on the spatial tasks for any of the
groups.
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Table 8.7h Mean rate of distractor task performance on low
vs high medication comparisons
Subject groups : Means (S.D. )Test All Subjects N = 16 CBZ N = 9 DPH N = 7
All CBZ DPH
Distractor tasks
(Combined scores)
Articulations L 2.52 (0.90) 2.62 (0.89) 2.40 (1.03)
H 2.37 (0.59) 2.50 (1.70) 2.21 (0.59)
Counting L 0.48 (0.21) 0.50 (0.19) 0.45 (0.23)
backwards H 0.44 (0.19) 0.47 (0.20) 0.40 (0.18)
Shapes L 0.16 (0.05) 0.19 (0.04) 0.13 (0.03)
H 0.17 (0.05) 0.20 (0.04) 0.13 (0.03)
Tapping L 2.10 (0.62) 2.06 (0.60) 2.15 (0.73)
H 2.01 (0.71) 2.03 (0.78) 1.98 (0.64)
Key : L ; Low and H :. High ACD concentration
Table 8.7i Analvsis of results of low vs high drug groups
"F" ratio, degrees of freedom and 
significance level
Distractor tasks (Effect of change)
Articulations Combined
CBZ
DPH
F
F
F
<
<
1.32
1
1
(1/15) P > 0.1
Counting Combined F = 2.76 (1/15) P > 0.1
Backwards CBZ F = 1.15 (1/8) P > 0.1
DPH F = 1.49 (1/6) P > 0.1
Shapes Combined F 1.15 (1/15) P > 0.1
CBZ F < 1
DPH F < 1
Tapping Combined F < 1
CBZ F < 1
DPH F < 1
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8.74 Distractor tasks
Although, the subjects were asked to maintain a steady
performance rate as indicated by the experimenter, the 
pattern of means did show that the means for the low 
concentration condition were generally hicgtieir than orr the 
high concentration group. However, this pattern of means 
did not produce significant findings in the within groups 
ANOVAs (see tables 8.7h and 8.7i). There were also no 
significant medication chaere ry distra.oror condition 
interactions (the details of these non-significant 
interactions have been omitted from the tables of results).
8.75 Summary
In summary, most of the tests did not rooucee 
significant differences between the high and low drug 
concentration conditions. This might have been expected as 
there were low numbers of subjects nr the group and 
relatively small changes in drug serum concentrations. 
However^, two of the memory tasks produced interesting 
findings. The spatial memory task showed a significant 
difference between the high and low drug concentration 
conditions of P < 0.05, in the direction of better 
performance in the low serum level onoditrhr orr the 
combined drug group. The trig^m task showed a trend in the 
direction of better performance by the low serum 
concentration condition (P < 0.1).
When the combined group analysis was broken down to
the two drug groups (CBZ and DPH) , if the change condition
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effect was maintained, this was present more in the DPH 
group and less in the CBZ. Also in the reaction times 
tasks, the analysis of the DPH group revealed a significant 
slowing of response times in the high concentration of
medication condition (P < 0.05) which was not present, even 
as a trend in the CBZ group, and did not show up in the 
combined group analysis.
A point worthy of note is the lack of any consistent 
pattern of standard deviations, unlike the results obtained 
in the between-groups comparisons^. Hence, the standard 
deviations did not increase with the higher levels of
medication.
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Table 8.8a Seizure occurrence in relation to testing
session
Last seizure before testing session (SE) 
Subject Recent (Test session) Distant (Test session)
438 2 days ago (SE 2) None in past weeks (SE 1)434 2 days ago (SE 2) None in past weeks (SE 1)467 2 days ago (SE 2) Minor two weeks ago (SE 1)455 1 day ago (SE 2) None in past weeks (SE 2)439 2 days ago (se 1) None in past weeks (SE 3)410 Earlier in day (SE 1) None in past weeks (SE 2)448 2 days ago (SE 2) Minor two weeks ago (SE 1)411 2 days ago (SE 2) Major two weeks ago (SE 1)
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8.8 : Changes in seizure frequency
Eight subjects had recent seizures, i.e close to the 
time of testing on one session and no recent seizures near 
other testing sessions. Therefore, the effect of recent 
seizures on performance on the test battery could be 
investigated. Table 8.8a shows seizure occurrence in 
relation to time of testing session for the eight subjects. 
None of the recent seizures occurred more than two days 
before the testing session, and all the distant seizures 
occurred more than two weeks before the relevant testing
session.
The details of the type of seizure were provided 
solely by the subject, in there own words, and could not 
therefore, be reliably classified as a particular seizure 
type. This differed to the main body of clinical data in 
which the seizure type was that identified by the 
Consultant Neurologists as recorded in the medical notes of 
each subject. There was also no differentiation between 
major and minor seizures in this analysis, with all 
seizures being combined together to form the subject group).
The data from the subjects were analysed using within- 
subject ANOVAs with a main factor of recency of seizure. 
The means (combined across conditions of task) and standard 
deviations from these analyses are summarised in tables 
8.8b. Once again the category-decision task and the 
attention-switching task had to be left out of the analysis 
because of the missing data.
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Table 8.8b Mean combined scores across conditions of tests
for two conditions : Recent vs distant seizure occurrence
Seizure occurrence : 
Test Recent
means (S 
Distant
.D.)
Motor tasks : Mean
(Combined score)
No of taps
205.6 (29.5) 203.2 (38.3)
Reaction time tasks 
(Combined score)
: Mean response 
378.2 (114.7)
time in msecs
376.8 (102.5)
Digit span : mean scaled score
12.1 (2.03) 11.6 (1.89)
Trigram task : Mean 
(Combined score)
No. correct
5.15 (0.47) 5.08 (0.52)
Visual task : Mean 
(Combined task)
No. correct
4.56 (0.96) 4.50 (1.02)
Spatial task : Mean 
(Combined score)
No. correct
3.74 (0.82) 3.87 (0.94)
Distractor tasks : 
Articulations
Mean rate of performance per sec.
2.69 (0.87) 2.62 (0.63)
Counting backwards 0.40 (0.17) 0.40 (0.09)
Shapes 0.19 (0.25) 0.18 (0.37)
Tapping 2,34 (0.58) 2.24 (0.51)
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The means and standard deviations revealed no
observable pattern. The ANOVAs showed no significant 
differences or trends in the main effect of recency of 
seizure occurrence (see table 8.8c) and no interaction of
recency of seizure occurrence with condition. The effects 
of conditions were present, as expected, but these result
are not included in table 8.8c. Hence, due to the lack of
significant findings, only the mean combined scores are 
presented in table 8.8b and only the ”F" ratios for the 
main effect of recency of seizure occurrence are presented
in table 8.8c.
Table 8.8c ANOVA of effect of recencv of seizure
occurrence
Test Seizure occurrence : "F" ratio and level <
Recent versus distant Significance
Motor tasks
Effect of seizure
F < 1
Reaction time
Effect of seizure
F < 1
Digit span F < 1
Trigram task
Effect of seizure
F < 1
Visual task
Effect of seizure
F < 1
Spatial task
Effect of seizure
F < 1
Distractor tasks : Effect of seizure
Articulations F < 1
Counting backwards F < 1
Shapes F = 1.06 (1,7) P > 0.1
Tapping F < 1
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Table 8 . 9c : Mean combined scores of tests across the
three sessions
Test Session : Mean (S.D)
Session 1 2 3
Motor tasks : Combined mean No. of taps
Effect of session 200.0 (57.2) 198.6 (53.5) 19 2 r 3 (56. 1)
Reaction time tasks : Mean combined response times in ms
Effect of session 363.5 (93.7) 363.0 (91.5) 347.4 (83 . 8)
Digit span task : Mean scaled score
Effect of session 10.7 (3.08) 10.8 (2.99) 11.3 (2.41)
Trigram task : Combined mean No. correct
Effect of session 4.84 (0.78) 4.89 (0.92) 5.50 (0.99)
Visual task : Combined mean No. correct
Effect of session 4.32 (1.45) 4.30 (1.32) 4r01 (1.36)
Spatial task : Combined mean No. correct
Effect of session 3.23 (1.18) 4.51 (1.23) 3.53 (1.09)
Distractor tasks : 
Effect of session
Combined mean rate per sec.
Articulations 2.771 (0.96) 2.71 ((.92) 2 . .5 (1.05)
Counting backwards 0.46 (0.19) 0.51 ((.22) 0 0 51 (0.21)
Shapes 1.835 ((^l) 1 . 84 ((.30) 1. .4 (0.32)
Tapping 2.377 ((0^^) 2.17 ((.63) 2 2 11 (0.66)
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8.9 ; Analysis of practice effects
Data across three testing sessions were obtained from
30 subjects. However, five of these subjects had changes in 
medication during the testing period and two had changes in
seizure frequency. Hence, the data of 23 subjects (4 CTL, 6 
UT, 7 CBZ, 4 VPA and 2 DPH subjects) were used to analyse 
practice effects on the test battery. (The category- 
decision and attention-switching tasks were not included in 
the analysis because of missing data and the tests of 
intellectual ability were excluded because they were only 
carried out in session one).
The combined means and standard deviations the tests,
across the three sessions are summarised in table 8.9a. No
obvious pattern arose across the means or standard 
deviations. The within-subject ANOVAs with factors of 
session and condition showed only one effect of session and 
no session by condition interactions. The distractor task 
of counting backwards did produce a significant main effect 
of practice (F = 10.89, 2,38, P < 0.01). The "F" ratios, 
degrees of freedom and level of significance for these
analyses are presented in table 8.9k).
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Table 8,9b ; ANOVA of practice effects for the test
battery across three sessions 
Test Effect of session : "F" ratio (DF) and
significance level
Motor tasks
Effect of session F < 1
Reaction time tasks
Effect of session F = 1.89 (2,38) P > 0 . 1
Digit span task
Effect of session F = 1.28 (2,38) P > 0 . 1
Trigram task
Effect of session F = 1.85 (2,38) P > 0 . 1
Visual task
Effect of session F < 1
Spatial task
Effect of session F < 1 .
Distractor tasks . effect of session
Articulations F < 1
Counting backwards F 10 . 89 (2,38) P < 0.01
Shapes F < 1
Tapping F = 2.4 (2,38) P > 0.1.
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Post hoc analysis
The significant result obtained in the counting 
distractor (P < 0.01) was analysed using Newman Keuls test. 
This analysis revealed that performance on sessions two and
three was significantly better than on session one (P < 
0.01), although performance in sessions two and three did 
not differ from each other. Hence, it appeared that there 
was a significant amount of learning of this task between
sessions one and two.
8.a For clinical interest ; Subjects with epilepsy
versus CTL subjects, and ACD versus non-ACD subjects.
The design of this study was a five groups analysis.
However, from a clinical view-point it is interesting to
explore firstly, how the CTL subjects compared with the
clinical group, irrespective of type of medication; and
secondly, how subjects on anticonvulsant medication
compared with subjects not on any medication. These areas
were explored in the main five groups analysis, by using 
Xthe Scheffe test, where appropriate. However, the Scheffe 
test is very conservative and did not provide fruitful 
comparisons. Hence, two sets of between-groups ANOVA were
carried out :
1. Comparing subjects with epilepsy (N=74) with CTL 
(N=10) subjects.
2. Comparing ACD (three drug groups combined, N=52)
with non-ACD (N=32, CTL=10 plus UT=22) groups.
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The differences in the sizes of the groups does mean
that any results obtained from these analyses are less 
robust and should only be read as possible indications of 
what might have occurred in the data set.
The CTL group means were in the direction of better 
performance compared to the subjects with epilepsy. 
However, very few of the between-groups ANOVAs produced 
significant findings between the groups. This was not a 
surprising finding, given the small number of subjects in 
the control group. A similar picture was obtained in the 
ACD versus non-ACD group), with the non-ACD group obtaining 
the better scores, but not producing significantly better 
performance than the ACD group). Given the length of this 
results section and the lack of interesting findings in 
these of analyses, the details of these two sets of ANOVAs 
are presented in appendix seven.
8.b Summary and preliminary discussion 
This study was very large and hence an extensive
analysis of the results was carried out. This preliminary 
discussion will summarise the main findings but will not
endeavour to relate these results either to the other 
studies contained in this thesis or the published 
literature. A more comprehensive discussion will be 
presented in the main discussion chapter (chapter eleven). 
This section will present an over-view.
The main points are as follows :
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1. The design of the study was a comparison of five 
groups, four of whom had epilepsy, and three of whom were 
taking anticonvulsant medication. All subjects completed an
extensive battery of tests on one or more occasions. The 
battery of tests included tests of mood, intellectual 
functioning, and verbal, visual and spatial working memory, 
perceptual and motor tasks, and tasks aimed to tap the 
central executive component of working memory, i.e. 
category-decision and an attention-switching task, 
requiring alternation between perception and memory. Most 
subjects were able to complete the battery of tests, 
although on a small number o f occasinns a subject would 
choose not to ccntinue the ts^s . Aso, , an error in the 
computer program, resulted in the loss of approximately one 
third of the results in the category-decision and 
attention-switching tasks.
2. The performance of the subjects on the dual tasks 
supported the theoretical view of the differing verbal and 
vssuo-spatsal systems in working memory, with verbal 
distracto-rs interfering to a greater degree on the verbal 
primary task, and visual and motor distract^s impairing 
the visual and spatial tasks to a greater degree. Also), 
there was some evidence that subjects changed their 
performance on the distractor tasks to different degrees 
dependent on the primary task. In particular, the motor 
tapping rate decreased to a significant degree on the 
spatial memory task, whereas performance on the drawing
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shapes distractor decreased significantly in the visual 
task. These two results support the view that there may be 
different spatial and visual systems in the working memory 
system.
3. Several clinical features of the epilepsy subjects 
were monitored to ensure a similar distribution of epilepsy 
variables across the groups. For the most part, the groups 
were well-matched on these variables, although the UT group 
was somewhat different to the three drug groups in that 
there were more subjects who were diagnosed with tonic- 
clonic seizures, subjects had a shorter duration of the 
disease and fewer subjects reported frequent seizure 
occurrence. The blood serum levels of the three drug groups 
were monitored. This revealed that there were more subjects 
with high levels (above the optimum range) of 
anticonvulsants in the DPH and VPA groups compared to the
CBZ group).
4. The five groups set of ANOVAs revealed no 
differences between the groups on the measures of mood and 
intellectual ability.
5. The ANOVAs did reveal a small number of significant 
group effects on test performance, particularly in the 
trigrams and spatial memory tasks, in which the VPA group 
performed significantly worse than the CTL group. Although, 
there were many significant effects of condition in the 
tests, there were no group by condition interactions. 
Hence, the hypothesis that increasing task
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complexity/difficulty would result in detrimental 
performance in some drug groups was not supported.
6. A small number of subjects (N=16) underwent changes 
in medication during the testing period, A set of within-
group ANOVAs was carried out on the performance data for 
the two conditions of high and low serum concentrations of 
ACD. The sample was also divided into those subjects on CBZ 
(N=9) and those on DPH (N=7) and further ANOVAs were 
carried out on these two sets of data. Although the pattern 
of means was generally in the direction of poorer 
performance in the higher drug group, only one of these 
differences was significant i.e. the spatial memory task (P 
< 0.05), with a trend in the trigram task (P < 0.1).
The subjects with epilepsy (N=16) were sub-divided 
into two drug groups and the pattern of results tended to 
show that the DPH group was more likely to show significant 
impairments in the high drug condition. It was interesting 
to note that the reaction times in the DPH group were
significantly slower in the DPH high drug concentration
condition compared to the lower drug concentration
condition, a finding that had not been shown in the larger
group of subjects i.e . CBZ and DPH combined *
7. A small number (N=8) of subjects had seizures very 
close to the time of testing and on another testing 
occasion had had no seizures in the previous two weeks. 
Hence, within-groups analyses with the main factor of 
recent versus distant seizures were carried out on the data
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set. No significant findings were obtained in these 
analyses. However, as all seizure types were combined into 
one analysis, it may be possible that effects of one type 
of seizure are masked in this combined analysis. 
Unfortunately, there were not the number of subjects 
available to carry out separate analyses with regard to the 
occurrence of particular seizure types.
8. The resu lte from 2 3 sub j ects, for whom neither 
seizure frequency nor medication changed over the testing 
period and who had completed the test battery on three 
occasions, were analysed for practice effects on the test 
battery. The results from these testing sessions were 
analysed using within-groups ANOVAs, with a within-subjects 
factor of session. This set of analyses revealed only one 
significant effect of practice. This was the distractor 
task of counting backwards in threes, in which there was 
significant improvement in performance between session one
and two.
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CHAPTER NINE
STUDY THREE : A . NEW DRUG : LAMOTROGINE
9.1 Aim of study
The aim of this study was to investigate whether 
Lamotrogine, a new anticonvulsant drug, would have an 
effect on cognitive functioning. A survey of the literature 
at the time of commencing the study, revealed that no 
studies on the possible effects of Lamotrogine on cognitive 
functioning had been published. Hence, the work was 
exploratory. However, as much of the literature supported 
the view that subjects on ACDs showed cognitive 
impairments, for example the work of Thompson and Trimble 
(1981, 1982 and 1983), the hypothesis for this study was
that subjects on commencing on Lamotrogine would show 
additional impairments of cognitive functioning.
9.2 Introduction.
Clinical trials for Lamotrogine were set-up at the 
Dundee Royal Infirmary (DRI) by Drs.Davidson and Roberts, 
on behalf of the Wellcome Foundation. The study described 
in this chapter was an additional study involving some of 
the same subjects participating in the Dundee clinical
trials.
The trials were of an add-on nature, whereby 
Lamotrogine was added to the anticonvulsant medication of 
patients with intractable epilepsy. All subjects were
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already on polytherapy. Given the severity of the epilepsy 
and that the subjects were on polytherapy, it was expected 
that these subjects would show cognitive impairments (refer 
to work of Thompson and Trimble (1982) amongst others, as
described in chapter three). In order to support the 
hypothesis that Lamotrogine has detrimental effects on 
cognitive performance, it is necessary to measure an 
increase in the degree of cognitive impairment after 
commencing on Lamotrogine.
The study was carried out over a period of 
approximately one year and involved a within-subjects 
design, in which the subjects were tested before and after 
starting on Lamotrogine. Eleven subjects were tested one 
month before commencing on Lamotrogine and approximately 
one month after starting on the drug. Ten of the subjects 
were re-tested after they had been taking Lamotrogine for a 
period of approximately three months. The eleventh subject 
was withdrawn from the study on clinical grounds. Control 
subjects also completed the battery to measure practice 
effects on the test battery across the three sessions.
9.3 Background and context of the study
A significant portion (approximately twenty per cent:) 
of individuals suffering from epilepsy continue to have 
seizures whilst taking anticonvulsant medication. There is 
therefore, great need for the development of new and
effective treatments. There is also the need for careful
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clinical trials on all prospective ACDs to ensure that the 
drugs are safe and cause the minimum of side-effects.
A lack of understanding of the cellular and molecular 
basis of epilepsy has hindered the development of new ACDs. 
In the past decade, hypotheses concerning the basis of 
epileptic activity have been proposed. One of these 
hypotheses is that epileptic activity is due to a defect in 
the excitatory neuronal systems in the brain. This 
hypothesis has produced one avenue for the rational 
development of new ACDs, i.e. drugs that decrease this 
neuronal excitation. Lamotrogine, a potential new ACD, is 
thought to act by decreasing the release of glutamate (an 
excitatory neurotransmitter) and so reduce the amount of 
epileptic activity (Meldrum, 1991).
Lamotrogine is chemically unrelated to any of the 
other main anticonvulsants drugs. Nevertheless, in 
extensive preclinical evaluations, Lamotrogine has been 
shown to be an extremely potent anticonvulsant (see 
appendix eight for a description of chemical structure and 
pharmacokinetics) and studies on healthy volunteers and 
patients with epilepsy have also been promising (Millar, 
Sawyer, Roth, Peck:, Leach, Wheatley, Parsons and Morgan,
1986).
Cohen, Ashby, Crowley and Peck (1985a, and 1985b), 
employing volunteer subjects, found negligible evidence of 
toxicity other than some subjects complaining of headaches.
In subjects with epilepsy, a reduction in photosensitivity
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(Binnie, Kastelleijn-Nolst Trenite, De Korte, 1985), and 
interictal spikes (Jawad, Oxley, Yuen and Richens, 1985)
have been observed. Piiot studie s carried out at the 
Chalfont Centre for Epilepsy and at other epilepsy centres
have provided preliminary evidence for positive effects 
regarding seizure control, but these studied were carried 
out on only a small sccle and, a s such , provid e limited 
evidence of efficacy.
A more recent study by Peck (1991) compared
Lamotrogine with CBZ and DPH on a number of tasks with 
large perceptual and motor components. Healthy volunteers,
taking Lamotrogine, were not impaired on these tasks,
whereas impairments were seen nn the CBZ a nd DPH
conditions. However, tte doses of Lamotrogine in the
volunteer study were low compared with the doses of
Lamotrogine prescribed. to the clinical subjects in this
study.
The clinical trials at the DRI investigated the 
effects of Lamotrogine on epilepsy variables i.e frequency 
and types of seizures. The monitoring of the epilepsy 
variables was detailed, as was the monitoring of possible 
side-effects and the effects on concomitant medication.
This information was made available for use in this study 
on cognitive function.
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9.4 Subjects
9.41 Criteria for Subject inclusion
The criteria for subject inclusion in this study were
necessarily those set-out in the Wellcome study and were as
follows :
1. Age of subject was between 12 and 70 years
2. Male and female (of non-childbearing potential).
3. Confident diagnosis of epilepsy, uncomplicated by 
suspected pseudo-seizures.
4. At least two seizures per month in the previous
three months.
5. A seizure diary kept for the previous three months.
6. Seizures resistant to standard anticonvulsant
medicat ion.
7. Anticonvulsant medication stable for the preceding 
two months and unlikely to change during the course of
the study.
8. Not taking more than three anticonvulsants and not 
participating in drug investigations in the previous
six months.
9. Not suffering from any severe organic or
psychiatric disease, severe mental subnormality, or
progressive neurological disease.
10. No abnormal medical laboratory values of any
clinical significance.
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11. Not on regular drugs other than anticonvulsants or 
oral contraceptives.
12. Not had status epilepticus (a particular type of 
epileptic activity) in the past six months, or more 
than once in the past two years.
13. No past record of serious non-compliance, or 
failure to attend clinic, or documented adverse 
experiences.
14. Given informed consent to participate in the
study.
The epilepsy parameters were monitored closely by the 
responsible clinician, and were categorised in this study 
as in studies one and two. Hence, the types of seizures 
were categorised into the three groups of (1) generalised 
tonic-clonic, (2) complex partial and (j) complex partial,
secondarily generalised.
The seizure frequency categories had to be expanded 
due to the larger number of seizures suffered by subjects 
in this study. Hence, category one i.e. more than three 
seizures in one week was expanded into four categories :
la : greater than three seizures per day. 
lb : greatrr than two seizures per day. 
lc : greater than one seizure per day.
Id : greatrs than three seizures per week.
The number of seizures was monitored for the period
before the first testing session and for the periods
between subsequent testing sessions as subjects were
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requested to keep a seizure frequency diary for the 
duration of the study.
Other parameters monitored were those of the serum 
levels of the other prescribed anticonvulsants at each 
testing session, and any changes in health which might
indicate possible side-effects of Lamotrogine.
299
Table 9a : Epilepsy variables for Lamotrooine subiects
Subj . Seizure Age at Duration EEG CT
No. Type onset (yrs) (yrs)
100 2(1) 3 19 A N
102 2(1) 5 30 A N
103 3(1) 8 18 A N
104 2(S) 9 31 A ?
106 2(1) 18 15 A N
107 3(1) 1 28 A N
109 2(1) 18 9 A N
110 2(S) 24 16 A ?
114 3(1) 11 6 A N
115 2(?) 9 16 A N
Key ; Seizure Type : 1 : Tonic-clonic I : Idiopathic
2 : Complex partial S : Symptomatic
3 : Complex partial, secondarily generalised 
A : Abnormal and N : Normal
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9.42 Subject details
The number of subjects with epilepsy who agreed to 
participate in the study was sixteen, although five dropped 
out before the second testing session i.e. were not tested 
whilst on Lamotrogine. One subject (subject 101) stopped 
taking Lamotrogine soon after the second testing session, 
and also had feeuuett disruptive seizures uuring the 
testing session. This tuuject was rrrnoved fror ttt study. 
Thus, the data if t tn suUjeetd were reported in the 
analysis. Their mete a ge was 22.4 years wtth a standard 
deviation of 7.17 years. All the subjects who were 
prescribed Lamotuogrns took it as an adjunct to their 
regular ACD medication. The other ACDs taken by the 
subjects included CBZ, VPA, DPH, Phenobarbrtone and 
Primidone.
Table 9a ^^^I^I^^]:Usus ttie ee Iiless daat (ft tht ten 
subjects. All the subjects were diagnosed as having complex 
partial seizures, with two subjects having complex partial 
seizures, secondarily generalised. Seven ft tht suejltUs 
had idiopathic s^usss , ttw hha suytPtmtgdr seizures and 
one wwa tunleas^f^ twit trgard to aatiology. The mean age 
of onset of the seizures was 10.6 years with a standard 
deviation of 6.94 years. The mean duration of the disease 
was 18.8 years with a standard deviation of 8.06 years. All 
subjects had an abnormal EEG, and of the eight subjects who
had had a CT scan all were normal.
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Six control subjects participated in the study. The
control subjects were all relatives of thes subjects with
epilepsy . The mean age of the controls was 34.6 years and
the standard deviation was 8.1 years.
9 .5 Procedure
The psychometric tests used in the study were a
combination of tests already in use in either the first 
Dundee study (see chapter four) or the Glasgow study (see 
chapter seven). Significant constraints on choice of tests 
were the availability of just one BBC microcomputer, the 
necessity to select tests that could be used on subsequent 
re-testing occasions and the administration of a battery of 
tests that was not draining on subjects. The battery of 
tests comprised the following tasks:
1. WAIS Vocabulary and Picture Completion test. 
(Completed on session one only)
2. MACL (Mood Adjective Check-list) 
j. Motor tapping task
4. Digit span
5. Trigram task
6. Benton Visual Retention task
7. Category-decision task (as designed for the Glasgow 
study)
8. Attention-switching task (as designed for the 
Glasgow study)
302
The rationale for all but one of the tests has already 
been explained in chapters four and seven. However, one 
unfamiliar test, the Mood Adjective Check List (MACL) , was 
already being employed at the DRI by other researchers, and 
provided measures of depression, anxiety, hostility, vigour 
and fatigue for the subjects in this study. The version of 
the test administered was that of Lishman's (1972) , an 
adaptation of McNair's and Lorr's (1964) MACL.
To mitigate the possible effects of fatigue on the 
test battery, the order of the tests was varied across the 
subjects. Wherever possible, the subjects also completed 
the tests at the same time of day to avoid daily 
fluctuations of drug concentrations affecting performance.
All subjects completed the tests on three occasions, 
approximately two months apart. The subjects with epilepsy 
completed the first test session before commencing on 
Lamotrogine, the second session after being on Lamotrogine 
for at least one month and the third session two months
later-.
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Table 9b : Drug variables across sessions for Lamotrogine
studv
a) Lamotrogine dose (mg)Subject b) Serum level of anticonvulsants ($mol/l)
Number Session 1 Session 2 Se^ion j
a) zero L. lOON, 50M L. lOON, 50M L.100 b) CBZ : 45 CBZ : 42 CBZ : 27PRM : 107 PRM I 1j9 PRM : 85
VPA : 515 VPA : 467 VPA : 712
a) zero L. lOON, lOOM L. lOON, lOOM L.102 b) CBZ ; j5 CBZ : j1 CBZ : jj
VPA : 796 VPA : 611 VPA : 579
a) zero L. 200N, 200M L. 200N, 200M L.
10j b) CBZ : j1 CBZ : j5 CBZ : j1
PRM : 77 PRM : 79 PRM : 70
a) zero L. 200N, lOOM L. 200N, lOOM L.
104 b) DPH : 8j DPH : 82 DPH : 71
PB : 4 j PB : jj PB : 47
a) zero L. 200N, 200M L. 200N, 200N L.
106 b) CBZ : j7 CBZ : j7 CBZ : j2
a) zero L. lOON, lOOM L. lOOM, lOON L.
107 b) CBZ : 52 CBZ : 4j CBZ : 48
VPA : 4j5 VPA : j59 VPA : 55j
a) zero L. 200N, lOOM L. 200N, 200M L.
109 b) CBZ ; 28 CBZ : 42 CBZ : ??
PRD : 99 PRD : 90 PRD : ??
a) zero L. 200N, 200M L. 200N, 200M L.
114 b) CBZ : j6 CBZ : j7 CBZ : ??
a) zero L. 400 daily j00 daily115 b) CBZ ; 29 CBZ : 25 CBZ : ??DPH ; 48 DPH : 64 DPH : ??
Key : PRM : Primidone; PB : Pheno^^^one
N : Nocte (i.e in the evening)
M : Mane (i.e. in the morning)
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9.6 Results
The data from the ten clinical subjects and the six 
control subjects were analysed using ANOVA, with a main 
effect of groups, a within-subjects factor of session and 
for some tests, a within-subjects effect of condition. 
Thus, the effects of Lamotrogine, if present, would become 
apparent with significant group by session interactions.
Before presenting the results from these analyses, the 
clinical data will be described.
9.61 Clinical Data
The doses of Lamotrogine and the serum level
concentrations of the other anticonvulsant medications 
taken by the epilepsy subjects are presented in table 9b. 
Subjects, in general, started on a twice daily regimen of 
Lamotrogine varying from 50 to 2 00 mg. Nine of the ten 
subjects remained on that dose for the second and third 
testing sessions. Subject 115, however was on a reduced 
dose by the third testing session.
With regard to the blood serum concentrations of the 
other anticonvulsant medications, no pattern of change was 
observed across the testing sessions. Unfortunately, the 
blood serum level concentrations of three of the subjects
for test session three were unavailable.
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Table 9c : Seizure Oueguencv and reported
srde-effelts in Lamotrogine studv
Subject a) Seizure frequency categories b) Sids-ef0ecttNumber Session 1 Session 2 Session 3
a) lb lb lc100 b) none intermittent
diplopia
nausea
unsteady
nausea
a) 2 3 5 .102 b) none headaches
diplopia
headaches
a) lb lb lc103 b) none none none
a) 2 2 2104 b) none unsteady gait none
a) 3 3 3106 b) intermittent
diplopia
intermittent
diplopia
intermittent
diplopia
a) 2 3 3107 b) mouth ulcers rash none
a) 2 3 2109 b) none depression none
a) 2 2 2110 b) constipation
poor sleep
constipation
rash
none
a) Id 2 4114 b) none headaches none
mild drowsiness
a) 2 2 2115 b) none nausea headaches
drowsiness 
mild anoxia
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The frequency of seizures was monitored at each testing 
session, and any changes in physical or mental health were 
recorded. Table 9c summarises this information presenting 
both the seizure frequency categories (category la being 
the most frequent seizure category and category 5 
indicating fewest seizures), and reported changes in
health.
Comparing the clinical data across the four sessions 
showed no change in seizure frequency for four subjects, a 
reported decrease in seizure frequency for five subjects, 
and subject 109 reported a decrease in frequency in session 
two, but returned to the same frequency in session three as 
was present in session one. Thus, where seizure frequency 
changes were observed, they were in the direction of 
improved seizure control.
The changes in health reported included headaches cited 
three times, nausea cited three times, diplopia, i.e. 
double vision, cited twice and unsteadiness cited twice. 
Several other health problems were cited by only one 
subject on one testing occasion. It was noticeable that 
some health problems were noted in testing session one, and 
could not, therefore, be associated with Lamotrogine.
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Table 9d ; Mean scores on test battery across three
sessions
Subject group : Means (S.D.s) 
Lamotrogine CTL
Test Session : 1 2 3 1
Intellectual Ability (Mean scaled scores)
(Combined score) 7.1 
(3.05)
8.8
(3.25)
Vocabulary 7.2 
(3.29)
9.2
(3.31)
Picture completion 6.9
(2.42)
8.5 
(3.21)
Digit span (Mean scaled scores)
8.5 
(2.01)
9.2
(2.35)
9.5 
(2.07)
10.8 10.8 12.3
(2.79) (2.86) (2.88)
Trigram task 
Condition 1
(Mean number correct) 
5.3 5.6 5.7 5.7 5.8 6.0
(0.94) (0.52) (0.48) (0.52) (0.41) (0.00)
Condition 2 5.0 4.3 3.5 5.3 5.2 5.7
(1.05) (1.64) (1.35) (0.82) (1.67) (0.52)
Condition 3 2.6 2.4 1.9 3.2 4.3 4.0
(1.08) (1.17) (0.88) (1.60) (1.63) (1.55)
Benton memory task (Mean no. correct and mean no. errors)
Score 5.4 5.4 5.0 7.8 8.7 7.8
(1.78) (2.59) (1.83) (2.14) (1.21) (1.84)
Errors 7.6 6.8 7.8 3.0 1.8 2.5
(3.75) (4.69) (4.05) (2.97) (1.84) (2.17)
Motor task 
Condition 1
(Mean no. 
266
taps in 
250
60 seconds) 
246 328 328 330
(50.5) (56.4) (66.4) (44.7) (56.7) (41.4)
Condition 2 133 129 131 176 181 185
(36.0) (37.1) (33.0) (31.5) (24.7) (20.2)
Category-decision (Mean response time in milliseconds)
Condition 1 768 796 726 493 511 525
(279) (362) (287) (66) (83) (125)
Condition 2 935 917 851 667 623 684
(279) (298) (257) (102) (119) (100)
Condition 3 1599 1623 1253 1015 921 920
(287) (257) (339) (125) (100) (335)
Attention switching (Mean response time in milliseconds)
Condition 1 2012 2086 2070 1559 1546 1753
(598) (595) (671) (439) (260) (266)
Condition 2 1976 2026 2106 1727 1686 1665
(661) (353) (589) (278) (261) (266)
Distraction tasks (mean rate of performance> per sec)
Articulations 1.76 2.33 2.25 2.15 2.55 2.39
(0.33) (0.71) (0.70) (0.47) (1.13) (0.74)
Counting 0.40 0.45 0.47 0.55 0.61 0.63
backwards (0.24) (0.27) (0.32) (0.08) (0.11) (0.14)
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9.62 Quantitative Analvsis
The quantitative analysis of the test performance data 
was carried out primarily by separate between-groups ANOVAs 
for each of the tests comparing the Lamotrogine group and 
the control (CTL) group. There was also a within-group 
factor of sessions, and on some tests a second within-group
factor of condition.
The MACL data was not obtained from interval scales and
the scores did not follow a normal distribution. Hence, a 
non-parametric test, the Mann Whitney test, was used to 
compare the groups in session one, and Freidman's test was 
used to compare performance across the sessions. There were 
no significant differences revealed by the across session 
analyses, but the subjects with epilepsy were significantly 
more depressed compared to the control group (P < 0.05) in
session one.
The means and standard deviations for the test battery 
results of the two groups are presented in table 9d. The 
”F” ratios, degrees of freedom and level of significance 
for these tasks are presented in table 9e.
Most of the tasks on the test battery were performed 
less well by the clinical group. Hence, the means were in 
the direction of poorer performance. For example, on the 
category-decision task, the mean response times in session 
one, for the group with epilepsy, across the three 
conditions, were 768, 935, and 1599 milliseconds, whereas 
the mean response times for the CTL group were 493, 667 and
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1015 milliseconds, respectively. The standard deviations
were generally larger for the Lamotrogine group, for 
example 279, 279, and 538 for the category-decision task, 
compared to 66, 102 and 459 respectively for the CTL group
on the same task.
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Table 9e : Lamotrogine vs CTL : Results of ANOVA
Test ratios (Df) and levels of significance
Intellectual Ability F = 1.55 (1/14) P > 0.1
(Main effect of groups)
Vocabulary F = 1.33 (1/14) P > 0.1
Picture completion F = 1.29 (1/14) P > 0.1
Digit span (GP) F = 3.87 (1/14) P = 0.0693
(Effect of GP/SE) F — 1.05 (2/28) P > 0.1
Trigram task (GP Effect) F = 9.56 (1/14) P < 0.01(Effect of gp/se) F = 6.26 (2,28) P < 0.017(Effect of GP/Cc) F = 3.47 (2,28) P < 0.05(Effect of GP/SE/CC) F = 1.58 (4,56) P > 0.1
Distraction tasks
Articulations (GP effect) F < 1
(Effect of GP/SE) F < 1
Counting backwards (GP) F = 1.85 (1/14) P > 0.1(Effect of GP/SE) F < 1
Benton Visual Retention task
Scores (Effect of GP) F = 10.36 (1/14) P < 0.01
(Effect of GP/SE) F < 1
Errors (Effect of GP) F — 8.26 (1/14) P < 0.05(Effect of GP/SE) F < 1
Motor task
(Effect of GP) F = 9.17 (1/14) P < 0.01(Effect of gp/se) F = 2.55 (2/28) P = 0.0964(Effect of GP/Cc) F = 1.92 (1/14) P > 0.1(Effect of GP/Se/cc) F < 1
Category decision task
(Effect of GP) F 6.97 (1,14) P < 0.05
(Effect of GP/SE) F < 1
(Effect of GP/CC) F = 2.60 (2,28) P = 0.0917(Effect of GP/Se/cc) F < 1
Attention switching task
(Effect of GP) F = 1.54 (1/14) P > 0.1
(Effect of GP/SE) F < 1
(Effect of GP/Cc) F < 1
(Effect of GP/SE/CC) F = 1.12 (2,28) P > 0.1
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Figure 9a: Graph of trigram data across sessions for the
Lamotrogine and control group
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Figure 9b: Graph of trigram data across conditions for the
Lamotrogine and control groups
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The ANOVAs (as summarised in table 9e) revealed a 
number of significant differences across the test battery 
and in each case, the performance was poorer in the 
clinical group. The motor task:, the trigram task and the 
Benton Visual Retention task all produced significant 
differences at the P < 0.01 level, whilst the category- 
decision task produced a significant difference at the P < 
0.05 level. The two groups were not significantly dfffreett 
on the measures of intellectual ability.
The trigram task also produced a significant group by 
session interaction (F 2,28 = 6.26, P < 0.05), in which the 
clinical group means decreased over the three sessions and 
the control group means increased over the sessions (see 
figure 9a) .
In relation to the group by condition interactions, 
there was a significant group by condition interaction in 
the trigram task (F 2,28 = 3.47, P < 0.05), (see figure
9b) .
Post hoc analyses
A group by session effect (F (2,28) - 6.26, P < 0.05) 
and a group by condition effect (F 2,28 = 33.-47, P < 0.05) 
were obtained on analysing the trigram data. Newman Keuls 
tests were used to analyse this set of results.
In relation to the Lamotrogine subjects, Newman Keuls 
test revealed a significant difference in performance 
between session one and session three (P < 0.05) and 
between session two and session three (P < 0.05), in the
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direction of poorer performance in each succeeding session. 
The CTL group did not reveal any significant effect of
sessions. Analysis of the effect of groups across sessions 
revealed that the groups were not significantly different 
in session one; there was a trend in the direction of
poorer performance for the Lamotrogine group in session 
two, and the groups were significantly different in session 
three (P < 0.05), in the direction of poorer performance by 
the Lamotrogine group.
In relation to the effect of condition on the trigram 
task, the Lamotrogine subjects displayed significantly 
poorer performance in condition two i.e with articulatory 
suppression distractor compared to condition one i.e with 
no distractor(P < 0.01). Also, condition three i.e with 
counting backwards in threes, was significantly more 
difficult compared to both condition one and to condition 
two (P < 0.0001) . The CTL group did not reveal a 
significant difference between condition one and two, but 
revealed significantly worse performance in condition three 
compared to both condition one (P < 0.0001) and condition 
two (P < 0.001). Hence, introducing the secondary task of 
articulatory suppression, was sufficient for the 
performance of the clinical group to decline, unlike the 
CTL group which was able to maintain performance on the 
primary task.
(Note; Unfortunately, the data from condition three of 
the attention switching task was not included in the
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analysis because five of the subjects with epilepsy could 
not complete condition three, and so the this part of the 
test was removed from the test battery.)
Table 9f summarises the significant findings both in 
terms of group effects and also significant interactions.
Table 9f Summarv of significant results of ANOVA (Main
effects and interactions) in Lamotrocrine studv
Test GP GP/SE GP/CC
Intellectual None
Ability
Depression * *
Anxiety None
Aggression None
Vigour None
Fatigue None
Motor task ***
Digit Span None
Trigrams k * k k k k k k
Task
Benton task k k k
Category k k None
Decision task
Attention None None None
switching task
Key : Significance level : ** : P < 0.05
: *** : P < 0.01
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9.7 Summary and discussion
Lamotrogine (a new anticonvulsant undergoing clinical 
trials) was given as an adjunct medication to ten subjects
with epilepsy. The ten subjects completed the test battery 
on three occasions, once before commencing on Lamotrogine 
and twice after starting on Lamotrogine. Six control 
subjects also completed the test battery on three 
occasions. The following points summarise the main findings 
from the study:
1. The group with epilepsy was a sample of relatively 
young adults (mean age 2 9.4 years), whose epilepsy had an 
early onset (mean age at onset was 10.6 years) and hence a 
long duration of the disease (mean duration of 18.8 years). 
The control group was a slightly older group (mean age 34.6 
years).
2. On most tasks, the subjects with epilepsy performed 
significantly worse than the control group). They were also 
significantly more depressed. However, the group with 
epilepsy did not perform significantly differently from the 
control group on tests of intellectual ability. 
Furthermore, the group with epilepsy had no history of 
other neurological disease and had normal CT scans. Hence, 
the differences in the performance of the control group and 
the epilepsy group supported the view that people with a 
long history of epilepsy, frequent seizures and
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polypharmacy tend to have impaired cognitive functioning 
(see chapter two and three for a review of these areas).
3. The subjects with epilepsy were monitored for 
changes in seizure frequency across the sessions. On
commencing Lamotrogine, half of the subjects had seizure 
frequencies that remained fairly constant, but for the 
other half the frequency of seizures decreased. Seizure 
frequency did not increase for any subjects, so any 
impairments in cognitive functioning in sessions two and 
three, could not be attributed to increased seizure 
frequency.
4. The health changes reported after subjects began 
taking Lamotrogine included headaches, nausea, unsteadiness 
and diplopia. However, it should be noted that most these 
health changes were noted by only one or two subjects and 
no health change was observed widely across the group.
5. In general, most subjects were able to complete the 
battery of tests, although one subject who had had repeated 
seizures in the testing sessions was withdrawn from the 
study and was not included in the analysis. Five subjects 
with epilepsy were unable to complete part three of the 
attention-switching task. Accordingly, this part of the 
task was excluded from the analysis for all subjects.
6. On the trigram task, the subjects with epilepsy 
performed worse across the three sessions, unlike the 
controls who maintained or even marginally improved
performance across the sessions. There was also a
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significant group by session interaction on the trigram 
task. This result provided a small amount of evidence that 
Lamotrogine may have an adverse effect on cognitive 
functioning.
7. The sub jeubs wit h epi lepsy app eappd to hav e mor e 
difficulty than the CTL group on the trigram task as the 
task conditions became more complex. This group performed 
significantly worse on conditions two and three compared to 
condition one, whereas the control subjects performed 
significantly worse only in condition three compared to 
condition one. Thus, the relatively simple distractor task 
of "articulatory suppression" was enough to impair subjects 
on Lamotrogine on the primary trigram task, whereas the 
performance of the control subjects was only significantly 
affected by the more difficult distracting task of counting
backwards in threes.
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CHAPTER TEN
EXPLORATORY STUDIES USING RESPONSE-TIMED TASKS.
10.1 Introduction
Towards the end of the data collection time for the
Dundee study described in chapters four and five, it became 
apparent that the number of significant differences between 
the drug groups was smaller than might have been expected 
based on the results of Thompson and Trimble (1981, '82 and 
'83) . At that time, I wondered whether one possible reason 
for this difference may have been that I had chosen 
predominantly memory tasks for this study. However, it was 
feasible that some of the Thompson and Trimble tasks had 
large perceptual and motor components, for example in the 
category-decision task, and that it was these aspects of
the tasks that were sensitive to ACDs.
A small and exploratory pilot study was carried out in 
Dundee using a set of measures to investigate perceptual 
and motor components of tasks, with clinical and control
subj ects.
10.2 Method
10.21 Rationale
The rationale for the design of the tasks was to 
systematically vary aspects of the perceptual and motor 
functioning required by subjects, and to identify, if
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present, possible impairments in specific areas of 
perceptual and/or motor functioning.
Simple reaction time tasks were used and were varied 
in both the size of the presented stimulus (affecting the 
amount of retinal stimulation) and also the dominance of 
the hand responding to the stimulus (varying sidedness of 
motor output).
Another task exploring motor output was employed. This 
task required the subject to respond using both hands on 
the response keys, either ipsilaterally or contralaterally 
to the stimulus presented on the screen.
Finally, perceptual discrimination tasks were 
employed. These tasks varied the difficulty of the 
discriminations of the two presented stimuli and required 
the subjects to respond using both hands.
10.22 Subjects
The subjects invited to participate in this study were 
all the monotherapy and CTL subjects who had participated 
in the Dundee main study (see chapters four and five) and 
those subjects in the Lamotrogine study (see chapter nine). 
This invitation to participate provided eleven CTL 
subjects, seventeen subjects on monotherapy (nine on CBZ, 
five on DPH and three on VPA) and nine subjects on 
polytherapy (i.e a range of ACDs, plus Lamotrogine). The
criteria for subject exclusion remained the criteria for
3 2 1
the original studies in which the subjects had
participated.
The subjects provided information about seizure
frequency since their last testing session. It was found
that the majority of monotherapy subjects reported no 
recent seizures, and all the monotherapy subjects fell in 
to categories three, four and five in terms of seizure
frequency.
The polytherapy group had more frequent seizures as 
described in chapter nine, but none on the actual day of 
testing.
The serum levels of ACDs were also measured after the
testing and revealed that all subjects had significant 
amounts of their prescribed medications in their blood
stream.
10.33 Procedure
Each subject completed the four tasks, in a specified 
order, on a BBC microcomputer. The stimuli appeared on the 
visual display unit and the responses were made on the 
attached response keys. All data were recorded in 
centiseconds by the microcon^f^i^^^^. Any data points of less 
than 12 centiseconds were treated as "anticipations" and 
were removed from the data sample before analysis. This 
procedure resulted in 0.35% of the data points being 
removed from the analysis.
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Task (a) ; Simple reaction time fSRT).
The subject was asked to press the response key with
his/her index finger of his/her dominant hand, whenever a 
stimulus, (a white square), appeared on the middle of the 
screen. The subject was asked to respond as quickly as 
possible. Each stimulus was cued by a warning signal, (a 
"bleep" produced by the computer). The tone-stimulus 
interval was variable (0.5 - 2.0 secs).
The stimuli varied in siie. Half the stimuli (the 
large itemufi^) , were 2cm by 2cm, and half (the small 
stimuli) , were 1cm by 1cm. The small stimuli were the same 
size as the stimuli used in the reaction time experiments 
in the Glasgow study. Large and small stimuli were 
presented in random order.
There were 20 practice trials and 80 experimental
trials.
Task fB) : Motor Task.
The sts-muli, both large and small s s in task (A) , 
appeared on the screen shifted either to the left or to the 
right of centre; the eccentr icity for the subject, as 
measured from the centre of the squares, was approximately
2.3 degrees.
The task was divided into four blocks of trials. In 
all trials, the subject placed his/her index fingers on two 
response keys placed 17.5cm apart. In two blocks of trials.
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the subject was asked to press the response key on the same
side (ipsilaterally) as the stimulus. In the remaining two 
blocks, the subject was asked to respond by pressing the 
key on the opposite side (contralaterally) to the stimulus.. 
The subject completed the trials in a specified order for 
the four blocks, balancing the order of ipsilateral and 
contralateral conditions across the subject groups.
Again, each trial was accompanied by an auditory 
warning signal ("bleep") and the signal to stimulus time 
was variable (0.5 - 2.0 secs). There were 12 practice 
trials, followed by trials in which 40 large and 40 small 
stimuli were presented randomly.
Task fC) : Simple reaction time (SRT).
This task was essentially the same as task (A), except 
that the subject was asked to respond with their non­
dominant hand.
Task fP) ; Perceptual Discrimination task fPDT).
In this task, two stimuli appeared on the screen 
simultaneousl y, on the left and right of the screen; the 
eccentricity again being approximately 2.3 degrees. The 
stimuli differed in size. One pair of stimuli were a 2.5cm 
by 2.5cm square and a 1cm by 1cm square, and the other pair 
were squares of 1.75cm by 1.75cm and 1.5cm by 1.5cm i.e 
they were more difficult to tell apart:. There were four
blocks of trials and the mode of responding was the same as
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in task (B). In two of the blocks, the subject was asked to 
press the key on the same side as the larger of the two 
stimuli, and in the other two blocks the subject responded 
on the same side as the smaller of the two stimuli. The
blocks were completed in a specified order to balance the 
possible effects of order of completing tasks.
Thus, the task involved rapid discriminations between 
two stimuli. Obviously, a more difficult discrimination was 
required for stimuli that were more similar in size. Equal 
numbers of easy and more difficult discriminations were 
presented randomly throughout the blocks of trials.
Again, each trial had a warning signal and a variable 
signal-stimulus interval (0.5 - 2.0 secs). For each block
there were 12 practice and 40 experimental trials.
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Table 10a ; Mean Response Times fin msec) and standard
deviations for three groups fPilot investigation)
Task CTL MONOT POLYT
a) Reaction Time task
(Dominant hand)
1. Large stimuli 286 (53) 295 (73) 433 (220)
2. Small stimuli 224 (60) 302 (75) 428 (119)
c) Reaction Time task
(Non-Dominant hand)
1. Large stimuli 296 (43) 328 (110) 394 (202)
2. Small stimuli 301 (46) 323 (69) 362 (110)
b) Motor Task
Ipsi Large 34 (192) 391 (241) 410 (321)
Ipsi Small 346 (201) 384 (236) 431 (328)
Contra Large 441 (183) 494 (261) 664 (410)
Contra Small 458 (216) 4 94 (281) 587 (389)
d) Perceptual Task
Easy Ipsi 3 57 (92) 388 (126) 476 (171)
Easy Contra (103) 408 (131) 525 (198)
Hard Ipsi 390 (105) 467 (101) 528 (189)
Hard Contra 4457 (117) 472 (131) 555 (210)
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10.3 Results
The means and standard deviations for the four tasks
are presented in table 10a. In all tasks and in all 
conditions of the tasks the CTL had faster response times
than the MONOT group), who in turn had faster response times 
than the POLYT group). The standard deviations in the CTL 
group were smaller than for the other groups, with the 
POLYT group having largest standard deviations.
The fastest response times were obtained in the simple 
reaction time responding with the dominant hand, followed 
by the simple reaction time task using the non-dominant 
hand. Not surprisingly, the perceptual discrimination task 
and the motor task had slower ^response times.
Each of the tasks was analysed using ANOVA with a 
between-groups factor of drug group and a within-groups 
factor(s) of condition of task. The "F" ratios, degrees of 
freedom and levels of slinlifcaaoc of the analyses rre
presented in table 10b.
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Table 10.b : Analysis of the response time tasks across the
three croups
Task "F" ratios, Dfs and levels of significance
RT {dominant)
Effect of group F = 5.22 (2, 34) P < 0.05
Effect of size F < 1
Effect of GP by size F < 1
RT fnon-dominant)
Effect of group F = 2.94 (2, 33) P = 0.0670
Effect of size F < 1
Effect of GP by size F < 1
Motor Task
(Ipsi/Contralateral)
Effect of Group F = 2.22 (2, 34) P > 0.1
Effect of Ipsi/Contra F = 42.27 (1, 34) P < 0.001
Effect of GP by IC F = 2.45 (2, 34) P > 0.1
Effect of GP by size F < 1
Effect of GP by IC by F = 1.24 (2, 34) P > 0.1
size
Perceptual Task
Effect of Group F 1.79 (2, 34) P > 0.1
Effect of easy/hard (EH) F = 56.85 (1, 34) P < 0.001
Effect of Ipsi/Contra F = 11.65 (1,34) P < 0.01
Effect of GP by IC F < 1
Effect of GP by EH F 1.37 (2, 34) P > 0.1
Effect of GP by IC F < 1
by EH
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There was a main effect of group in the simple 
reaction time task responding using the dominant hand (F 
2,34 = 5.22, P < 0.05) and a trend on the simple reaction 
time task with the non-dominant hand (F 2,34 = 2.94, P = 
0.067). However, there was no effect of condition, i.e 
large versus small stimuli, on either of these two tasks.
The maai eefeet of groups on the simple reaction 
time task was further analysed using Newman Keuls test, 
and it was found that both the CTL group and the MONOT 
group performed significantly better than the POLYT group 
at the P < 0.05 level.
There was no effect of groups on the motor task. 
There was a marked effect of condition (F 1,34 = 42.27, P 
< 0.001) such that subjects found responding on the
opposite ssie to the stimulus much more difficult than 
responding on the same side. However, there was no group 
by condition interaction.
There was no effect of groups on the perceptual 
discrimination task. There were two effects of 
conditions. The easy versus hard condition (F 1,34 =
56.85, P < 0.001), showed that the subjects performed
significantly worse on the more difficult discrimination. 
Also, there was an effect of condition for the side of 
response (F 1,34 = 11..C555, P < 0.01), ithh subjects 
responding significantly slower, if responding to the 
side of the 31^1. lle stimllss. BoeveM’ , there were no 
group by condition interactions.
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The analyses were repeated after removing the out­
lier scores i.e scores three standard deviations away 
from the subject's mean score. These analyses produced a
similar pattern of scores, in which the trend in the 
reaction time task with the non-dominant hand became a 
significant result (P < 0.05).
10.4 Summarv and Discussion
The finding that the POLYT group performed 
significantly worse on the simple reaction time tasks is 
not surprising given the impaired performance of this 
group as described in chapter nine. The lack of 
significant differences between the MONOT group and the 
CTL group would indicate that if perceptual and/or motor 
abilities are the important aspect in differentiating 
between MONOT and CTL subjects, the differences are not 
large enough to be picked up on a small scale study such 
as the one described.
It is possible that by combining the three drug 
groups into one MONOT group, impairments due to one 
specific ACD have not been identified. It is also 
possible that the design of the tasks employed were not 
of a type suitable to detect the effects of ACDs. For 
instance, the tasks did not require a large amount of 
visual scanning by the subjects as would be required in a 
visual scanning task. Nevertheless, this pilot study 
would not encourage one to develop further simple
perceptuo-motor tests to use in investigations of ACDs.
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CHAPTER ELEVEN
SUMMARY . AND DISCUSSION
11.1 Introduction
The first part of this chapter, section 11.2,
summarises the main findings of the studies described in 
the thesis. Section 11.3 discusses various aspects of the 
studies including the design, the clinical factors, the 
rationale of the test batteries and methods of data 
analysis. This part of the discussion also endeavours to 
discuss the findings and points of interest contained in 
the experimental work in relation to the literature reviews 
presented in chapters two, three and six. The third part;, 
section 11.4, describes future avenues of investigation, 
that may help to unravel some of the complexities of work 
in this area. The final section (11.5) consists of a short 
summary and concluding comments on the thesis and the
studies therein.
11.2 Summarv of main findings in the studies
11.21 Dundee studv One (chapters four and five)
This first study was a between-groups study comparing
four anticonvulsant drug (ACD) groups i.e polytherapy 
(POLYT), carbamazepine (CBZ), sodium valproate (VPA) and 
phenytoin (DPH) and one control (CTL) group, with a total 
of 63 participating subjects. The main emphasis of the 
study was to compare the performance of the monotherapy
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drug groups on a range of cognitive tasks, with a 
particular focus on memory tasks.
The hypotheses were only supported to the extent that 
the POLYT group was often impaired compared to the CTL
group and less frequently compared to the CBZ group). The 
POLYT group performed significantly worse than the CTL 
group on the Rivermead Behavioural memory test (P < 0.05) 
and significantly worse than the CTL and the CBZ group on 
the category-decision task (P < 0.05). The POLYT group also 
performed significantly worse compared to the CTL, the CBZ 
and the DPH group on the tests of intellectual ability (P < 
0.05).
The subjects on monotherapy did not differ 
significantly from the CTL group, although the pattern of 
means supported the view of the CTL and CBZ groups 
performing better than the DPH and VPA groups. The 
hypothesis that the DPH group would perform significantly 
worse than both the VPA and CBZ groups was not supported.
Although there were few significant differences 
between the groups, the pattern of mean scores across the 
test battery was very consistent, with the CTL group and 
the CBZ group obtaining means in the direction of better 
performance, followed by the VPA and the DPH groups, with 
the POLYT group obtaining the worst mean scores. Larger 
subject groups may have yielded more significant findings, 
but another possible reason for the very consistent pattern
in the means but few significant differences between the
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groups was the large standard deviations in the drug 
groups. Further analysis revealed that these large standard 
deviations were due, in part, to out-liers in the clinical 
groups. Hence, a sizeable minority of subjects with
epilepsy were impaired on the test battery.
The battery of tests used in this first study was
chosen from the literature on ACDs up to 1987 (in 
particular, the studies by Thompson and Trimble 1981, '82
and '83) These studies had identified memory tests as 
likely to be sensitive to ACDs. The Rivermead Behavioural 
memory test (RMBT) was chosen as a measure of memory that 
also endeavoured to have a greater degree of ecological 
validity. This test did reveal a significant difference 
between the POLYT group and the CTL group, unlike the 
memory questionnaire which was also included to measure 
everyday memory functioning.
11.22 Glasgow studv (chapters seven and eight)
This large study involved over one hundred subjects
and over two hundred testing sessions. The main design of 
the study was a between-groups design with four clinical 
groups and one CTL group. The repeated testing of subjects 
on the battery of tests allowed for two small within- 
subject comparisons; on the effects of changes in 
medication and the effects of recently occurring seizures.
With regard to the hypotheses for this study, the 
following points should be made; there was only a small
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amount of support for the hypothesis that the groups with 
epilepsy would be impaired, compared to the CTL group), and
where this arose it was the VPA group that performed worse 
than the CTL group i.e. on the trigrams task and the 
spatial memory task (P < 0.05). The between-group ANOVAs 
revealed no significant differences between the three drug
groups.
There was no evidence that the subjects with epilepsy 
on ACD medication performed less well than the subjects 
with epilepsy not on medication. There were no significant 
differences between the DPH group and the other drug 
groups, so refuting the hypothesis that the DPH would show 
more impairments. It was also hypothesized that where task 
demands increased, more impairments would be found in the 
ACD groups. As there were no significant condition by group 
interactions, this hypothesis was not supported.
The study did show a consistent pattern of means 
across the test battery. The CTL group consistently had 
means in the direction of better performance, followed by 
the CBZ, UT and DPH group, and finally the VPA group. One 
possible explanation for the paradox of a consistent 
pattern in the means, but very few significant differences 
between the groups, was the large variance of scores within 
the groups with epilepsy compared with the CTL group. This 
difference in the spread of scores appeared to be due, in 
part, to a number of subjects with epilepsy performing very
poorly. This point was supported by an analysis using mean
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z-scores that revealed large numbers of out-liers in the 
clinical groups compared to the CTL group), as was seen in 
the Dundee study. The reasons for the very poor performance 
of some of the clinical subjects was not obvious and a
correlation analysis revealed that no epilepsy or drug 
factor correlated to performance on any of the tests.
A small portion of the subjects with epilepsy (N=16) 
had a change in medication between the testing sessions. 
ANOVAs carried out on the battery of tests revealed a 
significant impairment for the subjects with higher, rather 
than lower drug serum levels, on the spatial task (P < 
0.05). A trend in the same direction was shown on the 
trigram task (P < 0.1). The group was divided into two 
smaller groups (CBZ=9 and DPH=7) and this revealed that the 
DPH group was more likely to show impairments with 
increases in drug serum concentrations, and indeed the DPH 
group also had significantly slower reaction times with 
higher drug concentrations (P < 0.05); this was a result 
not present in the combined group (N=16) analysis.
The within-group analysis of the subjects who had 
seizures near the time of testing during one session and 
less frequent seizures at another time of testing revealed 
no significant findings across the test battery.
The analysis of practice effects on the test battery 
revealed only one significant practice effect, which was on 
the counting backwards in threes distractor task on the
trigram task. There was a significant improvement in
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counting backwards in threes between session one and two (P 
< 0.01).
The battery of tests employed in this study was 
developed using the framework of working memory (Baddeley 
and Hitch, 1974) and attentional resource theory (Borman 
and Bobrow, 1975) . The range of tests and distractor 
conditions aimed to provide a balance of tests across 
perceptual and motor abilities, and verbal, spatial and 
visual working memory tasks. The tests were designed to 
gradually increase in difficulty so enabling the testing of 
the hypothesis that increasing the demands of tasks would 
have a detrimental effect on some drug groups. The analysis 
of the conditions of the tests supported the validity of 
the design. The tests did increase in difficulty as 
predicted and also tapped into different parts of the 
working memory system. Thus, different types of distractor 
condition had differential effects on performance on the 
primary tasks. Furthermore, different primary tasks also 
had differential effects on the performance of the 
distractor tasks.
11.23 Lamotrogine study (chapter nine)
The main emphasis of this study was a within-subject 
study in which ten subjects with epilepsy were given 
Lamotrogine as an adjunct medication to their normal ACD 
regime. The study was exploratory in nature, as Lamotrogine
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is a relatively new ACD, and as such the effects, if any, 
on cognitive functioning were unknown.
There was also a small control group (N=6) included to 
ensure that there were no significant practice effects
across the test battery. The inclusion of the CTL group 
revealed that the subjects with epilepsy were very much 
impaired on the test battery, as they performed very much 
worse than the CTL group, regardless of whether they were 
taking Lamotrogine. This result is interesting because the 
groups of clinical subjects in studies one (Dundee) and two 
(Glasgow) were, in general, not significantly different in 
performance, compared to the control groups. However, the 
severity of the epilepsy disorder was much more severe in 
the clinical group in this third study, both in terms of 
frequency of seizures and duration of the disorder, may 
account for the results obtained.
Analysing the results across the three testing 
sessions revealed that there was a significant 
deterioration in the performance of the subjects with 
epilepsy when they started taking Lamotrogine, on the 
trigram task (P < 0.01), and this was most apparent with 
the most difficult condition of the task. There was also a 
trend in the same direction showing poorer performance 
across the sessions on the motor task.
In terms of seizure frequency, half of the clinical 
subjects reported no changes on starting Lamotrogine, but 
the other half did report a reduced seizure frequency after
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starting Lamotrogine. A number of health changes were 
reported but with no one health change being noted widely 
across the group.
11.24 Further investigations using response-
timed tasks (chapter ten)
The small number of significant differences between 
the groups in the Dundee study led to speculation that 
choosing a battery of tasks which was heavily weighted 
towards memory tasks led to important aspects of the 
functioning of the clinical subjects being missed. It 
seemed possible that many of the tests reported by Thompson 
and Trimble had large perceptual and motor components, for 
example visual scanning tasks, and that it was these visual 
and motor components that were sensitive to ACDs. 
Researchers such as Dodrill (1977) had specifically 
identified DPH as impairing subjects on tasks with a large 
motor component, and Gillham, Williams, Weidman, Butler, 
Larkin and Brodie (1988) reported significant correlations 
between poor performance on psychomotor tests and
concentration levels of CBZ.
A pilot study was carried out using perceptual and 
motor tasks on subjects who had previously participated in 
either the Dundee study or the Lamotrogine study. The three 
groups (CTL, MONOT, and POLYT?) completed the battery of 
tests. The results revealed that the POLYT group was indeed 
slower on the simple reaction time tasks compared to the
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MONOT and CTL group). However, the tasks did not reveal 
significant differences between the CTL and the MONOT 
groups. It would have been preferable to have been able to 
investigate the individual ACDs in three separate groups,
but the number of volunteers for this study did not allow
for such comparisons. Hence, it is possible that if a 
particular drug did affect perceptual and/or motor
abilities, this would have been masked in the monotherapy
group.
11.3 Further discussion of studies
A number of interesting aspects from the research are 
not apparent from the description of the group comparisons. 
In this section, I shall endeavour to high-light some of 
these aspects and also to relate some of the points raised 
to the literature presented in chapter two, three and six.
11.31 Design of studies
The original design for both Dundee study one 
(chapters four and five) and Glasgow study (chapters seven 
and eight) were between-group designs with matched 
subjects, all on monotherapy, i.e on one of the three main­
line ACDs. This design was chosen because of the lack of 
availability of subjects changing medication, such that the 
option of within-subject comparisons was not available.
The control groups were included to provide a base­
line of normal performance on the tests batteries, as it 
had been expected that the groups with epilepsy would
34 0
perform at a lower level. Hence, a smaller number of 
control subjects were identified, enough only to provide an 
indicator of normal subject performance. On many occasions 
this poorer performance by groups with epilepsy did not in
fact occur. The groups with epilepsy performed at the same 
or similar levels as the control groups. Hence, it would 
have been advantageous to have had larger control groups, 
in order to make more sensitive comparisons with the 
clinical groups and to explore whether some of the trends 
in the results would indeed have become significant 
differences between the control and drug groups. However, 
as the identification of control subjects was mainly done 
via clinical subjects asking relatives or friends to 
participate in the studies, it would not have been easy to 
find a large number of control subjects, post the time of 
the initial testing.
In Dundee, the through-put of subjects was slow and it 
was found that a number of subjects, whose medical notes 
indicated that they were on a monotherapeutic regime, 
turned out to be on polytherapy. It therefore seemed 
sensible to test several other subjects on polytherapy to 
form a polytherapy group. As it transpired., this was a 
worthwhile avenue to take, as it revealed that subjects 
with epilepsy on polytherapy did perform significantly less 
well on the Rivermead Behavioural Memory task and the 
category-decision task, compared to the CTL group.
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An interesting group in the Glasgow study were the 
untreated clinical group). If the subject groups were well- 
matched and the ACD medication did affect cognitive 
functioning, then it would be reasonable to expect an UT
group to perform significantly better than some or all of 
the ACD groups. This was not the case. This could be 
interpreted as strong evidence that the ACDs do not affect 
cognitive performance in a marked way. However, one issue 
that would need to be addressed is why those subjects were 
not taking ACD medication. Although there appeared to be no 
hard and fast criteria at the epilepsy clinic in Glasgow, 
it did appear that for some of those subjects in the UT 
group, there were question marks over their diagnosis, and 
suspicions by the doctors involved that rather complex 
personality and other factors affected the reported 
frequency of seizures and symptoms of the disease. It may 
be possible that such vague personality factors, such as 
motivation and energy levels, may have partially affected 
the performance of some subjects in this group.
The design of the Glasgow study included repeated 
testing of subjects. This allowed for subjects under-going 
changes in medication to be tested before and after the 
changes were made. The reasons for the changes in 
medication were clinical, and the numbers of subjects that 
fell in to this group were small (N=16) ; but it still 
seemed worthwhile to carry out a within-groups analysis on 
this group of subjects. This analysis produced evidence
342
that increased levels of DPH produced some reduction in 
cognitive functioning, both on tests of working memory and
reaction time tasks.
The Lamotrogine study was also a within-subject design
and there was close monitoring of epilepsy and drug 
variables, making this study more robust because there was 
more information available on the clinical subjects. The 
ANOVA showed that there was some indication that taking 
Lamotrogine impaired cognitive functioning.
11.32 Clinical Aspects of the studies
A number of clinical factors were monitored in the 
Dundee and Glasgow studies, including type of seizures, 
frequency of seizures, and onset and Uulaninn of the 
disease. The monotherapy groups tended to be well matched 
and correlation analyses of test performances and these 
epilepsy variables supported the view that these factors 
did not have a large bearing on the performance of the 
subj ects.
However, the polytherapy group, in the Dundee study, 
reported more frequent seizures and a longer duration of 
the disease than the other three drug groupn. and the 
untreated group in the Glasgow study had a shorter duration 
of the disease than the three drug groups. Thus the 
matching of subjects in both studies was quite good, but
not as close as would be desirable.
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The analyses of the mean z-scores did reveal a number 
of subjects with epilepsy who performed very poorly, even 
though many subjects in the same drug groups performed in 
the normal range. lit is possible^ theerfore, that there
were epilepsy and other variables, which were not 
monitored, that could have had a bearing on the performance 
of individual subjects.
Dodrill (1986) reported that large number of seizures, 
i.e over oe e hundred , and pro loncged exposure to seizure 
activity as in status epilepticus for example, ouude eadd 
to deterioration of mental functioning. Although seizure 
frequency at and around the time of testing was monitored, 
the overall number of seizures was not recorded. Indeed, it 
would be difficult to obtain accurate information outside
of a residential setting.
Delaney et al (1980) reported that subjects suffering 
temporal lobe seizures are more likely to show impaired 
memory functioning and that the laterality of the seizures 
would affect the type of effects seen. The medical notes on 
the subjects included in the Dundee and the Glasgow study 
did not provide enough information to be certain of details 
of tth subjects' epilepsy. Hence, seizure types were 
categorised in three broad groups i.e tonic-clonic, complex 
partial and complex partial, secondarily generalised. As 
the laterality was for most subjects unknown, the possible 
effects of laterality of seizures of the temporal were not 
investigated.
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The presence and amount of interseizure activity and 
possible absence seizures were not measured in either the 
Dundee or the Glasgow studies. Given the number of clinical 
subjects performing poorly, it would have been desirable to
measure the amount of interseizure activity and to screen 
out absence seizures. Interseizure activity could have 
resulted in transitory cognitive impairment, "TCI", as 
described by Aarts et al (1984).
The amount of information, with regard to the 
aetiology of the seizure disorders and the possibilities of 
brain damage, was very small. The majority of subjects in 
the Glasgow study had had a CT scan and any subject with an 
abnormal CT scan was excluded from the study. However, in 
the Dundee study the majority of subjects had not had a CT 
scan. With the new brain imaging techniques, such as PET 
and MRI scanning, it may be possible to identify smaller 
areas and different types of brain damage that may not have 
been identified in the past. Although, the possibility of 
brain damage can not be ruled out in the subject samples 
included in the studies, as Dodrill (1992) has pointed out, 
there are individuals for whom small lesions of the brain 
have been identified using the newer imaging techniques; 
yet these individuals show few if any detectable cognitive 
impairments.
The dose and serum concentrations of the ACD 
medication were monitored in all the studies. A large
number of the results from the blood sample analyses at the
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Dundee Royal Infirmary did not reappear in the subjects' 
medical notes. Hence, there were fifteen missing serum 
concentration levels from the Dundee study. The results 
that were obtained revealed that the monotherapy and
polytherapy groups' mean serum levels fell within the 
therapeutic range for the ACDS, but that there were a few 
subjects who fell out-side of this range.
In the Glasgow study, the serum level results were 
more consistently available, and hence, there were few 
missing results. The mean serum level for the CBZ and the 
VPA groups were within the therapeutic range, but there 
were three subjects in the CBZ group and seven in the VPA 
group who had levels of medication above this therapeutic 
range. The DPH group mean serum level was above the 
therapeutic range and ten subjects were above the top of 
this range. The importance of this difference is hard to 
assess. There were very few significant differences between 
CTL and ACD groups, in terms of performance on the test 
batteries. However, one of the subjects with the highest 
levels of DPH did perform very poorly on the battery of
tests.
The studies carried out by Thompson and Trimble (1981, 
1982 and 1983) and by Brodie et al (1986) measured the 
serum concentrations of the ACDs involved in their studies
and revealed mean serum concentrations falling within the 
therapeutic range, although the range of serum levels 
reported would indicate that they also had subjects for
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whom their drug serum concentrations were markedly outside 
the therapeutic range. Thompson and Trimble (1983) did try 
to take account of the possible effect that subjects with 
very high blood serum concentrations might have on test
results. The data they obtained from 28 subjects having a 
reduction in their serum levels were re-analysed after 
removing fourteen subjects whose high concentrations were 
above the therapeutic range. This second analysis resulted 
in only four measures out of twenty being significantly 
different, compared to seven significant measures when all 
28 subjects were included in the analyses.
11.33 Test design
The subjects in the Dundee and Glasgow studies 
completed different test batteries. The subjects in the 
Lamotrogine study completed some of the tests from the 
Dundee study and some from the Glasgow study. The reasons 
for the tests being different in each of the studies were 
dependent both on the theoretical questions being asked of 
each study and also on practical constraints, such as the 
available apparatus.
The Dundee study included a range of tests aimed at 
exploring the nature of tests that may be sensitive to ACD 
medication. The tests were chosen after consideration of 
the literature described in chapter two and three. This 
literature (for example Thompson and Trimble, 1981 and 
Andrewes et al. 1986) had claimed that memory tests would
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reveal differences in cognitive functioning of subjects on 
specific ACDs. Interpretations such as these led to the 
inclusion of a number of memory tests in study one. Some of 
the memory tests were of a more visuo-spatial nature, as 
these types of memory test had rarely been used in relation 
to ACDs. Also, the Rivermead Behavioural memory test (RMBT) 
(Wilson et al. 1985) and a memory questionnaire (taken from 
the work of Sunderland et al. 1983) were included to 
measure memory impairments in a way that might indicate the 
nature of any identified impairments in everyday life. The 
results obtained showed no significant differences between 
the groups on the visual and spatial tests. There were also 
no differences on the memory questionnaire. The RMBT, on 
the other hand, did reveal a significant impairment for the 
POLYT group compared to the CTL group. There may be some 
value in employing this easy to use memory test to identify 
subjects with epilepsy having problems with their memory, 
particularly as this test may indicate in what type of 
everyday functioning the memory lapses occur.
As well as including this range of memory tests, a 
category-decision task (pen and paper version of the task 
designed by Thompson and Trimble, 1981) was included as 
this type of task was identified as being particularly 
sensitive to ACD effects. This version of the test did 
prove sensitive enough to distinguish between the POLYT 
group and the CTL group, but did not distinguish between 
the three individual drug groups.
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Tests of intellectual ability were also included in 
the battery, with the hope that if there were differences 
between the groups on the memory and category-decision 
tasks, that these would not be apparent on the tests of 
intellectual abilities. Unfortunately, where group 
differences were found in relation to the POLYT group), 
significant differences were found in the category-decision 
task, the RMBT and the tests of intellectual ability. One 
could interpret this finding in one of two ways. Either the 
subjects in the POLYT group had lower intellectual 
abilities, regardless of the fact that they were suffering 
from epilepsy and this lower intellectual ability could 
account for their poor performance; or epilepsy and/or 
taking multiple ACDs results in lower performance on tests 
of intellectual ability. One piece of information that may 
help to decide between these two alternatives was that this 
finding of significantly worse performance on the tests of 
intellectual ability was not found in the Lamotrogine 
study, where the polytherapy subjects performed less well 
than the CTL group on many of the tests but were not 
impaired on the tests of intellectual ability. The CTL 
group in this study were made up exclusively from family 
members of the clinical subjects and it would therefore 
have been surprising to find large difference in 
intellectual abilities between the two groups. This finding 
would tend to support the view that the POLYT group in the 
Dundee study may have had lower premorbid levels compared
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to the other groups and this may have affected their 
performance on the other tests.
The battery of tests used in the Glasgow study did
have tests in common with other researchers in this area.
For example, there was a simple motor task consisting of 
repeatedly tapping as quickly as possible for 60 seconds; a 
task that had been employed in the Brodie et al (1986) 
study. There was also a motor task involving tapping 
alternately on two switches, as described in the Thompson 
and Trimble (1981) battery of tests. The category-decision 
task employed by Thompson and Trimble was also used in this 
battery of tests.
However, the main rationale for the tests used in this 
study was to develop a battery of tests based on the 
theoretical frameworks of working memory and resource 
theory, as described in chapter six. Thus, the battery of 
tests included verbal, visual and spatial working memory 
tasks as well as tasks endeavouring to measure the central 
executive. T he tssks were designed to increase in 
complexity, so as to tesT the hypothesis that more 
demanding tasks are more likely to be sensitive to the 
effects of ACDs. One positive aspect of the battery 
selected was that there eees very significant effects of
condition such that all the tasks did increase in task
difficulty. Another positive factor was that the three 
specific working memory tasks did differentiate between the
verbal and visuo-spatial systems of the working memory.
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Furthermore, the significant slowing of tapping rate in the 
spatial memory task provided evidence that the visual and 
spatial tasks were, to some degree, different parts of the 
working memory system. Where differences were identified
between or within the subject groups, these working memory 
tasks, particularly the trigrams and spatial task, were as 
sensitive as the other tasks included in the battery such 
as motor and reaction time tasks.
With regards to the other tests included in the 
Glasgow test battery, unfortunately, a "bug" in the 
computer programme in the attention-switching and the 
category-decision tasks meant that approximately one third 
of the data for these two tasks were lost, and as such the 
numbers of subjects available for analysis was very small 
and revealed no interesting findings. These two tasks were 
again employed in the Lamotrogine study, but it was found 
that part three of the attention-switching task was so 
difficult for some of the polytherapy subjects that this 
condition of the test had to be removed from the test 
battery. The category-decision task was used in the 
Lamotrogine study and, although it revealed impairments in 
the polytherapy group compared to the CTL group, it was not 
sensitive to the effects of ttklnn Lamotrogine in addition 
to the original medication, unlike the trigrams and motor 
task. The category-decision task, therefore, did not prove 
to be a sensitive measure in the Lamotrogine study, whereas 
Thompson and Trimble had found it to be a very sensitive
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measure in their ACD studies;. In summary, the tests 
included in the test batteries, in an attempt to measure 
"central executive" functioning were not successful, either
in their ease of use or in the results obtained.
Tests of intellectual ability and measures of mood of 
subjects at the time of testing were also included in the 
Glasgow battery. Unlike the Dundee study there were no 
significant differences between the groups on the tests of 
intellectual ability. It was noticeable, however, that the 
pattern of means revealed that the VPA group obtained the 
lowest means on the intellectual ability measures as it did 
on many other of the measures. There were no significant 
differences between the groups on the mood scores.
Although the test battery used in the Glasgow study 
was comprehensive, it was also quite draining for some of 
the subjects (comments to this effect were made by some 
subjects at the time of testing) . Care must therefore be 
taken to design batteries of tests that are not too taxing 
for subjects. This point was taken on board for the 
Lamotrogine study and this battery of tests was shorter and 
therefore less taxing. A further constraint on the choice 
of tests in the Lamotrogine study, was that there was 
access to only one computer which meant, for example, that 
the combination of reaction time and motor tasks could not 
be included in this battery. Thus, only the motor tasks 
were included in this test battery.
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11.34 Method of data analysis
The data was generally analysed by analysis of 
variance, but some of the data analysed in this way did not 
show a normal distribution. In particular, there were 
ceiling effects on a number of the tasks and, a number of 
out-liers in the epilepsy groups. The decision to continue 
using ANOVA was based on the facts that most of the data 
did show approximate normal distributions; this type of 
analysis was used on similar tasks by most researchers in 
the field; and ANOVA allows for more detailed analysis, 
i.e. more than just the effects of groups.
In relation to the dtt s edalesis, n s ettreesteng 
finding in the Glasgow study was that subjects changed 
their performance on distractor tasks, dependant on the 
nature of the primary task. Hence, the ANOVAs of the 
distractor tasks across ths three primary tasks were 
necessary and provided more evidence that the three primary 
tasks were tapping into different parts of the working 
memory system.
The battery of tests employed in the Glasgow study was 
also analysed for practice effects. This analysis revealed 
that there was a learning effect on the distractor task of 
counting backwards in threes. It may, in hind-sight, have 
been worthwhile T o ks k the subjects to start counting 
backwards from a different number each time they completed 
the test battery which may have reduced the learning
effect.
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Additional analyses involving the identification of 
out-liers using mean z-scores, showed a number of clinical
subjects performing very poorly on the tests. Do the 
results of other researchers in this area show similar
patterns of results? The data from two of the studies were 
examined to investigate the nature of the spread of the 
individual scores on tests. The first study treated in this 
way was the Thompson and Trimble (1981) study comparing 
placebo and DPH taken by volunteer subjects (as described 
in chapter three). Of the sixteen means measured across the 
battery of tests, the DPH condition had higher standard 
deviations in twelve of the comparisons, two comparisons 
produced the same standard deviations for both drug 
conditions and the placebo group had the higher standard 
deviations on only two of the measures. On some of the 
measures, the standard deviations for the DPH condition 
were extremely large, for example in the Stroop task the
standard deviation for the DPH condition was almost three 
times the size for the placebo condition, and in the 
category-decision task the standard deviation was double 
the size in the DPH condition compared to the placebo 
condition. It is somewhat surprising that with such large 
variation across the subject samples, significant 
differences were found between the two conditions, but 
there was a within-subject design and the actual data used 
in the ANOVAs were the difference scores between the 
original base-line scores and the two drug condition
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scores. These two aspects of the design meant that
significant differences were more likely to be found.
Brodie et al (1986) compared a control group with an 
untreated group of subjects with epilepsy and a group of
subjects with epilepsy on medication. The results of this 
study were presented in terms of means and range of scores 
obtained. It was found that on the nine measures used, the 
range of scores for the treated group with epilepsy were 
larger than for the control group. Not all the ranges were 
very far apart but tasks such as the tapping task revealed 
a range of scores double that of the control group). This 
task produced a highly significant difference between the 
two groups (P < 0.001). A similar picture arose on other
tasks in the Brodie battery of tests including the choice 
reaction time measures.
The significant differences found by Brodie et al 
(1986) using the tapping task are very much at odds with 
the results obtained with the Glasgow study described in 
this thesis. One of the factors that may account for this 
difference in results was the fact that the Brodie et al 
study carried out non-parametric analyses (Mann-Whitney U) 
on their data. The variance within the groups does not 
affect this analysis to any large degree, unlike ANOVA in 
which the variance within the groups is intrinsic to the 
analysis. However, the using of Mann-Whitney U test would 
be considered a less powerful analysis than using ANOVA and 
does not allow for the analysis of two or more independent
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variables simultaneously, as is required in much of the
data presented in this thesis.
10.4 Future avenues of investigation
One of the main difficulties in the studies described 
in this thesis is the problem of disentangling the possible 
effects of epilepsy and drug variables on cognitive 
functioning. As described on a number of occasions earlier, 
there were no clear-cut differences between the drug 
groups, but there were a number of individuals performing 
very poorly (out-liers) on some of the tests. To 
investigate the poor performance of some subjects, two 
approaches were taken. Scrutinizing individual clinical 
details of these subjects did not point to any one factor 
that could account for their poor showing and correlating 
epilepsy, drug and performance variables did not yield 
fruitful results that could indicate relevant factor(s) 
either.
However, although many factors in relation to the 
subjects' epilepsy were monitored through the course of the 
studies, one factor, the amount of abnormal brain activity, 
of epileptiform nature or otherwise, at the time of testing 
was unknown, and it would seem plausible that such abnormal 
activity could account for some the poor showing of some 
subjects. Hence, one way forward in these types of studies 
would be to monitor brain activity at the time of testing.
In this way, the association between epileptiform activity
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and cognitive performance can be investigated. Also, if 
ACDs effect brain activity, the changes in brain activity
and the affect of these changes on cognitive performance 
may also be a worthwhile area to explore.
Another way forward from the type of studies described 
in this thesis, is to take a more clinical path. It may be 
possible to include tasks such as the Rivermead Behavioural 
Memory Test as part of a routine screening of subjects, in 
out-patient settings. This would allow clinicians to 
identify those subjects experiencing difficulties, both for 
the purpose of more intensive investigation of their 
difficulties and also to offer appropriate support, if
necessary.
11.5 Summary
The thesis consists of four studies, of which the 
Glasgow study is by the far the most substantial. The 
general conclusion was that the hypotheses developed from 
the literature presented in chapters two, three and six 
were not supported. The monotherapy groups did not differ 
from each other, and were frequently not significantly 
different from the CTL groups, with only a small number of 
significant differences between the VPA and the CTL group 
in the Glasgow study. The polytherapy groups in both the 
first Dundee study and the Lamotrogine study did perform 
significantly differently from the CTL groups, but a number
of factors relating both to epilepsy variables as well as
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medication could account for these differences. The two
small-within group drug change comparisons i.e in the
Glasgow study and hh e Lamotrogine study, did provide a 
small amount of evidence that larger levels of medication, 
both in terms of increasing levels of DPH and also 
commencing Lamotrogine, impaired cognitive functioning.
The small number of significant differences between 
the ACDs is in contrast to much work done in this area, 
particularly in comparison to the work of Thompson and 
Trimble (1981, '82 ade '83). This could have been because 
of the between-group design, but recent studies, for 
example Meador et al (1990), in which within-group designs 
have been used, have also found very few significant 
differences between the drug groups. Re-analyses by Dodrill 
and Troupin (1991) have also shown that differences may 
disappear when DPH subjects above the therapeutic range are 
removed from the subject sample. Other reasons, such as 
different types of statistica 1 analysis as in the Brodie et 
al 1986 study, may also account for why the studies in this 
thesis found so few significant differences. It appears 
that the effects of ACDs on cognitive functioning are 
subtle enough to only be apparent in very specific
circumstances.
An interesting observation across the studies were the 
large standard deviations across the clinical subject 
groups. There were a number of out-liers in the clinical
groups. The reasons for the poor performance of the out­
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liers may be because of some clinical factor not 
identified, but may also be possible that some, but not all 
subjects, suffer from cognitive impairment associated with
ACD medication, just as some but not all patients suffer 
different physical side-effects, i.e there are individual 
differences in response to the medication. It is 
interesting to note that large ranges of scores and large 
standard deviations were obtained in other published work, 
but to date I have not read any discussion on the reasons 
for these large ranges of scores.
Some of the clinical aspects of the studies described 
in this thesis were disappointing, for example, the 
identification of large numbers of suitable subjects was 
not as successful as was hoped for at the out-set. If one 
is to monitor and partial out the multitude of possible 
clinical variables that potentially may effect subject 
performance, one needs very large subject samples and good 
clinical information about the subjects identified. Also, 
the monitoring of on-going epileptiform activity was not 
possible, and such monitoring would be a step forward in 
these types of studies.
Ways of further improving the types of study described 
in this thesis include the rather obvious design change of 
increasing the amount of within-subject experiments. 
Adherence to a large number of clinical variables when 
selecting subjects would also be of benefit. In relation to 
the Glasgow test battery, one may wish to remove demanding
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tests, for example, the attention-switching task as this 
task was draining for some subjects.
I believe that the test batteries developed for the 
studies had many positive aspects to them. The Dundee study 
battery employed tests such as the RMBT which are designed 
to have more "ecological validity" and therefore may be 
more useful from a clinical perspective. The Glasgow 
battery of tests contained a balance of tests across 
perceptual, motor, working memory and control processes, 
and was developed from an established theoretical 
literature. The tasks also manipulated task complexity, 
allowing for the testing of the hypothesis that ACD effects 
on cognitive performance are more likely to occur with more 
difficult tasks (an hypothesis not supported in this 
study).
The general vein running through the thesis is that
the cognitive effects of the main-line ACDs seem to be 
slight, and that adverse outcomes may only become apparent 
under specific circumstances, for example, at high serum 
levels or when starting a new drug. Howe^^^, it would also 
seem important to take into account individual differences 
in possible reactions to medication and the consequent
effects on cognitive functioning.
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APPENDICES
Appendix One
Details of main-line anticonvulsant medication
(Information from Brodie and Hallworth, 1987)
Carbamazepine (CBZ)
Carbamazepine (CBZ) was synthesized by Schindler 
and Geigy in 1953 as part of a programme investigating 
analogues of Chlopromazine. The first study with 
patients with epilepsy was not carried out until 1963. 
Since then, CBZ has slowly gained acceptance and is 
now considered a first-line broad-spectrum
anticonvulsant.
Absorption of CBZ is slow and probably 
incomplete. The drug is metabolized in the liver, 
partly to CBZ 10, 11 epoxide (CBZ-E) which also has
anticonvulsant activity. The half-life of CBZ may be 
as long as 48 hours after a single dose, but is 
greatly reduced after prolonged administration 
(typically 7-14 hours). This is due to auto-induction 
of metabolism, the extent of which varies markedly in 
individuals.
Phenytoin (DPH)
Phenytoin (DPH) was synthesized by Blitz in 1908, 
but it's anticonvulsant properties were not discovered 
until 1936. It was quickly shown to be as effective as 
phenobarbitone and much less sedative. Despite an
37 3
impressive toxicity profile, it remains one of the
most widely used ACDs in clinical practice.
Absorption of DPH is slow, sometimes variable and
occasionally incomplete. The elimination and half-life
of DPH in an adult is in the order to 9-2 2 hours 
following a single dose, but is considerably longer at 
higher concentrations when saturation metabolism takes 
place. Hence, it may take several weeks for steady- 
state to be reached in some patients and unexpected 
toxicity may occur up to a month after altering
treatment.
Sodium Valproate (VPA)
The anticonvulsant activity of valproic acid was 
reecognised in 19t3 ty Meueitr and Grenoble, the 
sodium salt was marketed as an ACD in 1967, and in 
control studies the drug appears to be as effective as
CBZ and DPH.
VPA has; t complex phirmaooUiRtUi t profile which 
severely limits the usefulness co serum level 
measurements and target range. The drug has a 
relatively short half-life (8-15 hours) especially in 
children (4-16 hours) and tht drrg is primarily 
cleared by hepatic metabolism.
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Appendix Two
List of objects used in category-decision tasks
in Study 1 (pen and paper task) and in Study
(computerised task).
1. Boy 23 . Flag
2. Arrow 24 . Girl
3. Saw 25. Comb
4. Spotted dog 26. Octopus
5. Ambulance 27 . Spoon
6. Flower 28 . Hand
7 . Cup 29 . Man
8. Chair 30. Tree
9. Sauce-pan 31. Kettle
10. Basket 32 . Bird
11. Lizard 33 . King
12. Shoes 34 . Tap
13. Can of soup 35. Bat
14. Paint brush 36. Paddle
15. Elephant 37 . Mouse
16. Alligator 38 . Butterfly
17. Stool 39 . Snake
18. Fish 40. Knife
19. Horse 41. Cat
20. Umbrella 42 . Train
21. Key 43 . Watch
22. Coach
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Appendix Three
Clinical details of subjects in Dundee study one
The following tables summarise the epilepsy
variables monitored in Dundee study one for each of 
the drug groups as described in chapter five.
Table 2a Study One: Five group comparisons
CBZ group : Individual subject details
Subject No. Type of 
seizures
Frequency
of seizure
Age at
onset
Duration
(yrs)
07 3 TL/L 5 54 2
08 3 TL/R 5 12 10
12 1 5 33 0.5
14 1 I 4 11 6
15 3 5 36 2
18 1 5 45 2
19 ? ? ? ?
20 3 4 5 50
21 3 4 14 4
22 3 TL 4 4 40
23 1 5 36 16
25 3 TL 3 18 17
47 1 5 5 41
50 2 2 24 16
Key : TL : Temporal Lobe
: L : Left-side and R : Right-side 
: I : Idiopathic
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Subject
Table 2b Study One : Five group comparisons
VPA group : Individual subject details
No. Type of
seizures
Frequency 
of seizure
Age at Duration
onset (yrs)
09 3 4 16 9
10 1 5 10 13
11 2 TL 4 47 1
13 2 2 ? ?
17 3 5 46 1
29 1 5 10 6
30 1 5 15 17
39 1 5 28 12
4 2 2 3 14 4
48 3 5 47 5
53 1 2 12 11
54 1 5 9 11
67 3 5 16 3
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Appendix Three contd.
Table 2c Study One : Five group comparisons
Subject No.
DPH : Individual subject details
Duration
(yrs)
Type of
seizures
Frequency 
of seizure
Age at 
onset
06 3 TL/L I 3 42 9
26 2 3 4 47
31 1 4 28 11
37 1 5 20 0.5
38 1 7 47 3
44 1 5 41 7
52 1 5 7 20
58 1 I 5 5 14
60 1 5 23 9
61 1 5 18 17
62 1 5 29 10
64 1 5 17 17
65 ? 5 37 4
Subj ect
Table 2d Study One : Five group comparisons
POLYT group : Individual subject details
No. Type of
seizures
Frequency 
of seizure
Age at Duration
onset (yrs)
24 3 TL 3 1 2 4
32 1 5 ? 7
33 1 3 22 3
3 4 3 2 23 2
36 2 2 9 29
41 1 3 20 4
43 1 I 4 13 9
4 5 3 R 3 10 7
5 5 1 2 ' 5 48
59 1 2 31 3
63 3 5 0.5 19
66 2 1 ? ?
68 7 ? ? 7
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Appendix Four
The following tables summarise the individual drug 
details of the three monotherapy drug groups in Dundee 
study one as described in chapter five.
Table 3a Study one : Five groups comparisons 
CBZ group : Dose and serum concentration details
Subject No. Dose (mg per day) Concentration
07 400 27
08 1000 ?
12 3 00 22
14 200 42
15 4 00 35
18 800 27
19 ? 31
20 4 00 3 1
21 400 5
22 400 22
23 800 7
25 600 32
4 7 200 14
50 600 25
Table 3b Study one ; Five groups comparisons
VPA group ; Dose and serum concentration details
Subject No. Dose (mg per day) Concentration ((pmol/1)
09 800 294
10 1200 286
11 800 ?
13 400 281
17 400 226
29 1200 ?
30 800 ?
39 1500 ?
4 2 7 00 7
48 7 399
5 3 1500 7
54 1000 182
67 1000 3 27
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Appendix Four contd.
Table 3c
DPH group 
Subject No.
Study one : Five groups comparisons 
: Dose and serum concentration details
Dose (mg per day) Concentration ((mol/l)
06 300 ?
26 425 113
31 400 50
37 ? 15
38 200 62
4 4 300 7
52 250 7
58 300 68
60 400 7
61 100 ?
62 200 27
64 7 5
65 ? ?
380
Appendix Five
The following tables summarise the individual epilepsy- 
details of subjects in Glasgow study one as described in 
chapter severe.
Table 4a Glasgow study : Five group comparisons 
UT group : Individual subject details 
Subject No. Type of Frequency Age at Duration EEG CT
seizures of seiz. onset (yrs)
438 1 3 21 0.8 A N
493 1 (L) 5 35 0.5 A N4 63 3 (I) 5 17 1 A N419 2 (TL) 3 22 0.5 A 9
409 1 (L) 3 18 1 A ?
418 1 3 16 2 A N
4 69 2 3 20 1 A ?
488 1 3 18 0.5 A ?
402 3 2 15 1 A 7
458 P 5 13 5 A N
450 1 (I) 4 16 5 A N429 1 5 13 15 A N
431 3 3 1 17 A N
472 1 (I) 2 19 8 A N4 54 2 (TL) 3 19 4 A N
444 1 1 2 4 0.5 A N
461 2 2 11 21 A N
499 2 5 10 7 A ?
498 1 3 16 1 A ?
49 6 1 3 29 0,5 A N
413 3 (L) 1 12 12 A ?
417 3 3 21 6 A N
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Appendix Five contd
Table 4b Glasgow study : Five group comparisons 
CBZ group : Individual subject details
Subject No. Type of Frequency Age at Duration EEG CT
seizures of seiz. onset (yrs)
417 3 2 18 9 A
453 1 (I) 3 25 0.8 A428 1 (I) 5 29 8 A471 3 3 21 6 A
434 1 2 17 1.5 A
455 1 5 21 5 A
439 1 3 20 9 A
401 1 3 15 2 A
400 3 3 0 28 A
410 3 2 19 3 A
403 3 (R) 1 15 6 A
448 2 2 2 2 2 A
489 1 3 29 1 A
4 30 2 3 13 9 A
4 04 3 (LTL) 5 3 0 2 A
44 9 1 (I) 4 20 2 A413 3 (L) 1 12 12 A
418 1 3 16 2 A
433 2 (R) 5 18 8 a4 56 3 1 7 14 A
4 61 2 2 11 21 A
N
N
N
N
N
N
??
N
?7
7
N
N
Z 
Z 
Z Z
?
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Appendix Five contd
Table 4c Glasgow study : Five group comparisons
VPA group 
Subject No. Type of
; Individual subject details
Frequency 
of seiz.
Age at 
onset
Duration
(yrs)
EEG CT
seizures
4 42 1 (I) 4 15 5 A ?459 3 3 3 7 14 A 7
492 3 3 16 7 A N
479 3 (I) 5 28 3 A N485 3 (L) 5 33 1.5 A N
445 3 2 35 1 A N
411 2 1 14 4 A ?
4 25 1 (I) 5 12 10 A N432 1 (I) 5 13 11 A 74 27 1 5 16 2 A N
407 1 (I) 5 11 5 A ?4 64 3 2 8 15 A ?
470 1 2 2 39 A ?
4 52 1 5 14 4 A N
467 2 (I) 2 3 41 A ?
447 3 3 12 5 A N
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CT
Table 4d Glasgow study : Five group comparisons
DPH group : Individual subject details
Subject No. Type of Frequency Age at Duration EEG
seizures of seiz, onset (yrs)
462 1 3 7 22 A
435 1 (I) 3 12 11 A487 1 5 38 3 A
484 2 2 1 30 A
446 3 4 40 4 7
421 1 (L) 5 17 10 A
495 3 5 40 3 A
42 6 1 (I) 5 4 13 A468 3 1 22 24 A
443 1 4 36 4 A
416 3 2 6 23 A
408 3 (R) 3 56 1 A4 75 1 (TL) 3 27 3 7
497 3 3 17 40 A
474 3 (TL/L) 2 28 2 A
N
N
N
N
N
N
N
N
N
N
3 
53
7
?
N
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Appendix Six
The following tables summarise the individual drug
details of the subjects with epilepsy participating in 
Glasgow study one as described in chapter eight.
Table 5a Glasgow study ; Five group comparisons
CBZ
Subject No.
group
Dose
: Individual medication details
(mg per day) Concentration (mg/ral)
417 1000 10.6
453 400 11.5
42 8 4 00 6.9471 400 9.2
434 800 10.9
455 800 9.6
439 1200 9.3
4 01 600 3.1
400 1000 12.4
410 1000 9.9
403 800 11.1
448 1200 9.6
430 600 12.7
404 800 7.3
449 800 9.0
413 12 0 0 8.2
418 200 10.1
433 4 00 3.9
456 600 15.3
4 61 200 5.4
496 400 8.2
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Table 5b Glasgow study : Five group comparisons
Subject
VPA group : Individual medication details
No. Dose (mg per day) Concentration (mg/ml)
442 400 40
459 800 66
492 500 101
479 400 . 43
485 800 48
44 5 16 0 0 62
411 1000 127
425 1600 74
432 10 0 0 74
427 400 83
4 07 2000 147
464 1500 14 7
470 4 00 65
452 1500 114467 12 0 0 124
4 47 1500 145
386
Appendix Six contd
Table 5c Glasgow study : Five group comparisons
Subj ect
DPH group : Individual medication details
No. Dose (mg per day) Concentration (mg/ml)
462 400 33.4
435 425 47.4
487 350 14.9
484 350 19.6
446 600 23.1
421 400 12.6
495 400 3.3
426 300 26.2
4 68 425 40.8
443 325 18.6
416 250 29.3
408 450 37.5
475 250 47.5
497 375 13.5
47 4 47 5 39.4
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Appendix Seven ‘
For clinical interest ; Subjects with epilepsy vs CTL
subjects, and ACD vs non-ACD subjects.
The design of Glasgow study one was a five groups
analysis. However, from a clinical view-point it would be 
interesting to explore firstly, how the control subjects 
compared to the group with epilepsy, irrespective of type 
of medication, and secondly, how subjects on medication 
compared to subjects not on any medication. These areas 
were investigated in the main five groups analysis, by the 
use of Schef f test, where appropriate. However, the 
Scheffe test is very conservative and did not provide a 
picture of the data of these comparisons. Hence, two sets 
of between groups ANOVA were carried out :
1. Comparing subjects with epilepsy (N=74) with CTL 
(N=10) subjects.
2. Comparing ACD (three drug groups combined, N=52)
with non-ACD (N=32, CTL=10 plus UT=22) groups.
The differences in sizes of the groups meant that any 
results obtained from these analyses are was robust and
should only be read as possible indicators of what might be 
occurring in the data set.
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Table 8.9a ; Mean scores for the tests of intellectual
ability, the motor task, SRI?, cateqorv-decision task and
the attention-switching task for epilepsy vs control
comparisons
Test Subject Groups : Means (S.D)
Epilepsy Control
Intellectual Ability : Mean scaled score
(Combined score) 8.46 (2.14) 9.15 (1.17)
Motor tasks : Mean No. of taps in 60s
Condition one a) 1 key 294.5 (57.4) 320.6 (37.6)
b) 2 key 150.0 (34.6) 161.7 (25.3)
Condition two a) 1 key 259.8 (62.9) 288.9 (66.5)
b) 2 key 138.6 (35.1) 153.3 (36.1)
Reaction time tasks : Mean response time in ms
Condition
Condition
Condition
one
two
three
326.2 (107.0)
368.1 (130.0)
461.2 (196.8)
261.9 (30.6)
292.2
369.3
(44.1)
(52.0)
Category-decision task : Mean response time
(N=48 and N —10)
Condition one 602.6 (205.9) 552.9 (175.5)
Condition two 802.7 (287.5) 657.8 (114.3)
Condition three 1094.9 (495.9) 904.3 (337.7)
Attention--switching task : mean response time
(N=50 and N=10)
Condition one 1527.1 (^^1.4) 1514.0 (324.8)
Condition two 1662.8 (382.9) 1579.1 (227.9)
Condition three 5142.6 (l331.9) 4895.6 (932.2)
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Epilepsy subjects vs CTL subjects
The epilepsy and CTL groups were compared across all 
tests in the battery using a between groups ANOVA, with
within-groups factor of condition where relevant.
The means and standard deviations for the combined
intellectual ability score, the motor tasks, the reaction 
time tasks, the category-decision task, and the attention­
switching task are presented in table 8.9a.
In summary, the means of the CTL group were in the 
direction of better performance (i.e shorter response 
times) compared to the clinical group. In the category- 
decision task, for example, the means for the control group 
were 552.9 ms, 657.8 ms, and 904.3 ms, whereas the clinical 
group means were 602.6, 802.7 and 1094.9 ms respectively.
The standard deviations, were generally smaller in the 
control group, for example 175.5, 114.3, 337.7 versus
205.9, 287.5, and 495.9 in the category-decision task.
(Note: The number of errors in both the category- 
decision and the attention-switching task were very low in 
the first two conditions and slightly higher in the third 
condition).
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Table 8.9b : ANOVA of intellectual ability, motor tasks,
SRT, cateqorv-decision and attention-switching tasks for
Epilepsy vs Control comparisons 
Test Two groups : "F" ratio (Df) and
Epilepsy versus CTL significance level
Intellectual Ability 
(Effect of Group)
F = 1.03 (DF = 1/82) P > 0.1
Motor tasks
Effect of Group F = 2.14 (DF = 1/82) P > 0.1
Effect of Condition F = 30.68 (DF = 1/82) P < 0.001
Effect of Keys F = 336.34 (Df = 1/82) P < 0.001
Interactions
Group by Condition F < 1
Group by keys F ■ 1.02 (DF = 1/82) P > 0.1
Group by condition F < 1
by keys
Reaction time tasks
Effect of Group F 33.33 (1,22 ) P > 0.1
Effect of Condition F =f 16.3F (2,144) P < 0.001
Interaction F < 1
(Group by Condition)
Category-decision task
Effect of Group F = 1.74 (DF = 1/55) P > 0.1
Effect of Condition F = 29.39 (DF = 2/110) P < 0.001
Interaction < 1
(Group by Condition)
Attention-switching task
Effect of Group F < 1
Effect of Condition F = 366.89 (DF = 2,111) P < 0.001
Interaction F < 1
(Group by Condition)
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The ANOVA analyses across the tests of intellectual 
ability, the motor task, the simple reaction time tasks, 
the category-decision task and the attention-switching task
are summarised in table 8.9b. The comparisons revealed no 
significant differences between the group with epilepsy and 
control group. There were no significant group by condition 
interactions, revealing no effects of task complexity on 
group performance.
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Table 8.9c Mean scores correct in memory tasks and mean
performance rate of the distractors for the group with
epilepsy vs control group
Test Subject Groups : Means (S.D)
Epilepsy Control
Digit span 10.65 (2.94) 12.00 (2.24)
Trigram task 4.91 (0.85) 5.46 (0.40)
(Combined score)
Visual task 4.29 (0.99) 4.78 (0.95)
(Combined task)
Spatial task 3.33 (0.73) 3.78 (0.69)
(Combined score)
Distractor tasks : rate of performance per second.
Articulations 2.44 (0.91) 2.41 (0.79)
Counting backwards 0.43 (0.18) 0.53 (0.21)
Shapes 0.17 (0.07) 0.19 (0.06)
Tapping 1.97 (0.58) 1.98 (0.37)
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The mean scores and standard deviations for the memory 
tasks were summarised in table 8.9c. The control group 
means were in the direction of better performance on the 
memory tasks. For example, the combined score means on the
three memory tasks for the control groups were 5.46, 4.78 
and 3.78, whereas for the group with epilepsy, the combined 
score means were 4.91, 4.29 and 3.33 respectively. However, 
the standard deviations (S.D.s) were smaller in the control 
group, for example in the same three memory tasks the S.D.s 
for the control group were 0.40, 0.95 and 0.69, whereas for 
the group with epilepsy, the S.D.s were 0.85, 0.99 and 0.73 
respectively.
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Table 8.9d ; ANOVA of the memorv tests and distractor
tasks for the qrouD with epilepsv vs control croup
comparisons
Test "F” ratio (DF) and :significance level
Digit Span F = 1.92 (1,82) P > 0.1
Trigram task
(Group) F = 4 ) 11 (1,82) P < 0.05
Effect of Condition F = 45.15 (4,328) P < 0.001
Interaction F < 1
(Group by condition)
Visual task
(Group) F 2 ) 02 (1,81) P > 0.1
Effect of Condition F 33.58 (3,243) P < 0.001
Interaction F < 1
(Group by Condition)
Spatial task
(Group) F = 2 ) 77 (1,80) P = 0.089
Effect of condition F = 02.47 (3,240) P < 0.001
Interaction F < 1
(Group by Condition)
Distractor tasks
Articulations
Effect of Group F < 1
Effect of test F < 1
Interaction F = 2 ) 10 (2,114) P = 0.077
(group by test)
Counting backwards F = 1.73 (1,82) P > 0.1
Shapes
Effect of F < 1
Effect of test F = 4 ) 38 (2,112) P < 0.05
Interaction F < 1
(Group by test:)
Tapping
Effect of Group F < 1
Effect of Test F = 1.79 (2,112) P > 0.1
Interaction F < 1
(group by test:)
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The data from the memory tasks were analysed using 
ANOVA (see table 8.9d for the "F" ratios, degrees of 
freedom and levels of significance for all the tests). The
memory tasks did produce some interesting findings in the 
direction of poorer performance of the group with epilepsy, 
with the trigram task data being significant at the 0.05 
level (F (1,82) = 4.16, P < 0.045) and the spatial memory 
task revealing a trend (F (1,82) = 2.77, P < 0.09).
There were no significant group by test condition 
interaction on the memory tests, revealing no detrimental 
effect to task complexity on the clinical group.
The performance on the distractor tasks produced no 
differences between the two groups, although there was a 
trend in the group by condition interaction for the 
articulations (F 2,164 = 2.60, P < 0.078)
The effects of conditions were as expected from the 
previous analyses and as such have not been discussed in 
the five groups analyses.
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Table 8,9e Mean scores for the intellectual ability, the
motor tests, SRT, category-decision and attention-switching
tasks for the AGP vs non-ACD comparisons
Subjects : (Means and S.D.)
Test ACD Non-ACD
Intellectual Ability : Mean scaled score
(Combined score) 8.30 (1.92) 8.69 (2.05)
Motor tasks ; Mean No. of taps per 60s
Condition one a) 1 key 300.4 (57.84) 293.1 (53.55)
b) 2 keys 154.9 (33.00) 145.6 (34.58)
Condition two a) 1 key 270.4 (62.67) 251.8 (65.56)
b) 2 keys 144.3 (33.10) 133.9 (38.69)
Reaction time tasks : Mean response time in ms.
Condition one 336.4 (120.4) 289.4 (56.2)
Condition two 377.6 (148.7) 329.0 (64.3)
Condition three 482.2 (226.2) 398.0 (75.2)
Category-decision task : Mean response times
N=37 (ACD) N=21 (Non-ACD)
Condition one 615.6 (208.9) 553.7 (181.3)
Condition two 826.9 (294.4) 687.1 (l72.1)
Condition three 1135.3 (478.9) 924.8 (337.7)
Attention-switching task : Mean response 
N=38 (ACD) N
times
=22 (Non-ACD)
Condition one 1558.4 (384.6) 1443.0 (284.5)
Condition two 1694.8 (391.2) 1557.0 (308.4)
Condition three 5151.1 (1532.6) 5001.9 (l210.1)
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Anticonvulsant Drug versus non-ACD group
The total subject sample was divided into two groups, 
those taking anticonvulsant medication (N=54) and those on 
no medication (N=3 0) . The performance of the two groups on 
each of the tests was analysed using ANOVA, with within 
subject factor of condition where relevant. Again, because 
this analysis was less robust due the differences in sizes 
of the two groups and was not the original design of the 
study, any results must be viewed as tentative.
Tables 8.9e summarises the means and the standard 
deviations of the two groups for the intellectual ability, 
motor, reaction time, category decision and attention 
switching tasks. The picture from this set of means reveals 
no mixed set of mean scores. The ACD group had a higher 
mean scores in the tapping motor task, whereas the non-ACD 
group had faster response times in the reaction times 
tasks, category decision and attention switching tasks.
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Table 8.9f ANOVA for the tests of intellectual ability,
motor. SRT. categorv-decision and attention-switching for
the ACD vs Non-ACD comparisons.
Test GGoups : ACD vs : "F" ratio (Df) and
Non-ACD Significance level
Intellectual ability
Effect of Group F < 1
Motor tasks
Effect of Group F 1.48 (1,82) P > 0.1
Effect of Condition F — 82.91 (1,82) P < 0.001
Effect of Keys F = 788.82 (1,82) P < 0.001
Interaction
Group by Condition F — 1.49 (1,82) P > 0.1
Group by Keys F <
Group by Condition by 
keys
F= 1.70 (1,82) P > 0.1
Reaction time tasks
Effect of Group F 4.98 (1,82) P < 0.05
Effect of Condition F — 40.55 (2,114) P < 0.001
Interaction
(Group by Condition)
F 1.07 (2,164) P > 0.1
Category-decision task 
Effect of Group F 3.21 (1,55) P 0 . 078
Effect of Condition F = 51.70 (2,110) P < 0 . 001
Interaction
(Group by Condition)
F 1.41 (2,110) P > 0 . 1
Attention-switching task 
Effect of Group F < 1
Effect of Condition F = 311.88 (2,111) P ■< 0.001
Interaction
(Group by condition)
F < 1
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Table 8.9f presents the "F" ratios, degrees of freedom 
and significance levels for the motor, reaction time, 
category decision and attention switching tasks. The groups 
were significantly different in the simple reaction time 
task (F 2,82 = 4.98, P < 0.05) in the direction of better 
performance of the Non-ACD group. Also, a trend was 
observed in the category decision task (F (1,55) = 3.21, P 
= 0.0798, in the direction of better performance of the 
Non-ACD group. There were no other group differences. The 
expected condition effects were observed, but there were no 
group by condition interactions, revealing no specific 
effect of test condition on group performance.
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Table 8.9a Mean score correct for the memory tasks for the
ACD ands non-ACD arouo data
Test Subject group : Drug vs Non Drug
Mean, (S.D.)
Group Drug Non-Drug
Digit span 10.98 (2.78) 10.53 (2.95)
Trigram task 
(Combined score)
4.93 (0.88) 5.04 (0.68)
Visual task 
(Combined score)
4.18 (1.12) 4.59 (0.92)
Spatial task 
(Combined score)
3.39 (0.79) 3.53 (0.65)
Distractor tasks 
Articulations 2.50 (0.94) 2.34 (0.63)
Counting backwards 0.42 (0.19) 0.47 (0.19)
Shapes 0.17 (0.06) 0.18 (0.06)
Tapping 2.04 (0.56) 1.89 (0.55)
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Table 8.9g summarises the means for the primary memory 
tasks and the secondary distractor tasks. In the memory 
tasks, the Non-ACD group means are in the direction of
better performance. Hence, in the Non-ACD group the 
combined score means for the three primary memory tests 
were 5.04, 4.59 and 3.53, whereas for the drug group the
means were 4.93, 4.18 and 3.3 9 respectively. The standard
deviations, on the other hand, were smaller for the non­
drug group in these three same tasks.
The means and standard deviations for the distractor 
tasks showed no obvious pattern, with similar means being 
obtained by both groups.
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Table 7.9h ANOVA of the memory task comparisons of the ACD
Test
and non-ACD groups
"F" ratio (Df) and significance level
Digit Span F < l
Trigram task
Effect of Group 
Effect of Condition 
Interaction
(Group by condition)
F < 1
F = 119.60 (2,32)) P < 0.001 
F < l
Visual task
Effect of Group 
Effect of Condition 
Interaction 
(Group by Condition)
F — 2.81 (1,8))
F — 72.23 (35,224))
F = 1,11 (3,24))
P — 0.097 
P < 0.001 
P > 0.1
Spatial task
Effect of Group 
Effect of condition 
Interaction
(Group by Condition)
F < 1
F -■ 17.04 (3,240) P < 0.001
F < 1
Distractor tasks 
Articulations
Effect of Group
Effect of Test 
Interaction 
(group by test:)
F < 1
(2,164) P < 0.05
F < 
F =
1
3.71
Counting backwards F = 1. (5 4 n/fj). P > 0.1
Shapes
Effect of Group F < 1
Effect of Test F < 9.73 (1,11-1) P < 0.001
Interaction F < 1.08 (2,164) P > 0.1
(Group by Test:)
Tapping
Effect of Group F < 1.92 (1,81) P > 0.1
Effect of Test F < 4.81 (1,1S2) P < 0.01
Interaction F < 1
(Group by Test)
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Table 8.9h summarises the "F" ratios, degrees of 
freedom and levels of significance for the primary memory 
tasks and the distractor task analyses. There were few
significant different differences between the groups, with 
only a trend in the visual memory being of interest 
(F(l,80) = 2.81, P = 0,097) in the direction of better 
performance of the non-ACD group.
The effect of condition was again very apparent, but 
there was also only one interaction of group by condition, 
in the articulation distractor task (F = 3.71, Df 2,164, 
and P < 0.027)
In summar^y^, although there were few differences 
between these two groups, those differences found showed 
poorer performance in the ACD group compared to the non-ACD
group
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Appendix Eight 
Details of Lamotrogine
Lamotrogine acts by inhibiting the release of 
excitatory amino acids, particularly glutamate. It does not 
alter the half-life of other ACDs, nor does it stimulate or 
inhibit other drug metabolizing enzymes.
The half-life in healthy volunteers has been shown to 
be in the region of 24 hours and animal studies have shown 
that Lamotrogine is well absorbed being mainly eliminated 
in the urine.
Test Battery: Dundee Study One
1. 2 Sub-tests from WAIS-R
a) Vocabulary test
A list of vocabulary consisting of 35 words of increasing difficulty.
b) Picture completion test
20 individually presented incomplete pictures.
Mean scores are converted to age-scaled scores, based on a mean population score of 10 and a 
standard deviation of 3.
2. Category Decision Task
A pen and paper rapid response timed task, consisting of three conditions, each with 20 trials 
repeated twice.
Condition one: control condition.
Condition two: pressing Yes/No to say whether or not an object is presented on a dark 
background.
Condition three: pressing to show if the object presented is animate.
The trial time to complete the second set of each condition (20 trials) was recorded in seconds.
3. Perceptual Maze Task
The test material was composed of dot patterns super-imposed on a diagonal lattice background. 
The subject was required to join as many dots as specified in the allotted time. The number of 
patterns complete was recorded.
4. Revised Benton Visual Retention Test
The subject was presented with each of 10 simple drawings for 10 seconds, then was asked to 
wait 15 seconds, and they then attempted to draw the shapes from memory. The maximum score 
was 10.
5. Riyermead Behavioural Memory Test (RBMT)
The RBMT (an easy to use battery of memory tests) is designed to detect the impairment of 
everyday memory fimchoning. The raw score provided a profile score, and the profile score was 
converted into a screening score (maximum score 12).
6. Rey Figure
A measure of visuo-spatial abilities. The subject was required to a) copy a complex geometrical 
figure, b) to recall it from immediate memory and c) to recall the figure from delayed memory. 
Hence, there were 3 parts to the test with a maximum possible score of 36 m each part.
7. Memory Questionnaire
The subject was asked to rate the frequency of their memory Lpses on 15 possible everyday 
examples of situations where one might expect them to show memory loss.
Maximum score 15 x 3 = 45.
Test Battery: Glasgow Study
1. 2 Sub-tests from WAIS-R
a) Voca blurry test
A list of vocabluary consisting of 35 words of increasing difficulty.
b) Picture compedon test
20 individually presented incomplete pictures.
Mean scores are converted to age-scaled scores, based on a population mean of ten and a 
standard deviation of three.
2. Finger tapping tasks
a) Tapping one switch with one finger continuously, as fast as possible for 60 s.
b) Tapping bwo switches (placed 17.5 cm ahemately u quickly with the
same finger for 60 s.
The total number of taps in 60 s was recorded.
3. Simple reaction time
Pressing the space bar on a BBC compter as quickly as possible, as soon as an orange cursor 
appeared in the middle of the screen.
The mean response time in milliseconds over 20 trials was recorded.
Note: The simple reaction time tasks were then combined with tapping tasks a) and b) making 
two dual-tasks.
4. Digit span task
The procdure and list of digits are those employed in WAIS-R and involve completing forward 
and backward digit span tasks.
The raw scores obtained were converted to age-scaled scores which have a mean population score 
of ten, and a standard deviation of three.
5. Trigram task
A working memory task requiring the subject to remember three consonants over a 10 s period. 
The task becomes more difficult when the subject is required to complete a secondary task in the 
10 s period, before recalling the consonants.
Varying the secondary tasks resulted in five conditions of the task. The maximum score per 
condition was six, for six correctly recalled consonants.
6. Visual task
A working memory task requiring the subject to remember line-drawn simple shapes over a 10 s 
period. The task becomes more difficult when the subject is required to complete secondary tasks 
in the 10 s period, before recalling the shape. Varying the secondary tasks employed resulted in 
4 conditions of the task.
The maximum score per condition was six, resulting from six correct shapes being recalled.
7. Spatial task
The subject was required to recall the position of three squares positioned randomly on a ten-by- 
ten square grid after a 10 s period.
The task becomes more difficult when the subject is required to complete secondary tasks. There 
were 4 secondary tasks, hence 4 conditions, each with a maximum score of 6.
8. Category-decision task
Objects, that could be categorised as animate/manimate and were coloured red or green, were 
presented on the computer screen. The task consisted of three conditions:
i) Pressmg he YES switch ff hie object was coloured green anid NO f coloured jed.
ii) Pressing YTS f it was animme,, and NO f it was marnmaate.
in) Pressmg he approprhtte switch to whichever question was asked ie. animate/inaramntte
or red/green.
The mean response time in milliseconds per condition (20 trials per condition) was recorded.
9. Attention-switching task
The task consisted of three conditions:
a) Recaallmgat set <ff 3 conornmts ass quickly as pxssiibte afeer a 5 s pericd.
b) I^^r^cinrg aloud a set of 3 rornommits as scon as heey appeared on hie scireem.
c) Altemaimg as c^iiK^il^y as posssibee between commuth o bet recallled. and consonants to 
be read from the screen.
The mean response time in milliseconds over the 10 trials per condition was recorded.
10. Multiple affect adjective check-Iist (MAACL)
Subjects were given a questionnaire assessing their levels of anxiety, depression and hostility at 
the time of testing. It consisted of the following items:
21 anxiety items 
40 depression items
28 hostility items
Studies for a non-clioical population give the following results:
Mean Standard deviation
Anxiety 5.8 3.3
Depression 10.0 5.3
Hostility 6.3-- 3.3
